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ABSTRACT 
In this study, SV5 infection of Balblc mouse fibroblast cells has been used as a 
model system to investigate the possible mechanisms underlying the establishment and 
maintenance of Paramyxovirus persistence. 
It was found that following entry to these cells, the virus initiated a wave of 
transcription and replication, similar to that of a permissive infection, in which normal 
levels of each of the virus proteins were synthesized. However, by 48-72 hours post 
infection (pj.) there was an almost complete cessation of virus mRNA and protein 
synthesis. Despite the decrease in virus activity, full length viral genome RNA and P and 
NP, the proteins involved in transcription and replication, could be detected at consistently 
high levels up to 5 days pj., although the levels ofHN, M, F and V declined. 
Immunofluorescence analysis supported these data showing that at later times pj. 
although there were some cells positive for all the viral proteins, a high proportion of cells 
were strongly positive for NP, L and P, but negative for M, F and HN. In these cells, NP, L 
and P were often located in discrete cytoplasmic foci. These results suggested that the 
persistently infected cell population consisted of some cells in which the virus was active 
and other in which it was quiescent within cytoplasmic inclusions. 
A series of cell lines was established from a monolayer of Balb/c cells that had been 
infected at a high multiplicity. Immunofluorescence studies showed only a minority of 
cells in these clones to be infected with virus, indicating that during division, not all 
daughter cells became infected. Of the infected cells, some were positive for all the viral 
proteins, while others were positive for only NP and P. Co-cultivation of the cloned cells 
with Vero cells, which are permissive for SV5 replication, rapidly yielded non-defective 
virus, suggesting that the virus was active in some cells. These results suggested that the 
persisting virus was in a state of flux, able to reside as inclusions of inactive nucleocapids 
from which it could reactivate to initiate a new round of infection. 
Experiments aiming to determine if the persistently infected cells were resistant to 
immune attack demonstrated that cells at 5 days pj., in which the majority of cells were 
quiescently infected, were less susceptible to immune lysis than cells at I day p.i. in which 
there was ongoing protein synthesis. 
Further experiments were carried out both to try to determine what had induced the 
persistent state in mouse cells and also to examine factors which might induce a similar 
state in different cell lines. 
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CORRIGENDUM 
Since this thesis was written, the International Committee on Taxonomy of Viruses has 
made recommendations for virus identification (the International Committee On Taxonomy of 
Viruses: Virus Taxonomy. The Sixth Report of the International Committee on Taxonomy of 
Viruses, Springer-Verlag, Wein/ New York, 1995). The following nomenclature has been agreed; 
in formal taxonomic usage, the first letters of virus family, subfamily and genus are capitalized and 
the terms are italicized. Species terms are not capitalized (unless they are derived from a place name 
or a host family or genus name) nor italicized; for example: family Paramyxoviridae, genus 
Morbillivirus, measles virus. Having been defined in formal tenns, a virus can be referred to by 
infonnal vernacular terms. In this case, the virus family. subfamily, genus and species names are 
written in lowercase Roman script; they are not capitalized nor italicized. However, ambiguity 
should be avoided by following the taxonomic unit with the name of the taxon; for example: the 
paramyxovirus family. This thesis was written before the above was published and therefore the 
appropriate recommendations have not been followed in all cases. 
INTRODUCTION 
This thesis aims to explore how Paramyxoviruses may be able to persist in vivo. 
Persistence by Paramyxoviruses is a widely acknowledged phenomenon: Paramyxoviruses 
are implicated in a number of chronic diseases and one, measles virus, is known to be the 
aetiologic agent of the disease subacute sclerosing panencephalitis (SSPE). Although it is 
generally accepted that Paramyxoviruses are able to give rise to persistent infections, it is 
unclear how an RNA virus is able to be maintained in a host without being cleared by the 
host's immune system. In the results section of this thesis, evidence is presented which 
suggests a possible model to explain how a virus could persist in the face of the immune 
response, whilst still being able to cause disease. 
As an introduction to the thesis, two subjects are considered. The ftrst section is a 
review of the current literature concerning the molecular biology and replicative cycle of 
Paramyxoviruses. The second section deals with viral persistence. This section covers a 
number of topics, including ways in which persisting viruses may be able to avoid immune 
clearance, factors which are known to influence viral persistence and a review of some 
diseases in which Paramyxoviruses are implicated. 
1 
PART 1: PARAMYXOVIRIDAE CLASSIFICATION, MOLECULAR 
STRUCTURE AND REPLICATION 
1.1 CLASSIFICATION 
The Paramyxoviridae are a family of enveloped, non-segmented, negative stranded 
RNA viruses. They bear resemblances to two other RNA virus families, namely the 
Orthomyxoviridae (eg. influenza A), with whom their envelope glycoproteins share 
common features (Lamb, 1993) and the Rhabdoviridae (eg vesicular stomatitis virus, 
VSV), which have a similar genome organisation and mode of replication (Pringle, 1987). 
Like the Rhabdoviruses, the Paramyxovirus genome acts as a template both for mRNA 
transcripts and for the synthesis of a full length positive stranded RNA species, which acts 
as an intermediate during RNA replication (see figure 1). 
The Paramyxoviridae family is subdivided into two subfamilies, the 
Paramyxovirinae and the Pneumovirinae. The Pneumovirinae contains the genus 
Pneumovirus, and the Paramyxoviruses are divided into three genera, the Parainfluenza 
viruses, the Rubulaviruses and the Morbilliviruses. Examples of viruses found within each 
genus are shown in table 1 (Lamb and Kolakofsky, in press). The Parainfluenza and 
Rubulaviruses are very similar to one another and were previously classified in a single 
genus, Paramyxovirus (Kingsbury et al., 1978). These viruses are differentiated on the 
basis of their cross reactivity with antibodies and on the coding organisation of their P 
genes . The Parainfluenza and Rubula viruses are distinguished from the Morbilliviruses 
on the basis of the biological activity of the attachment protein (Matthews, 1982). The 
Pneumoviruses are quite different from the Paramyxovirinae. Although their gene order is 
similar, these viruses encode a number of additional genes, NS 1, NS2 and M2, and their 
attachment protein is very different both in terms of biological activity and structure. The 
genome structures of the different Paramyxoviridae are shown in figure 2 (Pringle, 1991). 
2 
w 
3' •••••••••••••••••••••••••••• 5' genomic 
-ve sense RNA 
5' AAAAA 3' 5' •••••••••••••••••••••••••••• 3' antigenomic 
+ve sense RNA 
mRNA j 
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Figure 1: A schematic diagram showing the replication strategy of the Paramyxoviridae. 
The genome of these viruses is in the negative sense and has to be transcribed to yield mRNA for protein synthesis. 
The genome of the virus is replicated via a full length positive sense intermediate RNA molecule, known as the antigenome. 
Both the genomic and antigenomic RNAs are encapsidated with a nucleoprotein •• as indicated. 
FAMILY: PARAMYXOVIRIDAE 
Subfamily: Paramyxovirinae 
Genus: Parainjluenzavirus 
Sendai virus (SV) 
Human parainfluenza virus type 1 (hPIV1) 
Human parainfluenza virus type 3 (hPN3) 
Bovine parainfluenza virus type 3 (bPN3) 
Genus: Rubulavirus 
Simian virus type 5 (SV5) 
Simian virus type 41 (SV41) 
Human parainfluenza virus type 2 (hPN2) 
Human parainfluenza virus type 4a and 4b (hPN 4a and hPN 4b) 
Newcastle disease virus (NDV) 
Mumps virus (Mu V) 
Genus: M orbillivirus 
Measles virus (MV) 
Canine distemper virus (COV) 
Phocine distemper virus (PDV) 
Rinderpest virus (RV) 
Peste-des-petits-ruminants virus (PPRV) 
Subfamily: Pneumovirinae 
Genus: Pneumovirus 
Human respiratory syncytial virus (RS virus) 
Bovine respiratory syncytial virus (bRS virus) 
Pneumonia virus of mice (PVM) 
Turkey rhinotracheitis virus (TRTV) 
Table 1: Table showing the organisation of the family Paramyxoviridae. Examples of 
the family members are shown. with the abbreviations by which they are referred to 
throughout this thesis, indicated in parenthesis. 
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Parainfluenza virus- SV 
3' I NP P/CN M F HN L I 5' 
Rubulavirus- SV5 
3'1 NP I VIP I M F IsHi HN L I 5' 
MOIbillivirus- MY 
3' I NP I P/cN M F H L 
Pneumovirus-RS virus 
3'!NS4NS~ NP! P ! M ISH! G I F 22K I L 
Figure 2: A schematic diagram showing the genome organisations of the different genera of 
the Paramyxoviridae. It should be noted that these are examples from each genus and that 
there can be differences between different members of the same genus. 
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1.2 PARAMYXOVIRUS STRUCTURE AND REPLICATIVE CYCLE 
Paramyxovirus particles are pleiomorphic structures comprised of a helical 
nucleocapsid core surrounded by a matrix protein (M) and a lipid envelope through which 
two viral glycoproteins project as spikes (figure 3). The infectious cycle of 
Paramyxoviruses begins with the attachment and fusion of the virion with the host cell 
plasma membrane. This step is mediated by two glycoproteins, the attachment protein 
(HIHN or G) and the fusion protein (F). One interacts specifically with receptors on the 
surface of the host cell and the other fuses with the membrane, thus allowing release of the 
viral nucleocapsid into the cell cytoplasm (reviewed by Choppin and Compans, 1975). It is 
in the cytoplasm of the cell that transcription and replication of the viral genome take 
place. The nucleocapsid is the fundamental unit required for viral transcription and 
replication (Hamaguchi et al., 1983). It is comprised of the viral genome !ightly encased in 
a nucleoprotein (NP). More loosely associated with the nucleocapsid are the polymerase 
proteins, the large protein (L) and the phosphoprotein (P). The NP protein protects the 
viral RNA from nuclease attack and facilitates recognition of the template by the viral 
polymerase. The P and L proteins function together as a polymerase, using the viral 
genome RNN NP complex as a template. 
Following entry to the cell, a round of primary transcription is initiated. When there 
are sufficient levels of nucleoprotein in the cytoplasm in order to encapsidate RNA, 
replication and secondary transcription, from the newly generated genomes, can begin. 
Following their synthesis, the nucleocapsids are transported to the cell surface. The M 
protein is responsible for the alignment of the nucleocapsids with the viral glycoproteins 
which localise in patches in the cell membrane (Yoshida et al., 1976). Once the virus 
particle has been assembled, the structure buds from the surface of the cell and is released. 
Alternatively, the virus can spread by fusion of the infected cell with its neighbour. This 
action results in the formation of syncytia, a common feature of acute viral infection. 
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Matrix (M) 
protein 
Nucleocapsid: 
[Nucleoprotein (NP), associated with Large (L) and Phospho- (P) 
proteins complexed with negative sense RNA genome] 
Haemagglutinin-
neuraminidase (HN) 
protein 
Figure 3: A schematic diagram showing the structure of a Paramyxovirus particle 
Modified from D.Young M.Sc. thesis, 1991 
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1.3 THE PARAMYXOVIRUS GENOME 
The Paramyxovirus genome is approximately 15 kb in length and encodes 6 to 10 
genes, depending on the virus (figure 2; Pringle, 1991). The viral genome is in the negative 
sense, meaning that it cannot be directly utilised as mRNA. Instead, the nucleocapsid 
template is transcribed sequentially to yield capped and polyadenylated mRNA copies of 
each of the viral genes. These are subsequently translated into proteins on host cell 
ribosomes and the glycoproteins are modified by cellular enzymes. Viral replication occurs 
using the same template RNA as for transcription. However, whereas during transcription, 
each gene is copied in isolation (there are exceptions, described below), during replication, 
a copy of the entire genome is made. The fact that the RNA genome can direct the 
synthesis of two different sets of RNA products would suggest that there are a number of 
cis acting signals inherent to the genome which are selectively acknowledged or ignored, 
and that the differential recognition of cis acting sequences by the pol~rase 
distinguishes between transcription and replication. The genomes of a number of 
Paramyxoviruses have now been sequenced (reviewed by Galinski, 1991). Using this 
information, several predictions have been made as to what sequences comprise the 
coding and non-coding regions of the genome. Furthennore, by comparing regions of 
sequence homology and by analogy with other negative stranded viruses, putative 
functions have been assigned to some of the non coding sequence. 
At the 3' and 5' ends of the genome are extracistonic sequences which act as 
templates for positive and negative strand leaders. These sequences are well conserved 
between the Paramyxoviruses (Galinski, 1991) and also between the very 3' and 5' ends of 
the genome; for example, 33 of the first 39 nucleotides are conserved in the positive and 
negative strand leaders of hPIV3 (Galinski et al., 1988). Because of their conservation and 
position on the genome, these regions are suspected to contain signals pertaining to 
polymerase attachment to the template and encapsidation of the nascent strand (Blumberg 
et aI., 1991). 
With the exception of the L gene of RS virus (Collins et al., 1987), each of the 
virus genes lies sequentially on the template. There are distinct gene boundary regions 
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composed of a gene end signal, a non transcribed intergenic region and a gene start signal. 
The gene end and gene start signals comprise the ends and beginnings of the mRNA 
transcripts. These sequences are semi-conserved within the different viruses, suggesting 
that they may have an important regulatory role during transcription (Galinski, 1991). The 
gene end signal contains a run of U residues which are presumably part of the 
polyadenylation signal. Apparently, the polymerase occasionally does not efficiently 
recognise the gene junction sequences, and rather than synthesising a monocistronic RNA 
species, it produces a polycistronic transcript (Collins et al., 1982, Wilde and Morrison, 
1984; Gupta and Kingsbury, 1985; Spriggs and Collins, 1986; Elango et ai, 1988; 
Castaneda and Wong, 1989). 
The level of conservation of the intergenic region is dependent on the virus, in the 
cases of measles virus, Sendai virus and PIV3, the intergenic regions are consistently 
trinucleotides of either GAA, GGG or GCf (Galinski, 1991). In contrast, the other 
Paramyxovirus intergenic regions can vary in sequence and in length, with RS virus 
intergenic sequences ranging from 1 to 52 nucleotides (Collins, 1991). Thus the influences 
of the intergenic regions on the activity of the polymerase complex may vary from virus to 
virus. 
1.4 THE PARAMYXOVIRIDAE ENCODED PROTEINS 
1.4.1 The Attachment Protein 
The attachment protein of the virus can have several functions. It is responsible for 
binding the virus particle to receptors expressed on the surface of host cells and therefore 
is responsible to some extent for the host range specificity of the virus. The attachment 
proteins of some Paramyxoviruses also have a neuraminidase activity which enables newly 
released virus particles to dissociate from the cell membrane and from each other upon exit 
from the cell. In addition, some Paramyxoviruses require the attachment protein in order to 
negotiate cell fusion. 
The different genera of the Paramyxoviridae family possess attachment proteins 
with different enzymatic activities; the Rubula and Parainfluenza virus attachment protein, 
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HN, has both haemagglutinating and neuraminidase activities, the Morbilliviruses have a 
haemagglutination protein, H, with no neuraminidase activity and the Pneumovirus 
attachment protein, G, does not possess haemagglutinating nor neuraminidase activities 
(Choppin and Compans, 1975; Matthews, 1982; Gruber and Levine, 1983). These 
functional differences are reflected in the primary sequences of the proteins. There is poor 
amino acid sequence conservation across the Paramyxoviridae family, although structural 
features are conserved within the different genera. The different attachment proteins of the 
Paramyxoviridae do have one shared feature in that, like the Influenza virus neuraminidase 
protein, they are all type II integral membrane proteins. Thus these proteins are anchored 
to the membrane of the virus and cell via a sequence at their N-termini, and have long C-
terminal ectodomains (reviewed by Morrison, 1988; figure 4). 
The HN protein exists as disulphide linked dimers that fonn either non-covalently 
linked or disulphide linked tetramers (Ng et ai., 1989). The stable formati.on of a tetrameric 
structure is dependent on the transmembrane domain and the cytoplasmic tail of the 
protein (Ng et ai., 1990; Parks and Lamb, 1990; McGinnes et al., 1993). During its 
synthesis, HN interacts with the cellular protein GRP78-BiP. It is thought that this 
interaction allows the protein to attain its correct oligomeric structure prior to export to the 
Golgi network (Ng et ai., 1989). The HN protein is glycosylated by N-linked 
oligosaccharides. In the cases of Sendai virus and mumps virus, glycosylation is necessary 
for virion incorporation (Nakamura et ai., 1982; Herrler and Compans, 1983). In contrast, 
the NOV HN protein does not require glycosylation to be incorporated into virions, but is 
required for virus infectivity (Morrison et ai., 1981). The glycosylation sites are found 
towards the C-terminus of the protein (Morrison, 1988) which suggests that HN consists of 
a globular head containing the regions of enzymatic activity, supported by a stalk -like 
structure which inserts into the plasma membrane (Thompson et al., 1988). 
The three dimensional structure of HN remains to be elucidated and as yet, the 
different functions of the protein have not been assigned to regions of the primary 
sequence. However, a number of studies have compared the structures of the 
Paramyxovirus HN protein with the Influenza neuraminidase (NA) protein. The three 
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Figure 4: A diagram showing the notable features of the attachment proteins of the genera of the Paramyxoviridae. 
The attachment protein of the Rubula and Parainfluenza viruses is similar and is represented here by SV5. 
Modified from Morrison, 1988. 
dimensional structure of the Influenza virus NA protein has been resolved, and the amino 
acids involved in the active site determined (Colman, 1989; Colman et al., 1983). 
Comparison of the sequences of Influenza virus NA and Paramyxovirus HN proteins 
shows that the primary sequences of the proteins can be aligned. This study suggests that a 
number of amino acids known to reside in the active site of the neuraminidase, and which 
contact the substrate sialic acid residue, are conserved in the lIN protein (Colman et al., 
1993). Most of these amino acids are found in four conserved motifs, three of which are 
absent in the H protein of MY, supporting the hypothesis that they are involved in the 
neuraminidase activity of the protein. The motifs are located in different regions along the 
length of the primary sequence and presumably are brought together to form the 
neuraminidase active site in the conformationally mature protein. 
Despite the low levels of sequence similarity, there are elements of the 
Parainfluenza! Rubulavirus and Morbillivirus attachment proteins which are common. 
Like the lIN protein, the measles virus H protein forms disulphide linked dimers and also 
possibly homotetramers. Alignment of sequences of the two genera shows that a number 
of residues potentially important for the three dimensional structure of the protein, ego 
glycine and cysteine residues, are conserved (Morrison and Portner, 1991). Mutation 
analysis of the cysteine residues of MY have shown that a number of these are essential for 
the correct folding and transport of the protein (Hu and Norrby, 1994). Each of these 
structurally important cysteine residues corresponds with an equivalent residue in the HN 
protein, suggesting that the structural frameworks of the proteins are similar. Like HN, the 
H protein is decorated with N-linked glycans. However, whereas in Parainfluenza virus 
and Rubulavirus lIN they are distributed towards the C-terminus of the protein, in the MY 
H protein they are located closer to the N-terminus (Alkhatib and Briedis, 1986). Four of 
the five potential N-linked glycosylation sites in H of measles virus are utilised. It was 
found that removal of individual sites had little effect on the folding, oligomerization or 
biological activity of the molecule, but it is thought that they are collectively required to 
assist the folding of the protein into its native structure (Hu et al., 1994). 
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Although the G protein of the Pneumoviruses is a type II integral membrane 
protein, in all other respects it is quite different to the attachment proteins of the 
Paramyxovirinae. Its primary sequence is significantly shorter than that of the HN and H 
proteins (Wertz et ai., 1985) and no alignments can be made (Morrison and Portner, 1991). 
Furthennore, the glycosylation patterns of the G proteins are different, with evidence that 
this protein is modified by addition of O-linked, as well as N-linked, oligosaccharides 
(Gruber and Levine, 1985; Wertz et ai., 1985). Because of its differences from the other 
Paramyxoviridae attachment proteins, it has been hypothesised that the Pneumovirus G 
protein has a different ancestry to HN and H. Instead, it has been speculated that G is more 
similar in structure to a group of cellular mucinous proteins (Wertz et ai., 1985; Sullender 
and Wertz, 1991). 
1.4.2 The Fusion Protein 
The fusion protein of Paramyxoviruses mediates both the entry of the virus into the 
host cell, and viral spread by cell to cell fusion (Choppin and Compans, 1975). The 
primary sequences of the Paramyxoviridae fusion proteins are similar and there are several 
structural features which are conserved throughout the family (Morrison, 1988; Morrison 
and Portner, 1991). An example of a Paramyxovirus fusion protein is shown in figure 5. 
The fusion proteins are synthesised as a precursor polypeptide, FO (Scheid and Choppin, 
1974). This polypeptide has a membrane anchor domain at its C-terminus and an N-
terminal signal sequence domain, which is cleaved following synthesis. In addition, there 
is a third hydrophobic domain located in the N-terminal portion of the polypeptide and 
lying immediately following a basic peptide cleavage site (paterson et ai., 1985; Spriggs et 
ai., 1986; Kawano et ai., 1990; Bando et ai., 1991). An essential step in the maturation of 
the fusion protein is cleavage at this site, usually by cellular proteases located in the Golgi 
apparatus, to produce a heterodimer composed of the peptides F 1 and F2 linked by a 
disulphide bond (Schied and Choppin, 1977; Hsu et ai., 1981). The cleavage process 
exposes the hydrophobic fusion sequence and is prerequisite for the fusion protein to be 
biologically active. It is thought that by maintaining the fusion sequence at an internal 
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Figure S: A diagram showing the structure of the fusion protein of SV5 
location until a late stage in the protein's synthesis, it is prevented from acting as a stop 
transfer signal during translocation of the FO peptide across the membrane of the 
endoplasmic reticulum. This mode of maturation thus allows the fusion domain to 
ultimately be expressed, externally to the cell (Paterson and Lamb, 1987). 
Immediately adjacent to the fusion sequence, is an amphipathic alpha helix motif 
(Chambers et al., 1990). This domain is thought to be important in either folding or 
transport of the protein to the trans golgi (Wang et aI., 1992). The arrangement of a 
hydrophobic domain followed by a heptad repeat sequence is a feature common to other 
viruses and may represent a structure vital to the mechanism of viral fusion. In addition, 
there is a second amphipathic alpha helix located at the C-terminal end of Fl. This domain 
has also been shown to be critical for measles virus fusion (Buckland et al., 1992). 
In addition to the domains that are described above, the fusion proteins contain a 
number of conserved cysteine residues. As previously mentioned, the mature fusion 
protein comprises of a heterodimer linked by disulphide bonds. Therefore, at least one 
cysteine in each subunit of F must contribute to disulphide bond formation. There are a 
number of cysteine residues clustered together on the FI peptide (Morrison, 1988). The 
conservation of these residues suggests that the protein might be folded by intramolecular 
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bonds. Like th~attachment proteins, F is glycosylated by N-linked oligosaccharides 
(Morrison and Simpson, 1980; Herrler and Compans, 1983). The finding that 
unglycosylated F is only cleaved inefficiently, suggests that the sugar additions may 
maintain the precursor polypeptide in the correct confonnation to expose the cleavage 
peptide (Collins and Mottet, 1991). 
1.4.3 Small Hydrophobic Protein 
The Pneumoviruses, mumps virus and SV5 each encode a third integral membrane 
protein, called the small hydrophobic (SH) protein, from a gene which lies between F and 
HN on the viral genome of SV5 and mumps virus (Hiebert et 01., 1985; Elango et 01., 
1989) and M and G of RS virus (Collins et 01., 1986; Olmstead and Collins, 1989). The 
predicted amino acid sequence of the SV5 SH protein suggests that it is comprised of 44 
amino acids and consists of two domains; an N-terminal hydrophilic domain and a slightly 
longer C-tenninal hydrophobic domain. The hydrophobic domain of the protein spans the 
plasma membrane such that the hydrophilic domain lies in the cytosol and a short region of 
5 amino acids protrudes extracellularly. The protein has been found to co-localise with HN 
in infected cells but is not detected in virions, suggesting that it is selectively excluded 
from the membrane of the budding virus particle (Hiebert et 01., 1988). 
The function of the SH protein is not yet known. It has been found that the RS 
virus SH protein can enhance the fusion properties exhibited by F and G, or F alone. 
However, the same study established that no such role exists for the SV5 SH protein 
(Hemin way et 01., 1994). 
1.4.4 Matrix Protein 
In the virus particle, the matrix protein lies between the glycoprotein containing 
envelope and the nucleocapsid. In the infected cell, it is thought to act as the orchestrator 
of virus maturation, by acting as a bridge between the viral glycoprotein containing plasma 
membrane and the newly synthesised viral nucleocapsids (Yoshida et 01., 1976). It is 
known that the matrix protein is essential for viral release, as the absence of functional M 
15 
leads to an accumulation of nucleocapsids within the cell (Wechsler and Fields, 1978; Hall 
et al., 1979). The primary sequences of the Morbilli, Parainfluenza and Rubulavirus matrix 
proteins are similar, but there are no obvious structural features of note. In each case it is a 
basic protein, with a number of paired basic residues. It is hydrophobic in nature, but does 
not have any hydrophobic stretches long enough to traverse a membrane (reviewed by 
Peeples, 1991). It is thought that its hydrophobic character allows it to associate with 
membranes and that its positively charged residues facilitate binding to the negatively 
charged nucleocapsid (Morrison, 1988; Sheshberadaran and Lamb, 1990). M protein is 
also able to bind to itself, to give rise to a paracrystalline sheet structure and is reported to 
bind to actin (Giuffre et al., 1982; Morrison and McGinnes, 1985; Bohn et al., 1986). This 
interaction may be important for virus budding. 
1.4.5 Nucleoprotein 
The nucleoprotein is the most abundant protein in the viral nucleocapsid (Lamb et 
01., 1976). This protein is responsible for the characteristic helical structure of 
nucleocapsids (Spehner et al., 1991; Das and Banerjee, 1993; Fooks et al., 1993) and 
protects the viral genome from nuclease attack (Banerjee, 1987). In addition to protecting 
the viral RNA, the NP enables the genome to act as a template (Kingsbury, 1974), 
probably by acting as a foundation on which the polymerase complex can attach and 
possibly by ironing out the secondary structure of the RNA which might otherwise hinder 
the progress of the polymerase along the RNA template. The nucleoprotein also has a role 
in viral assembly as it is this component of the nucleocapsid which contacts the matrix 
protein (Markwell and Fox, 1980). 
In the infected cell, NP exists in two fundamental forms; either in the context of the 
viral nucleocapsid or as a soluble unit During replication, the soluble units of NP are 
presumably recruited to the polymerase complex and, together with the newly synthesised 
RNA, incorporated into a growing nucleocapsid. Several studies in which NP has been 
expressed in cells, independently of the virus, have found that is able to self assemble into 
nucleocapsid like particles. This finding suggests that it is the interaction of NP molecules 
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with one another which gives rise to the nucleocapsid morphology (Blumberg et ai., 1983; 
Spehner et aI., 1991; Buchholz et ai., 1993; Fooks et ai., 1993). In some cases, the density 
of these nucleocapsids was found to be the same as of nucleocapsids derived from virally 
infected cells (Blumberg et ai., 1983; Spehner et aI., 1991; Buchholz et ai., 1993). From 
this finding, the investigators suggested that. in the absence of other viral components, the 
NP non-specifically uses cellular RNA as a basis upon which to build the nucleocapsid 
structure. Deletion analysis has shown that the N-terminal three quarters of NP is sufficient 
and necessary for nucleocapsid assembly, suggesting that this region holds domains for 
NP-NP and possibly NP-RNA interactions (Buchholz et aI., 1993). In the case of Sendai 
virus, this region is composed of two domains. The N-terminal domain is enriched in 
positively charged residues which may interact with the negative charges of the 
phosphodiester backbone of the viral RNA (Morgan et al., 1984). The second domain is in 
the central region of the protein, and involves a sequence that is highly conserved between 
the Paramyxoviruses (figure 6; Parks et al., 1992). This domain is hydrophobic and it has 
been suggested that it may promote NP-NP interactions during nucleocapsid assembly 
(Morgan et ai., 1984). During viral replication, soluble NP has to be sequestered to the site 
of nucleocapsid assembly. There is evidence to suggest that it is the P protein which guides 
the NP to the polymerase complex (Horikami et aI., 1992; Buchholz et ai, 1993; Curran et 
ai, 1993). Deletions in the N-terminal three-quarters of the Sendai virus NP protein 
abolishes P binding (Homann et al., 1991). Possibly there is a binding site for P in this 
region which overlaps with the regions responsible for NP-NP and NP-RNA interactions. 
It may be that P binding to this site prevents self assembly of NP until a further interaction 
with the polymerase releases the P protein, allowing the NP to specifically assemble the 
nascent RNA. 
Although the N-terminus of NP carries sufficient structural information to mediate 
nucleocapsid assembly, the reaction carried out by this portion of the protein is non-
specific. In vitro Sendai virus replication systems have shown that NP lacking the C-
terminal 124 amino acids forms nucleocapsid structures more readily in the absence of 
virus replication, than full length NP protein (Buchholz et al., 1993). This evidence 
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suggests that the specificity of encapsidation is dependent, in part, on the C-terminal 
quarter of NP. 
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a region necessary for nucleocapsid assembly 
Figure 6: A schematic diagram of the nucleoprotein of Sendai virus, with regions 
that are conserved between the Paramyxoviruses shown. 
The C-terminus of NP has also been attributed with other functions. It has been 
found that when antibodies against NP are reacted with nucleocapsids, most antibodies 
bind to the C-terminus of NP, suggesting that this region is exposed at the surface of the 
nucleocapsid and is not directly involved within the nucleocapsid structure (Ryan et al., 
1993). In keeping with its proposed location, the C-terminal tail of NP seems to be 
responsible for a number of processes involved in coordinating viral replication. The 
encapsidation property of NP is distinct from its ability to enable the RNA to act as a 
template. In addition to conferring the specificity of encapsidation, it has been found that 
the C-terminus of NP is also required for the nucleocapsid to function as a template for the 
viral polymerase. A block of negatively charged residues, proximal to the C-terminal end 
of NP are well conserved throughout the Paramyxoviruses (Parks et ai., 1992). It has been 
found that this region is absolutely required for the nucleocapsid to serve as a template for 
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mUltiple rounds of genome synthesis (Curran et a/., 1993). Possibly this site provides a 
transient anchorage for the viral polymerase as it moves along the template. 
As well as having a role in genome replication, the NP protein is the nucleocapsid 
constituent that is suspected to bind to the M protein, thus enabling the assembly of newly 
fonned nucleocapsids into viral particles (Markwell and Fox, 1980). The sites on NP 
which are responsible for such interactions have not been characterised, but given that M is 
positively charged, it has been speculated that the block of negatively charged residues 
described above, might be involved in this interaction (Parks et a/., 1992). 
1.4.6 The L Protein 
Due to its large size and low abundance within the viral particle and the infected 
cell, the catalytic functions required for RNA synthesis have been attributed to L. 
Biochemical and genetic studies of the VSV L protein confmns that poly~denylation, 
capping and methyltransferase activities are all associated with this protein (Abraham et 
a/., 1975; Hunt et a/., 1984; Hercyk et a/., 1988). Sequence alignment of the L proteins of 
several Rhabdoviruses and Paramyxoviruses has identified six conserved regions. It has 
been suggested that the protein is made up of several distinct domains, each responsible for 
the different functions involved in RNA transcription and replication (Poch et a/., 1990; 
Parks et al., 1992). The active site for phosphodiester bond formation and/or template 
recognition has been suggested to lie within region m. The basis for this hypothesis is the 
similarity between the conserved motifs found in this region, QGDNQ, and the GDD motif 
found in RNA dependent RNA polymerases of a variety of viruses (poch et ai., 1989; Poch 
et a/., 1990; Sleat and Banerjee, 1993). In agreement with this suggestion, it has been 
reported that in the case of Sendai virus L protein, any change to this consensus 
pentapeptide motif ablates polymerase activity, whereas changes outside this region, did 
not affect replicative activity (Graef et ai., 1994). 
In addition to its polymerase activity, the presence ofL leads to a higher level of 
phosphorylation of P (Einberger et ai., 1990). In the case of VSV, phosphorylation of P by 
the L kinase is necessary for the transcriptional activity of the complex. In the 
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Paramyxovirus~s, a kinase site was proposed to reside at region VI, as this site resembles 
an A TP binding motif (poch et al., 1990). However, in the case of Sendai virus, it has been 
found that although the presence of L is required to phosphorylate P, region VI can be 
deleted without abolishing kinase activity. This finding suggests that, either there is an 
alternative, previously unacknowledged, kinase motif in the Paramyxovirus L proteins or 
that L is an essential co-factor for a cellular kinase (Graef et al., 1994). 
1.4.7 The Phosphoprotein 
Although L has been assigned the catalytic properties necessary for transcription 
and replication, the phosphoprotein, P, is absolutely required for the polymerase to be 
functional (Curran et al., 1991). Surprisingly, given its pivotal role, the P proteins of the 
Paramyxoviruses are each quite different, with no obvious regions of conservation. This 
may be because the protein acts in a structural capacity; P seems to act as a mediator 
between the different components of the polymerase complex as it has been shown to bind 
to both NP and L (Ryan and Kingsbury, 1988; Ryan and Portner, 1990; Horikami et al., 
1992; Parks, 1994; Smallwood et al., 1994). The binding sites for L and NP have been 
mapped by deletion mutation analysis and have been found to lie in the C-terminal region 
of the Sendai virus P protein (see figure 7). Two noncontiguous regions within P enable it 
to bind both to soluble NP, and to the viral nucleocapsid (Ryan and Kingsbury, 1988; Ryan 
and Portner, 1990; Homann et al., 1991). A single smaller region lying between the NP 
binding domains allows binding with L (Curran et al., 1994; Smallwood et al., 1994). P 
seems to be able to confer encapsidation specificity on NP. Co-expression of NP with P 
maintains the solubility of NP, presumably the P protein maintains NP in a soluble state 
until it contacts the nascent RNA being synthesised by the RNA polymerase (Horikami et 
al., 1992; Buchholz et aI., 1993). Thus the P protein seems to act as an escort for the NP, 
bringing it into juxtaposition for encapsidation. Also, as P interacts with NP within the 
nucleocapsid structure (Ryan and Portner, 1990), it may be the component of the 
polymerase which attaches to the nucleocapsid template (Figure 8). 
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Figure 7: A figure showing the characterised domains of the P and V proteins of Sendai virus. 
Region a is necessary for RNA synthesis activity of the polymerase. P and V are amino co-terminal 
proteins, the residues common to both are the bracketed regions, marked b. 
P/NP 
complex 
newly synthesized RNA 
encapsidated in NP 
NP/RNA template 
Figure 8::A schematic diagram showing the possible interactions of P with L and NP 
In this scheme, one P or group of P molecules binds to L and anchors the polymerase to the 
template. Another P, or group of P molecules binds to free NP. It has been suggested that the P/NP 
complex then interacts with the nascent strand of RNA and that following delivery of the NP to 
encapsidate the RNA, the P protein is released. 
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Althou&h the C-tenninus of P is the region of the protein responsible for binding to 
NP and L. the N-terminal region of the protein is also important. Deletion of the N-
terminal 77 amino acids of Sendai virus P yields a protein which is able to participate in 
transcription. but is incompetent for replication. Although this part of the protein does not 
bind in a stable manner to NP, it appears that these residues are essential for genome 
encapsidation (Curran et al., 1994). The N-terminal region of P has another interesting 
property. either residues 1-77 or residues 78-145 are required for RNA synthesis, however, 
these regions appear to be able to substitute for each other to restore wild type like activity. 
Strangely. the middle region of P serves no obvious function, although this is the most 
highly phosphorylated part of the protein (Vidal et al., 1988). Possibly this region has a 
more subtle role in coordinating virus transcription and replication. 
1.4.8 V Protein 
Due to a frameshifting event which sometimes occurs during transcription, the P 
genes of most Paramyxoviruses are able to specify two different mRNA molecules. The 
two mRNAs code for proteins, P and V, which are amino co-terminal but which differ in 
their C-tenninal sequences (Thomas et al., 1988; Cattaneo et al., 1989a; Paterson and 
Lamb, 1990; Southern et al., 1990; Vidal et ai., 1990a; Samson et ai., 1991; Kawano et ai., 
1993; figure 7). Interestingly, despite the very weak levels of conservation between the P 
proteins of the Paramyxoviruses, the C-terminal regions of the V proteins, encoded by the 
same nucleotides, are well conserved, with an abundance of cysteine residues being the 
most striking feature. The necessity for V during viral infection is in dispute. The fact that 
the protein shares sequences with P, and is highly conserved, suggests that V may have an 
important role in transcription and/or replication. However, in disagreement with this 
conjecture. is the finding that hPIV 1 does not code for a V protein, showing that for this 
virus, V is not an essential element (Matsuoka et ai., 1991). It may be that V fulfills a 
"luxury" role during a viral infection, possibly by enabling an additional level of control 
over replication and transcription. Evidence in support of this notion comes from 
replication and transcription assays which show that V inhibits genome replication in a 
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dose dependenrfashion but does not affect transcription (Curran et aI., 1991; 1994). 
During a viral infection, the effect of high concentrations of V could be to promote 
transcription over replication. That V might fulfIll some role during viral infection is 
possibly demonstrated by the characteristics of hPIVl infection. This virus only replicates 
to low levels and infected cells show no obvious cytopathic effects (Matsuoka et aI., 
1991). It may be that the restricted nature of infection is due to a lack of coordination of 
the relative levels of transcription and replication. 
1.4.9 C Proteins 
In addition to being able to code for two different mRNA molecules, the P gene of 
some viruses can yield several other proteins by the use of alternative initiation sites in an 
overlapping reading frame. These are known as the C proteins and are found during 
infection with Sendai virus, HPIV3, MV and COV (Dethlefsen and Kolakofsky, 1983; 
Barrett et al., 1985; Bellini et al., 1985; Spriggs and Collins, 1986). The Sendai virus C 
proteins are the best characterised. In this virus, the C open reading frame lies at the N-
terminal region, in the + 1 frame, relative to P. From this reading frame, four different 
proteins are expressed, each from a different start codon (reviewed by Kolakofsky et al., 
1991). An interesting property of these proteins, which suggests a possible role during 
infection, is that they have a strong inhibitory effect on transcription, with little effect on 
genome replication (Curran et al., 1992). The mechanism for repressing transcription has 
not been elucidated, although it is known that inhibition depends on a region lying near the 
N-terminus of the C protein chain and on co-expression with P and L. There are apparently 
no C proteins synthesised during infection with the Rubulaviruses, implying that for these 
viruses they are not essential. Similarly to V, this group of proteins may serve a "luxury" 
function to refine control over transcription and replication. 
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1.5 THE PARAMYXOVIRUS REPLICATION CYCLE 
1.5.1 Virus Entry 
The initial stage in viral entry is the attachment of the virus particle to a specific 
receptor molecule on the surface of the host cell. This interaction is mediated by the 
attachment protein of the virus. Different receptors are used by different viruses. In the 
case of the parainfluenza viruses, mumps virus, NOV and RS virus, the receptors are 
molecules containing sialic acid residues. This has been demonstrated by experiments in 
which neuraminidase treatment renders normally susceptible cells resistant to virus 
infection (Markwell, 1991). The receptor for Sendai virus is the best characterised and has 
been shown to be a ganglioside molecule (Markwell et al., 1981). Infections with the 
Morbilliviruses are not affected by prior treatment with neuraminidase (Howe and Lee, 
1972), demonstrating that these viruses interact with a different surface receptor. The 
receptor for measles virus has recently been identified as CD46 (Dorig et aI., 1993; 
Naniche et al., 1993). This protein is involved in regulation of complement activation and 
is widely distributed throughout human tissue (Dorig et aI., 1993). 
Following attachment to the receptor molecule, the viral membrane fuses with the 
cellular membrane to release the viral nucleocapsid into the cell. An alternative means for 
viral nucleocapsids to enter cells, is by fusion of an infected cell with its neighbour. As yet 
the fusion process is poorly understood. It takes place at neutral pH and begins with the 
formation of a 2nm wide pore, which dilates as fusion progresses (Spruce et al., 1991). 
There has been some controversy as to the viral components that are necessary for fusion; 
some viruses need the attachment protein, in addition to F, for cell fusion to occur. The 
differing requirements for fusion presumably reflect slightly different mechanisms for the 
process in different viruses, however, for each of the viruses examined, it has been found 
that the presence of the attachment protein enhances the fusion process (reviewed by 
Lamb, 1993). 
To some extent, the role of the attachment protein can be attributed to the binding 
of the protein to its receptor, thus bringing the fusion protein into close proximity to the 
cellular membrane. This has been demonstrated in the case of Sendai virus, in which it was 
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found that reconstituted virus envelopes fuse with erythrocytes in the presence of wheat 
germ agglutinin (Hsu et al., 1979). However, this is not always the case. The F protein of 
bPN3, hPIV3 and NDV can only induce fusion if co-expressed with HN (Sakai and 
Shibuta. 1989; Ebata et al., 1991; Morrison et al., 1991) suggesting a more specific 
association between the two proteins. Furthermore, Hu et aI. (1992) have found that the 
homologous HN is required rather than HN from related viruses. One possible explanation 
for the need for homologous F and HN/H proteins is that the F protein needs to be 
precisely positioned in order to interact with the cellular membrane to induce fusion, and 
that only the homotypic HN interacting with its cellular receptor will be able to achieve the 
correct bridging distance. 
The interaction of the attachment protein with its receptor may also be required to 
activate the fusion protein. Lamb (1993) has hypothesised that F proteins undergo a 
conformational change at the correct time and place in order to mediate fvsion. It is 
possible that in the cases of viruses for which HN is absolutely required for fusion, binding 
of lIN with the sialic acid receptor initiates a specific interaction of lIN with F causing a 
conformational change in F and subsequently positioning the fusion domain in the correct 
configuration for interaction with the plasma membrane. In the less stringent viruses, 
possibly a less specific interaction of the fusion protein with the cell plasma membrane 
triggers the prerequisite conformational change. 
1.5.2 Adaptation of the nucleocapsid for transcriptional activity 
Having fused with the cell membrane, the viral nucleocapsids are released into the 
cytosol of the cell, the site of virus transcription and replication. Prior to transcription, the 
nucleocapsid has to be depleted of the surrounding matrix protein. In the case of 
Paramyxoviruses. this process takes place at neutral pH and may be linked to viral fusion 
(Zhirnov, 1990). In addition, having entered the cell, the P protein on the nucleocapsid 
changes from a random distribution to discrete clusters, often co-Iocalising with L. 
suggesting a transition from a quiescent state to a transcriptionally active complex (portner 
and Murti, 1986; Portner et ai., 1988). The components of the transcriptase/replicase 
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complexes are !lot characterised, but consist of at least the NP/RNA complex and the P and 
L proteins. Host cell factors are thought to playa role during transcription, as demonstrated 
by the necessity for the presence of uninfected cell extract during in vitro transcription 
reactions (Moyer et ai, 1986; 1990; De et aI., 1991; Barik, 1992). In the case of measles 
virus and Sendai virus, the critical cellular component was found to be tubulin (Moyer et 
al., 1986; 1990), whereas PIV3 transcription is dependent on actin (De et al., 1991). De 
and coworkers (1993) have suggested that actin polymerisation concomitantly induces a 
confonnational change of the PIV3 viral nucleocapsid, and that the change of the 
nucleocapsids from a loosely coiled to a condensed arrangement is necessary for 
transcriptional activation. 
1.5.3 Virus Transcription 
As previously described, virus transcription involves synthesis of individual copies 
of each of the viral genes. It is suspected that there are cis acting signals which direct the 
viral polymerase to attach to the template genome and then to copy each viral gene, . 
generating a capped and polyadenylated mRNA transcript. It has been found that the 
relative levels of each of the mRNA transcripts reflects their order in the genome, with a 
decrease in abundance from the 3' to the 5' ends of the template. Hence the NP proteins are 
the most abundant and the L proteins the least so (Glazier et al., 1977). The level ofL 
mRNA synthesised during RS virus infection, is even more heavily curtailed, as this gene 
overlaps with the gene for the M2 protein and does not have its own independent start site 
(Collins et al., 1987). Because of the attenuated gradient of mRNA species synthesised, the 
currently favoured model for transcription is that the viral polymerase initiates 
transcription at a single promoter site, at or near the 3' end of the genome (Galinski, 1991). 
From here it sequentially synthesises the leader and each of the viral mRNAs. At each of 
the gene junctions, the polymerase is thought to pause, possibly during polyadenylation 
and/or capping (Iverson and Rose, 1981) at which points the polymerase complex may 
disengage from the template. If the polymerase is only able to reinitiate at the extreme 3' 
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end of the genome, this would lead to an attenuation of transcription throughout the length 
of the genome. 
The single promoter theory is not yet proven and there has been some data which 
throws it into some doubt. One piece of evidence to suggest that there might be more than 
one promoter is that, during infection with the virus SV41, the M gene can never be 
detected as a monocistronic transcript but rather is always bicistronic with F. However, the 
F gene is also transcribed as a monocistron (Tsurodome et aI., 1991). There are several 
possible explanations for this phenomenon. There could be an internal start site for the 
polymerase at the beginning of the F gene which allows this gene to be transcribed 
independently of M transcription. Alternatively, the polymerase might occasionally read 
through the M gene without synthesising an mRNA transcript, but reinitiating RNA 
synthesis at the start of the F gene. Finally, it is possible that a monocistronic M gene 
transcript is synthesised, but is extremely unstable and so cannot be detec.ted. If the single 
promoter theory is correct, then it is difficult to envisage that there could be any temporal 
control of gene expression. Instead, it would appear that the only factors which could 
influence gene expression, are the position of the gene on the template and its 
neighbouring cis-acting signals. 
The P genes of most of the Paramyxovirinae (with the exception of hPIV1) are 
prone to an editing event during mRNA synthesis, enabling them to increase their coding 
potential. In this event, the polymerase does not directly transcribe the templated sequence 
but instead inserts either one or two additional a residues, hence accessing a second 
reading frame. Thus from one gene, two different mRNAs are transcribed, yielding the 
proteins P and V. These proteins initiate from the same AUa codon and share their amino 
terminal sequences, but have different C-terminal amino acid sequences following the a 
insertion site (the structures of the P and V proteins are described in sections 1.4.7 and 
1.4.8). The manner in which these two proteins are encoded varies, depending on the virus. 
The Rubulaviruses all carry the V RNA sequence within their genome. These viruses 
access the second reading frame by the addition of two nontemplated a residues and in 
doing so produce P. In contrast, PIV1, MV, PIV3 and SV genomes code for the P specific 
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mRNA and the.J.atter three of these viruses access the V open reading frame by the 
addition of one non-templated G residue (reviewed by Jacques and Kolakofsky, 1991). 
These mRNA editing events are carried out co-transcriptionally by the viral 
polymerase complex, and do not occur during replication, or if the template ,is copied by 
other transcriptases such as reverse transcriptase (Vidal et al., 1990a). The insertion event 
is thought to occur by a stuttering mechanism, similar to the mechanism used to 
polyadenylate mRNA transcripts (Vidal et al., 1990b). Although the polymerase does not 
consistently add the correct number of residues, the frequency with which the requisite 
number of residues is added is high, and the number of added residues is significantly 
lower than during polyadenylation. A model to explain the stuttering event has been 
proposed by Vidal and coworkers (1990b) who suggest that the number of inserted 
residues is dependent on the preceding sequence. For the viruses in which two G residues 
are insertecL the editing site on the template sequence is 3'UUCUCCC5' one base insertion 
would lead to an unstable A:C pair, so the polymerase slips another base and inserts two 
residues. In the MV/SV group of viruses, the editing site is 3'UUUUCCC5'. In this case a 
one base slippage is more stable than two, and so will occur more frequently. 
1.5.4 Genome Replication 
One of the peculiarities of Paramyxovirus transcription is that, the polymerase does 
not synthesise copies of the intergenic regions. Rather, it is proposed that the polymerase 
remains associated with the genome template but disengages from the nascent RNA strand 
at the gene end sites and reinitiates synthesis at the gene start sites. During genome 
replication, the copying strategy of the polymerase is quite different. Now the polymerase 
complex is required to initiate at the 3' end and to synthesise an entire complement of the 
genome, ignoring the gene junction signals. Because polymerase activity has only been 
ascribed to one of the Paramyxovirus proteins, L, it is thought that this protein is 
responsible for both transcription and replication, but that the transcriptase and replicase 
functions of L are modulated by the presence or absence of other viral proteins. 
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The mechanism distinguishing between replication and transcription is probably 
dependent on the fact that neither the genome or the anti genomic RNA are found as naked 
RNA molecules. Instead they are associated with NP (portner et ai., 1982; Carlsen et ai., 
1985). It is thought that the encapsidation process occurs concurrently with replication and 
that possibly the binding of the NP protein with the nascent RNA causes the polymerase to 
ignore the cis acting signals which would nonnally be acknowledged during transcription 
(Kolakofsky et aI., 1991). In vitro studies have shown that for replication of a defective 
interfering genome to occur, P-L and NP-P complexes are required (Horikami et ai., 
1992). The complexes only form if the respective genes are co-expressed in the same cells, 
implying that the protein-protein interactions either take place co-translationally, or very 
soon following translation (Horikami et ai., 1992; Parks, 1994). The necessity for 
complexes of NP-P and L-P suggests a replication model for the Paramyxoviruses 
(previously shown in figure 8). In this model, the moveable polymerase L-P, is anchored to 
the template (RNA + NP) via P. This complex is able to mediate the synthesis of RNA. 
However, for replication to occur, the nascent RNA has to be encapsidated with soluble 
NP.IfL has a second binding site for P, then this would enable NP-P complexes to be 
brought into the complex, allowing interaction of NP with the newly synthesised RNA. As 
the newly synthesized RNA is wrapped up with NP, the gene-end signals which signal 
polyadenylation and the cessation of RNA synthesis, may become obscured (Curran et ai., 
1991). 
Although the RNA, NP, P and L seem to be fundamental components of the 
polymerase complex, other proteins may also be involved. The V and C proteins seem to 
be able to interfere with replication and transcription respectively, but how these proteins 
exert their effects is not known. However, given that V has the same N-terminus as P, 
postulated in P to be a transactivator region, it may be that V interferes specifically with 
the encapsidation function of P (Curran et ai., 1994). Cellular proteins may also be 
involved during replication. It has been found that if VSV NP was expressed in E. coli, it 
was able to self assemble into nucleocapsid like structures in vitro (Das and BaneIjee, 
1993). However, this process was enhanced in the presence of uninfected cell extract, 
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suggesting the possibility that cellular proteins, such as chaperones, may assist the folding 
of NP during encapsidation in vivo. Cellular proteins have also been shown to associate 
with the extracistronic sequences on the measles virus genome and are potentially involved 
in genome replication (Leopardi et ai., 1993). 
1.5.5 Virus Maturation and Release 
Once a nucleocapsid has been synthesised. it is transported to the plasma 
membrane and assembled into a viral particle. Because of its ability to bind to the 
nucleocapsid and to membranes, it is the M protein which has been assigned the role of 
assembly organiser (reviewed by Peeples, 1991). A hypothetical model of the 
stoichiometry of the interactions of the different virus components has been suggested. In 
this model, dimers of F and dimers of the HN glycoproteins interact with the M protein 
which in turn interacts with a turn of the nucleocapsid in a 1: 1: 1 relationship (Peeples, 
1991). The conventional model of viral assembly is that the M protein interacts with viral 
glycoprotein containing cell membranes. The M/glycoprotein complexes migrate in the 
plane of the membrane until the attached M protein meets and interacts with another M 
protein. This process continues until the viral membrane proteins accumulate into a patch 
which can bud from the cell. Concurrent with this process is the association of viral 
nucleocapsids with the M protein on the cytoplasmic side of the plasma membrane, thus 
when the plasma membrane pinches away from the cell, it carries with it a viral 
nucleocapsid. Recent studies have revealed data which challenge the notion of the plasma 
membrane being the site of virus assembly. Sanderson et ai. (1993), have shown that 
Sendai virus matrix protein is able to associate with perinuclear Golgi like membranes. 
Furthennore, these authors found that the localisation of M corresponded with the 
distribution of the glycoproteins along the exocytic pathway, suggesting that following 
synthesis in the cytoplasm, M binds specifically to viral glycoprotein containing 
membranes and in this way is transported to the plasma membrane (Sanderson et ai., 1993; 
Sanderson et ai., 1994). In a different study, it was found that M protein could only 
migrate to the plasma membrane when bound to viral nucleocapsids (Stricker et ai., 1994). 
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Taken together these results suggest that possibly, the components of the virion particle 
convene together on intracytoplasmic membranes such as those of the Golgi. They are then 
transported "piggy back" style to the plasma membrane, by the normal exocytic pathway 
of the cell. 
Having arrived at the plasma membrane, the progeny virions bud from the cell. The 
driving force behind the budding process is not known. As previously mentioned, the M 
protein is able to bind to actin. Bohn et al. (1986) showed by electron microscopy that the 
growing end of an actin fIlament protruded into the virus particle. Possibly virus particle 
formation involves migration of nucleocapsidlMlglycoprotein complexes in the plasma 
membrane, until they become anchored to an actin filament via M protein. Then, because 
of the modified nature of the plasma membrane in this region, the growing actin fllament 
is able to extrude the virus particle from the cell. 
There is evidence to show that once the viral particle has been forpled, the 
interactions holding the different components together are released. The M protein 
becomes antigenically mature (Sheshberadaran and Lamb, 1991) and cannot be chemically 
cross-linked to the NP protein (Markwell and Fox, 1980) and the crystalline array of 
membrane-associated M protein disappears (Bachi, 1980). The intravirion dissociation 
process correlates temporally with the development of haemolytic virions (Honuna et al., 
1976). During paramyxovirus particle release, the neuraminidase activity of the HN 
protein probably comes into play, to cleave sialic acid residues which would otherwise 
bind the progeny virus particles to each other. It has been observed that in the case of 
influenza virus release, if virions are formed which lack the neuraminidase, they aggregate 
together and are not efficiently released from the cell (Air et al., 1994). 
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PART 2: VIRAL PERSISTENCE 
2.1 DEFINITION OF VIRUS PERSISTENCE 
The phenomenon of viral persistence. by both DNA and RNA viruses, is becoming 
increasingly recognised as an alternative consequence of viral infection. In this event, the 
acute infection is not resolved by either the death of the host or by clearance of the virus. 
Instead, virus genetic material is able to remain in the host for prolonged periods of time, 
sometimes with pathological sequelae. There are two demands which a virus has to meet 
in order to establish and maintain a persistent infection. To reside in a host for extended 
periods of time, it is important that the virus does not damage the host. Secondly, the virus 
and the virus infected cell have to be able to evade the host immune system, to avoid 
clearance and incidentally to avoid damaging the host as it is frequently the pathological 
effects of the immune system that cause tissue damage (reviewed by Oldstone, 1989; 
1991; Ahmed and Stevens, 1990). 
During persistent infection with DNA viruses, or RNA viruses that replicate via a 
DNA intermediate, replication of the viral genome often does not occur, or is linked to 
replication of the host cell genome (reviewed by Garcia-Blanco and Cullen, 1991). 
Persistence in this manner obviates the need for viral encoded proteins to be present in the 
cell to maintain the virus genome. In contrast to DNA viruses, RNA virus replication 
(with the exception of Retroviruses) is carried out by virus encoded enzymes and is 
independent of host cell DNA synthesis. For this reason, it is more difficult to envisage 
how an RNA virus genome can be sustained in the hostile intracellular environment, 
without prompting immune attack. Because of the underlying differences in the way in 
which the persistent state is initiated and maintained between these two types of viruses, 
the remainder of this chapter will focus on viruses which replicate via RNA intermediates, 
and on the problems that have to be addressed in understanding these types of persistent 
infection. 
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2.2 DAMAGE LIMITATION 
Damage to host cells can occur in several ways, depending on the infecting virus. 
By defInition, viruses are intracellular parasites and depend, to varying degrees, on the 
host cell's energy resources as well as enzymes, membranes and other intracellular 
structures in order to replicate; many viruses are able to specifically switch off host cell 
synthesis to further their own needs. The presence of a virus usurping the host's 
transcriptional and translational machinery may be sufficient to kill the cell. Many viruses 
express proteins which can mediate the fusion of adjacent cells, resulting in the formation 
of multinucleated syncytia and ultimately, cell death. Virus infections can affect cell 
membranes in other ways, insertion of viral glycoproteins into the plasma membrane may 
perturb its fluidity and function and the action of maturing virus particles hijacking the 
membrane in order to envelope themselves, could cause cell lysis (reviewed by Mims, 
1987). Fmally the effect of viral infection could be to incite the cell to lyse itself. For 
example, in many cell types, infection with Sindbis virus instigates apoptosis, resulting in 
self destruction of the cell (Levine et al., 1993). 
How does a virus overcome its destructive nature? Some viruses are not lytic, even 
during acute infection. Most Arenaviruses are able to replicate in cells without doing them 
any obvious damage, making these viruses well suited to a persistence phenotype. Indeed, 
Arenaviruses are readily able to give rise to persistent infections. Those viruses that would 
normally be cytopathic need to temper that aspect of their replication cycle which causes 
damage to the host cell. For example, VSV infection of tissue culture cells is usually 
accompanied by downregulation of the host cell's metabolism. This virus achieves 
persistence by generation of mutants which avoid shut off of cellular synthesis, while 
maintaining viral replication (Frey and Youngner, 1982; Jordan and Youngner, 1987). In 
contrast, measles virus does not suppress macromolecular synthesis. Instead, this virus 
destroys cells by causing cell fusion and so establishment of MY persistence requires that 
the virus either specifically decreases the expression of the glycoproteins or decreases 
overall genome expression to a sufficiently low level that the infection is maintained 
without cell damage. 
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An altetnative to a non-lytic phenotype is for the virus to only infect a small 
number of cells at one time. These cells would die, but if only low levels of virus were 
released or only a small number of progeny virus could efficiently infect cells, then the 
neighbouring cells may be able to replicate as rapidly as the infected cells were dying and 
the tissue damage could be limited to the extent that the host could repair itself as rapidly 
as the virus damages it (Ahmed and Stevens, 1990). 
2.3 THE IMMUNE RESPONSE TO VIRAL INFECTION 
Persistent infections are known to occur in immunocompetent individuals (Randall 
and Russell, 1991) and it has been shown experimentally that measles virus can persist in 
cells in the presence of MV cytotoxic T cells (perrin et a/., 1977). These observations 
suggest that persisting viruses are able to elude immune surveillance. There are a number 
of ways in which viruses have been shown to be able to overcome the host immune 
X' response; these are detailed later in this section. FIrstly, in order to understand what is 
required for a virus to evade the immune system. the typical immune response to viral 
infection is described. 
2.3.1 Launching an immune response against .viral infection 
Having infected an animal, a virus faces a specific, coordinated attack by humoral 
and cellular defence mechanisms (reviewed by Male et a/., 1987). The effector 
components of the humoral immune system are antibodies, released by activated B cells. 
Effector antibodies and B cells are able to recognise viral antigens that are exposed at the 
surface of the viral particle and infected cell. The cell mediated immune response 
comprises of essentially three types of T cells; effector cells, which are able to specifically 
lyse infected cells, known as cytotoxic T lymphocytes (CfLs), and two types of regulatory 
cells; T helper and T suppressor cells, which coordinate the immune response. In contrast 
to the humoral immune response, the cell mediated immune response recognises viral 
antigens which are displayed by antigen presenting cells. The antigens are recognised in 
association with cellular glycoproteins, encoded by the major histocompatibility complex, 
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MIlC molecule.s. Because of the nature of their recognition mechanism, T cells are able to 
recognise viral antigens derived from a number of viral proteins, including internal and 
non structural proteins. 
Launching an attack against a viral infection requires that the different elements of 
the immune response are stimulated to become active and to proliferate. T-helper cells are 
responsible for releasing factors which provoke the immune system into activity. Before 
they can release such factors, the T helper cells must themselves be activated. Activation 
of T helpez cells begins following recognition of a foreign antigen bound to a class II 
MIlC glycoprotein. These molecules are only found on specialised antigen'presenting 
cells, such as macrophages and B cells, although they can be induced on other cell types 
by the action of cytokines. The T helper cell induces the antigen'presenting cells to release 
interleukins. The interleukins, in tum, act upon the T cell to release interleukin 2 (IL-2) 
and to express IL-2 receptors. Binding ofIL-2 to the receptors, stimulates the T cell to 
proliferate. The activated T helper cell then has a number of roles. IL-2 will continue to be 
released by an autocrine mechanism and can help to stimulate the proliferation of other T 
cells, including CTLs, which have enountered antigen and are themselves expressing IL-2 
receptors. T helper cells also release other interleukins, which activate B cells and 
stimulate B cell proliferation and antibody release. In addition to interleukins, the 
activated T helper cell releases interferon y. The effect of this cytokine can be to inhibit 
viral replication, activate macrophage activity and also to induce some cells which would 
not normally express MIle molecules, to do so. 
2.3.2 Recognition of viral antigens by effectors of the immune system 
Cytotoxic T cells recognise their target antigen in the form of a peptide associated 
with an MHC class I molecule (reviewed by Hanke and Randall, 1993). In contrast to 
class II molecules, class I molecules are found, or can be induced, on most nucleated cells. 
MIlC class I molecules are composed of a heterodimeric structure, consisting of an a 
chain bound to a polypeptide called ~2-microglobulin, which associates in the 
endoplasmic reticulum of cells. Also associated with the MHC dimer is a peptide 
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molecule of eight or nine residues. The peptides which associate with MHC I molecules 
are derived from both cellular and viral proteins, present in the cytosol of cells. It is 
suggested that cytoplasmic proteins are routinely degraded by proteosomes, and that the 
resulting peptide fragments are transported to the lumen of the ER. It is thought that in the 
ER that the peptide becomes associated with a newly synthesised MHC molecule and that 
the MHC-peptide complex is then transported to the cell surface. In contrast to T cells, 
antibodies recognise native antigens, to which they have access. The upshot of the two 
recognition systems is that, whereas the humoral immune response is only effective 
against antigens that are expressed at cell or viral surfaces, potentially any viral antigen is 
able to be presented to circulating CfLs. 
2.3.3 Effects of the components of the immune response 
Effector antibodies are able to prevent viral infection of cells by inhibiting virus 
particle attachment and penetration (reviewed by Male et al., 1987; Hanke and Randall, 
1993). Thus antibodies are able to prevent viral spread within a host, and can be important 
for protecting the host during subsequent infection by a similar virus. In addition, 
antibodies can aid the destruction of virally infected cells by activating the complement 
pathways and by identifying infected cells for macrophage and killer cell attack (antibody 
dependent cell mediated cytotoxicity, ADCC). Cytotoxic T cells are able to directly kill 
infected cells. Binding of the CfL to the MHC I-antigen complex activates the T cell to 
release perforins which form non-specific ion channels in the target cell membrane, thus 
destroying the osmotic and ionic balance of the infected cell. In addition, binding of the 
cytotoxic T cell may activate a signal transduction pathway within the target cell which 
results in apoptosis. Destruction of infected cells, either by cell or humoral mediated 
cytotoxicity, is the most effective means of curtailing virus spread, and is the only way in 
which the host is able clear the virus from its tissues. Cells are far more sensitive to cell 
mediated lysis than to lysis due to antibodies. 102 or fewer viral molecules are required on 
the surface of a cell for it to be recognised by an activated T cell, compared with 106 or 
more viral molecules needed for antibody and complement mediated lysis (Sissons et al., 
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1979; 1980; D~motz et al., 1990). Thus cytotoxicT cells are the most stringent arm of the 
immune response for clearance of viral infections. 
The relative importance of the two arms of the immune response in clearing a viral 
infection can vary from virus to virus. In the case of Paramyxovirus infections, it seems 
that it is the cell mediated immune response which is of greatest significance. Clearance of 
RS virus and SV5 from the lungs of infected mice has been shown to be mediated by 
primed T cells but not by neutralising antibodies (Cannon et al., 1987; Young et al., 
1990). In humans, children with a T cell deficiency suffer very severe measles virus 
infections compared to children with agammaglobinaemia, a disease in which the patient 
is unable to make antibody molecules (Hanke and Randall, 1993). 
2.4 MEANS BY WHICH VmUSES CAN OVERCOME THE IMMUNE 
RESPONSE 
In order to establish and maintain a persistent infection in vivo, the virus must be 
able to maintain its genome in a cell whilst avoiding elimination by the host immune 
response. A virus could evade humoral immunity by reducing the levels of viral antigens 
expressed at the cell surface. If levels of viral antigen at the cell surface were below a 
threshold required for lysis by antibody and complement, or by ADCC and natural killer 
cells, the infecting virus would not be vulnerable to clearance. Reduction of the levels of 
surface viral antigen could be achieved by mutations and deletions of those genes whose 
products are normally expressed at the cell surface, a common characteristic of viruses 
isolated from SSPE patients. However, given the sensitivity and specificity of cell 
mediated immunity, and its importance in clearance of Paramyxovirus infections, it is 
difficult to understand how these viruses could avoid this arm of the immune response. 
There are a few special circumstances in which viruses are able to avert cell mediated 
/. immunio/:'these are described below. Although some of the cited examples pertain to 
viruses outwith the Paramyxovirus family, they may illustrate common approaches which 
viruses have developed to overcome the host immune response. 
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2.4.1 Tissue T-::opism: Virus Persistence In The Central Nervous System (CNS) 
Many persistent viral infections are known to be harboured by cells of the central 
nervous system (ter Meulen and Hall, 1978; Griffin, 1989; Fazakerley et aI., 1993). The 
nervous system is often considered to be an immunologically privileged site and it is 
thought that it is because of this, some viral infections are able to remain hidden in the 
tissue without being cleared (Joly et al., 1991). However, it has been shown that the 
immune system does playa role within the eNS but because nerve cells are unable to 
regenerate, it is carefully modulated to avoid cellular damage. Three factors distinguish 
immunity within the CNS from the situation in the rest of the body (reviewed by Wekerle 
et aI., 1986). Firstly, it has been shown that only activated lymphocytes are able to cross 
the blood brain barrier, meaning that compared to the numbers of lymphocytes circulating 
through other tissues, the brain has only small numbers of patrolling lymphocytes. 
Secondly, there are cells in the brain which can express MHC class I and II molecules and 
hence present antigen to lymphocytes; astrocytes, oligodendroglial cells and microglial 
cells, but they can only do so if induced by interferon y, meaning that they require the 
presence of activated T lymphocytes in order to present antigen. Finally, some astrocytes 
are able to release factors which have a profound suppressive effect on the activation of T 
cells, thus having an overall dampening effect on the immune response within the nervous 
sytem. For these reasons, in the CNS of a healthy animal, T lymphocytes and the 
expression of MHC molecules are virtually undetectable and it has been shown that a 
strong systemic immune response is required to induce an immune response in the CNS. 
As it has been shown that Paramyxoviruses, and many other viruses capable of initiating 
persistent infections, are able to infect lymphocytes and cause a short term immune 
suppression (Notkins et al., 1970), it is possible that if these viruses can gain access to the 
nervous system, they will be able to avoid immune surveillance, at least in the initial 
stages of a persistent infection. 
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2.4.2 Age of Infection: Tolerance 
There is some evidence to show that the age at which an animal is infected, can 
determine whether the virus is cleared by the immune system. One of the best studied_ 
models of virus persistence is infection of mice by the Arenavirus, lymphocytic 
choriomeningitis virus (LCMV). The outcome of infection with the wild type strain of this 
virus, is dependent on the age of the host H immunocompetent adult mice are infected, 
they launch an effective immune response and the virus is cleared, primarily due to the 
action of CfLs (reviewed by Oldstone, 1989). However, if mice are infected in utero or at 
birth, a long lasting persistent infection ensues. The probable reason for this is that the 
immune system acquires tolerance to the virus (Tishon et al., 1993). During the 
development of a foetus, the immune system undergoes a maturation step in order to 
eliminate T cells which react with 'self antigens. The selection takes place in the thymus 
and involves a negative selection procedure in which T cells which react with 'self 
antigens are prevented from leaving the thymus (Takahama et ai., 1992). If a foetus or a 
newborn animal suffers a viral infection at this maturation stage, viral specific antigens 
may be presented in the thymus and so viral specific T cells may be selected out. H this 
was to happen, the immune system may then be unable to recognise or clear the virus. 
2.4.3 MHC Haplotype of the Host Animal 
The genetic makeup of the infected animal may have an effect on the outcome of 
viral infection (Liebert and ter Meulen, 1987; Niewiesk et ai., 1993). Although, the 
genetic background of an animal could influence the course of infection in a number of 
ways, it has been found that the susceptibility of a particular strain of animal to viral 
infection can, in some cases, be attributed to the MHC haplotype of the animal. MIlC 
molecules are encoded by a cluster of genes called the major histocompatibility complex. 
Some of these genes are highly polymorphic, with a number of alleles having been 
identified In humans, there are three MHC class I loci, meaning that up to six different 
molecules are expressed within an individual. The situation is similar in mice. As 
previously described, MIlC molecules present peptides generated from proteolysed 
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cytoplasmic proteins. Not all peptides generated by proteolysis will have an affinity for an 
MHC molecule. It has been estimated that each type of MHC molecule can present 
approximately 1000 different peptides, with each species of MHC molecules presenting a 
different panel of peptides (reviewed by Hanke and Randall, 1994). This means that only a 
selected set of peptides will be presented to T cells. Because of the polymorphism and 
multiplicity of the MHC genes, different individuals within a population (apart from 
identical twins) will express differing panels of MHC molecules and so will display 
different arrays of peptides to circulating T cells. Thus, this is how the genetic background 
of the host may influence virus clearance. 
In the case of measles virus, it has been found that different inbred strains of mice 
have varying abilities to resist encephalitis, correlating with the abilities of the mice to 
generate a CI1... response. The experiments suggested that the mice which were highly 
susceptible to encephalitis, were unable to launch an effective CI1... response because MV 
antigens were being inefficiently presented by MHC class I molecules (Niewiesk et aI., 
1993). Similar evidence has been reported in individuals infected with human 
immunodeficiency virus (HIV). It has been found that the haplotype of an individual can 
determine the infection prognosis, with individuals with certain haplotypes having a 
poorer outcome of infection than other individuals (Kaslow et aI., 1990). It is known that 
mv is able to rapidly mutate and in one study it was found that variation had a tendency 
to occur in or near a CI1... epitope (Phillips et ai., 1991). Similarly, it has been shown that 
isolates of LCMV that have escaped CI1... recognition have mutations in a T cell epitope 
(Pircher et ai., 1990). It is possible that variant viruses which have mutated T cell epitopes 
may escape recognition by the majority of circulating CI1...s. However, such variation 
might only be tolerated within certain epitopes, if the epitope lies within a protein essential 
for viral replication, then the wild type epitope may be more likely to be maintained. 
Because different MHC I molecules select distinct epitopes from the virus to stimulate the 
CTL response, the MHC haplotype of the individual could have an effect on the ability of 
the virus to escape immune surveillance, with the possibility that individuals whose MHC 
40 
molecules pres~nt a non-essential epitope having an increased likelihood that they may be 
unable to effectively present viral antigen. 
2.4.4 Immune Suppression: Infection of Immune Cells 
One means by which viruses may be able to avoid immune clearance, is by infecting 
cells of the immune system and in doing so, revoking their function. A number of viruses, 
including some Paramyxoviruses, are known to be able to infect lymphocytes and to alter 
their behaviour (Notkins et ai., 1970). Measles virus infection and vaccination are well 
known to have a generalised immunosuppressive effect. It was observed that patients who 
were tuberculin positive lost skin reactivity and patients with inactive tuberculosis 
frequently developed disease symptoms, following an acute measles virus infection (von 
Pirquet, 1908). 
The molecular mechanisms by which the infecting virus enforces immune 
suppression are not well characterised and different Paramyxoviruses may act upon 
different cell types. Measles virus infection is the best understood. MV is able to replicate 
in T cells, B cells, macrophages and natural killer cells (Joseph et ai., 1975; Casali et ai., 
1984). Infection of B cells dampens the ability of these cells to synthesize 
immunoglobulins, even in the presence of B cell growth and differentiation factors (Casali 
et ai., 1984; McChesney et ai, 1986). Infection ofT cells does not affect the ability of 
these cells to release T or B cell growth maturation factors when stimulated, but it does 
impair their ability to proliferate. In general, it seems that infected lymphocytes are 
blocked in the late G 1 phase of the cell cycle and so the effect of measles virus infection is 
to suppress T and B lymphocyte responses that require cellular activation and 
proliferation, prior to the expression of differentiated functions (McChesney and Oldstone, 
1987). Similar observations have been recorded for other members of the paramyxovirus 
family. Aborted lymphocyte proliferation, due to infection has been shown for PIV3 
(Basaraba et ai., 1993; Sieg et ai., 1994), RS virus and Sendai virus (Roberts, 1982). In 
vivo, such effects would probably impair the orchestrated response to viral infection. 
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In the case of measles virus infection, and possibly for other Paramyxoviruses, the 
immunosuppressed state lasts for about 4 weeks following the acute infection, after this 
period. the immune system functions nonnally. It is therefore unlikely that 
immunosuppression allows maintenance of the persistent state but maybe by dampening 
the immune response in the initial stages of infection, the virus is allowed to establish a 
persistent infection (Griffin, 1991). 
2.4.5 Immune Suppression: Antagonism of tbe CTL Response 
In some cases it has been found that the virus need not infect cells of the immune 
system in order to abrogate lymphocyte function. It has previously been described how 
some virus variants may arise which may not be efficiently presented by MIlC molecules. 
Recent evidence has shown that some variant viruses might have even greater 
implications. Studies of HIV and Hepatitis B virus isolated from infected.individuals 
(Bertolucci et al., 1994; Klenennan et al., 1994) found that variant peptides presented on 
MHC I molecules were able to inhibit normal lysis of target cells presenting the original 
wild type epitope. This was the result of a specific interaction between the T cell receptor 
and the variant peptide-MHC complex and was not simply a competition between wild 
type and variant peptides for MHC binding. Similarly an LCMV variant which is able to 
establish a persistent infection, has been shown to have an amino acid change in a CTL 
epitope which results in suppression of the antiviral C1L response (Salvato et al., 1991). 
In these instances, the effect of virus mutations in MHC epitope domains could be far 
reaching, as these mutations may benefit the entire virus population and not just the 
variant viruses. 
2.4.6 Summary 
In summary, there are certain circumstances in which a virus may be able to evade 
the host immune response during a persistent infection. If a virus is able to become 
established in a host either in an immunologically privileged site, during the maturation of 
the immune system, or in an individual whose MHC is unable to present stable virus 
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epitopes, it may not be detected by the immune response. Alternatively, if a virus 
undergoes mutation so that it is no longer recognised or so that it aborts the activity of the 
immune response, it might evade immune surveillance. Finally, a virus may be able to 
avoid immune recognition by being transcriptionally inactive. If virus antigens are not 
available for MHC presentation, then the virus will not be recognised by CILs. 
2.5 FACTORS THAT INFLUENCE PERSISTENCE: HOST FACTORS 
In vitro and in vivo systems have shown that persistence is often associated with a 
curtailment of some aspect of virus replication. Presumably, in this way, the virus is 
prevented from completing a lytic cycle of infection and so the infected cell survives. 
However, in vivo, the virus also has to overcome the host immune response. Given the 
sensitivity of the CfL response to viral infection, unless the infection conforms to the 
situations described in the previous section, it is still diffICult to understand how 
persistence is achieved. 
Although the ways in which persisting viruses are able to prevail in cells is still not 
fully understood, there are numerous factors which have been associated with the onset of 
virus persistence. So~e factors inhibit cell fusion or virus release, others directly inhibit 
genome replication. Some of these factors are virus dependent, but many are instigated by 
the host. 
2.S.1 Tissue Tropism 
Viruses are highly dependent on the host cell for a number of modifications; 
phosphorylation, glycosylation, acetylation. Differences in the way in which these 
processes are regulated in different cell types, could affect the maturation of a virus 
particle. For example, lymphocytes do not possess the protease necessary to cleave the FO 
protein of measles virus. For this reason, the virus is not able to cause fusion of 
lymphocytes and so can persist in these cells (Fujinami and Oldstone, 1981). The inability 
of a cell to correctly process viral proteins may be a common feature of viral persistence. 
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As prevJously mentioned, a number of persistent infections are localised to the 
central nervous system (eNS). There is a possibility that there are a number of features 
particular to this tissue which favour viral persistence. Neural cells are postmitotic cells 
which following maturation of the animal, remain for its lifetime. The fact that these cells 
are highly differentiated and non-dividing may mean that they possess special attributes 
which contribute towards persistence. One aspect of nerve cells which may predispose 
them to persistent infection, is their peculiar structure. Neurones consist of a nerve cell 
body from which long extentions ofaxons and dendrites branch out. The functional centres 
of the neurones are located in these extensions, but protein synthesis and glycosylation 
take place in the nerve cell body. This has meant that nerve cells have developed elaborate 
transport mechanisms to enable conveyance of newly synthesized molecules to the 
functional regions of the cell. The means by which neurones control intracellular 
trafficking has implications for viral infection, as newly synthesized viral components will 
follow defined neuroanatomical pathways. The viral glycoproteins being associated with 
intracellular membranes may be transported more rapidly than the nucleocapsids and the 
matrix protein which are in the cytosol of the cell (Kristensson and Norrby, 1986). It has 
been shown in other cell types that in the absence of matrix protein, the glycoproteins are 
not stable at the cell surface and their turnover increases (fuffereau and Roux, 1988). Thus 
it would be envisaged that disparate transport mechanisms might inhibit virus budding. 
Cells of the central nervous system might possess factors which influence 
persistence in other ways. For example, neuroblastoma cells are reported to have an 
enzyme activity which can promote viral mutation (Rataul et al., 1992). Another example 
is that Sindbis virus infection leads to the initiation of apoptosis in most cell type~~') 
however. this virus is able to persist in the eNS. Neural cells express the cellular oncogene 
bC/-2 which blocks apoptosis thus allowing virus infection without cell lysis (Levine et 
al., 1993). 
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2.5.2. Cell CycJe And Differentiation 
The intimate relationship between the virus and the host cell means that the state of 
the cell can sometimes have a profound effect on the viral infection. A number of studies 
have implied an association between Paramyxovirus replication and cell cycle. Generally, 
it has been found that virus release from resting cells is greatly reduced as compared to 
release from actively dividing cells. In a study of a persistent measles virus infection of a 
human cell line, it was found that although the intracellular viral proteins could be 
consistently detected, viral antigens expressed at the cell surface fluctuated depending on 
cellular growth and density. More specifically it was found that cells in the stationary 
phase were prone to loss of surface antigen and that renewal of the surface associated 
antigen was only achieved upon entry of the cell into a new cycle (Ehmst, 1979). A study 
of Sendai virus replication in both persistently and lytically infected mouse 3T3 cells, 
showed that low levels of virus release from resting cells was due to a restriction imposed 
at the level of viral RNA and protein synthesis (Ogura et al., 1984). Similarly, an 
investigation in which cell cycle was interrupted by using temperature sensitive BHK cells, 
defective in DNA synthesis, showed that viral RNA synthesis and antigen expression were 
inhibited in the absence of cellular DNA replication (Prasad, 1981). Many investigators 
have found that measles virus infection of resting lymphocytes results in a limited 
infection. However, stimulation with mitogens such as phytohaemagglutinin, which forces 
the cells to re-enter the cell cycle, greatly enhances the level of virus release (Joseph et al., 
1975). These findings would suggest that in some cases cell cycle might playa role in the 
progression from an acute to a persistent infection, allowing establishment of persistence 
and also maintenance of the virus in an inactive state if the cells remain stationary. Such a 
situation could have particular implications for nerve cells which, having matured, remain 
in a post mitotic state for the lifetime of the animal. 
Studies carried out using compounds that alter intracellular levels of cyclic AMP 
(cAMP) have yielded evidence to suggest that the differentiation state of the infected cell 
is able to affect viral replication. cAMP is found in particularly high levels in neural cells 
and correlates with induction of neural specific function and tenninal differentiation 
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(Rubin and Rosen, 1975; Greengard, 1978). In one study, addition of papaverine, a 
compound that increases intracellular cAMP concentrations, was found to induce 
differentiation of two human glioma cell lines. Having undergone differentiation, these cell 
lines were unable to support viral replication. It was found that in these cells, viral 
translation was almost completely inhibited leading to a subsequent decline of viral 
transcription and replication (Schneider-Schaulies, S. et al., 1993). In similar studies; in a 
neuroblastoma cell line, papaverine treatment inhibited phosphorylation of P, NP and M 
and the synthesis of viral RNA (Yoshikawa and Yamanouchi, 1984), and Miller and 
Carrigan (1982) found a decrease in virus release from neural cells which had been treated 
with agents that increased cAMP levels. These authors attributed the inhibition of virus 
release to a selective disappearance or modification of the matrix protein. 
2.S.3 Antibody Mediated Antigenic Modulation 
Viruses are often able to persist in the face of high levels of circulating antibodies 
(eg. SSPE), a fact that has raised the possibility that antiviral antibodies might playa role 
in the establishment and/or maintenance of persistence. There are a number of experiments 
in animal models which show that when present, antiviral antibodies are able to contribute 
to persistence of Paramyxoviruses (Wear and Rapp, 1971; Albrecht et aI., 1977; 
Rammohan et al., 1983; Liebert et al., 1990). Wear and Rapp (1971) showed that by 
suckling MV infected hamster pups on mothers which were MY immune, the expected 
acute measles virus infection was averted and instead, a prolonged persistent infection 
ensued. Similar results were obtained in an SSPE infection of monkeys (Albrecht et al., 
1977) and measles virus infection of rats (Liebert et al., 1990). 
In vitro studies, aimed at determining how antiviral antibodies could alter the 
course of infection have not always given consistent results but have shown that antibodies 
could contribute to the establishment of persistence in two different ways. Firstly, in the 
absence of complement, antibodies against the viral glycoproteins form antibody-antigen 
complexes at the cell surface which are eventually shed from the cell. In this way, the cells 
are stripped of the fusion protein and do not form syncytia. As the cytopathogenicity of 
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measles virus lies in its fusion activity, the cells survive and the virus is able to persist 
(Joseph and Old stone, 1975). However, for this process to contribute to persistence in vivo, 
it must occur at sites such as the central nervous system and areas of lymphoid drainage 
which are devoid of the components of the complement cascade system. 
It has also been shown that antibody treated cells are resistant to en. lysis (Joseph 
and Oldstone, 1975), an observation that cannot be accounted for by the reduction of 
glycoprotein molecules at the cell surface, as CI1..s are able to recognise potentially any 
viral antigen. This phenomenon may be explained by the finding that the action of 
neutralizing antibody binding to antigen at the plasma membrane can affect the expression 
of internal viral proteins. Fujinami and Oldstone (1979; 1980) found that addition of MY 
immune serum to HeLa cells acutely infected with measles virus, resulted in the altered 
expression of P, M and F1, with P and F1 expression being selectively reduced. In the case 
of M, it was found that in treated cells, a larger proportion of this protein adopted the 
phosphorylated state. In similar experiments, Schneider-Schaulies et al. (1992) found that 
incubation of persistently infected rat glioma cells or mouse neuroblastoma cells with 
neutralizing anti-H antibodies, resulted in a overall reduction of MY specific mRNA 
transcripts. In a study of MY infection of rats, Liebert and co-workers (1990) showed that 
the onset of a clinically silent encephalitis correlated with a pronounced attenuation of 
virus transcription, rendering the glycoproteins virtually undetectable in the treated 
animals. A role for antibodies has also been established in other persistent viral infections. 
If SCID mice are infected with Sindbis virus (an Alphavirus), they develop a highly 
productive persistent infection, however, if they are treated with monoclonal antibodies to 
the E2 envelope glycoprotein, the virus is apparently cleared (Levine et al., 1991). Further 
investigation, demonstrated that in fact that the viral RNA was persisting in a non-
productive form in neurones, at such low levels that it was undetectable by in situ 
hybridisation (Levine and Griffin, 1992). 
It is not known how the binding of antibody to the cell surface of infected cells 
could influence the transcriptional state of the virus, but G protein mediated stimulation of 
phosphoinositide breakdown has been implicated (Weinmann-Dorsch and Koschel, 1989). 
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Although these_results have been contested (Segev et aI., 1994), it seeems plausible that 
antigen-antibody interactions could stimulate cellular transduction pathways and that 
possibly. by altering their phosphorylation states, some components of the virus become 
defunct. 
Although antibodies may well influence the outcome of the viral infection, they are 
not responsible for the initiation and maintenance of all cases of persistence in vivo. In 
humans. this fact is exemplified by measles inclusion body encephalitis (MIBE). MillE is 
a disease similar to SSPE, which manifests in immunocompromised individuals, in whom 
there may be no detectable antibody (Swoveland, 1991). 
2.5.4 Interferon 
Upon viral infection. some cell types are stimulated to release interferons (IFNs). 
Interferons are soluble factors whose action upon receptive cells is to induce a number of 
effects. including the establishment of the anti-viral state. The anti-viral state can 
sometimes curb virus propagation. Thus, IFNs form part of the first line of defence of the 
host. important in halting the spread of infection until a full immune response is 
established. There are three types of interferon: a. p and y. a interferon is produced by 
leukocytes. P by fibroblasts and y by stimulated lymphocytes. Interferons mediate their 
effects indirectly by inducing the transcription of interferon responsive genes. There are a 
number of IFN inducible proteins. many of which are, as yet, poorly characterised. The 
best understood include a 2, 5 oligo A synthetase (2-5A synthetase), whose product 
activates a latent ribonuclease able to degrade mRNA, and 67kd protein kinase. The kinase 
is activated by the virus to autophosphorylate, it then phosphorylates the small subunit of 
the protein synthesis initiation factor, eIF-2 rendering it inactive. Thus the ultimate effects 
of these two proteins is to halt translation (both cellular and viral), which will inhibit the 
replication of the invading virus (reviewed by Staeheli, 1990). 
Release of interferons by infected cells can enable neighbouring cells to resist viral 
infection but cannot aid viral elimination from a cell that is already infected. Instead, it is 
possible that by down-regulating protein synthesis and other steps in the viral replication 
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cycle, the action of interferon leads to the establishment of a persistent infection. Interferon 
has been shown to have a role in a number of cases of Paramyxovirus persistence. 
Infection of mouse L929 cells with mumps virus results in only low yields of progeny 
virus, even though it has been shown that the cells are capable of synthesising the viral 
proteins. It was demonstrated that following infection, L929 cells released interferon and 
had 2-SA synthetase activity. The presence of an anti-IFN serum throughout the infection 
was investigated and was found to increase the yield of virus release. This finding led to 
the conclusion that interferon played a significant role in the restriction of infection in this 
cell line (Yamada et al., 1984). Endogenous interferon production has also been shown to 
playa role during Newcastle disease virus infection in L cells (Nagai et al., 1981) and RS 
virus infection in primary Balb/c mouse embryo cells (Hanada et aI., 1986). It was found 
in both of these studies that there was a parity between levels of virus release and 
interferon activity, both of which varied over the infection period. Interferon can also 
affect virus infection of lymphocytes. Jacobson and McFarland (1982) showed that, during 
a persistent measles virus infection of human peripheral blood lymphocytes, high levels of 
interferon a. were released. Similarly to the experiments described above, it was found that 
if the cells were cultured in the presence of anti-human leukocyte interferon serum, the 
infections became productive, with at least a 30-fold increase in virus release. 
As more is learnt about the different proteins induced by interferon, attempts are 
underway to determine which stages of the virus replication cycle might be affected. It has 
been found that in a human monocytic cell line which had been transfected with the MxA 
gene (MxA is a poorly characterised IFN induced protein), the synthesis of the measles 
virus glycoproteins was inhibited at a post transcriptional stage (Schnorr et al., 1993). In 
addition, it has been proposed that interferon released by MV infected neuroblastoma cells 
leads to the phosphorylation of NP. It was speculated that this may alter the ability of 
nucleocapsids to bind to M protein (Segev et al., 1993). Thus in both these cases, virus 
maturation would be inhibited and persistence could be induced. 
In addition to having an antiviral effect, by inducing the expression of genes which 
are normally repressed, interferons can have a profound effect on cell regulation. Amongst 
49 
other effects, it.has been shown that interferons can inhibit cell growth, concomitantly with 
an increase in intracellular cAMP, and to affect differentiation in various ways (reviewed 
by Clemens and McNurlan, 1985). Although it thought that the cellular effects of 
interferon are distinct from its antiviral activity, it is possible that alteration of the 
intracellular environment could promote virus persistence. 
2.5.5 Host Cell Evolution 
There is evidence to show that in some situations, cells can evolve to accomodate a 
residing virus and to promote persistent infection. Virus that was isolated from a persisting 
infection of foot and mouth disease virus (FMDV) was found to be more cytolytic than the 
parent virus originally used to establish the infection. From this observation, it was 
concluded that the host cell must be evolving to counter the increasing cytolytic effects of 
the virus (de la Torre et ai., 1988). By cloning the persistently infected cells, it was shown 
that the cell population w~s diverse, with multiple cell variants. It was proposed that the 
presence of a heterogeneous cell population could promote viral persistence as there would 
be a wide variety of different conditions for the persisting virus to overcome in order to 
achieve a lytic infection (de la Torre et ai., 1989). Similarly, Rustigian (1966) 
demonstrated the emergence of HeLa cell variants which were better adapted to persistent 
measles virus infection than parent HeLa cells. However, in contrast to the FMDV/BHK 
system, it was found that in this case both the cells and the virus had also evolved towards 
a persistent phenotype. 
2.6 FACTORS WHICH INFLUENCE PERSISTENCE: VffiAL FACTORS 
A common means for a virus to achieve persistence is by the generation of viral 
variants or mutants which either specifically facilitate the decrease of viral antigens 
expressed at the cell surface, lead to a general decrease in viral replication, or indirectly 
downregulate the cytocidal effects of the virus. A number of examples have been cited in 
which during persistent infection, viral variants arise with characteristics different from the 
parental phenotype (reviewed by Youngner and Preble, 1980). The newly acquired 
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phenotype will tend to diminish the cytocidal tendencies of the virus and so, from virus to 
virus, will depend on what aspect of the viral replication cycle is damaging to the host cell. 
For example, VSV infection initiates the shut off host protein synthesis, and it is due to 
this effect that the cell dies. For VSV to be able to persist, the virus (or the cell) must be 
able to avoid inhibition of host metabolism (eg. Jordan and Youngner, 1987). In the case 
of Paramyxoviruses, the virus effects its damage by causing cell fusion and during the 
release of viral particles from the cell. Hence, a reduction of virus particle production 
seems to be a prerequisite for Paramyxovirus persistence. Virus production seems to be 
attenuated in two ways. Sometimes virus RNA synthesis is inhibited so that the infection 
proceeds at a reduced level. Otherwise mutant viruses arise, which are defective in the 
proteins responsible for maturatio~ of the virus particle. For example, Ogura et al., (1982) 
found that cells surviving a Sendai virus infection, harboured protease activation mutants 
whose F protein was failing to be cleaved, thus ablating the fusogenic PTQperties of the 
virus and allowing survival of the cell. 
A more dramatic type of viral mutation can give rise to defective interfering (DI) 
particles. DI particles arise due to polymerase copying errors and consist of only a part of 
the viral genome. Defective particles can interfere with wild type virus replication, either 
by appropriating the wild type virus encoded proteins for their own replication, or by 
producing aberrant proteins which interact with wild type proteins and render them 
obsolete. 
2.6.1 Defective interfering particles 
Defective interfering particles have been shown to be able to initiate persistent 
infections in vitro and to modulate some infections in vivo (Cave et al., 1985; Calain and 
Roux, 1988) DI particles arise spontaneously during viral replication, as a result of internal 
deletions (Leppert et al., 1977; Lazzarini et ai., 1981). They contain viral structural protein 
and a part (as little as 10%) of the viral genome, which by necessity includes the cis acting 
signals specifying encapsidation and polymerase attachment. Because DI genomes lack the 
information necessary to produce the full complement of viral proteins, they can only 
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replicate with t!te aid of helper virus. Because of their smaller size, they will be replicated 
more rapidly than the helper virus. Huang and Baltimore (1970) were the ftrst to propose 
that DI particles might have a role in the viral disease process. They suggested the 
following model: occasionally a DI particle will arise from a standard virus infection. 
Unable to coordinate its own replication, the DI virus will usurp the standard virus' 
resources and because of its smaller size will quickly begin to predominate in the 
population. The relative levels of standard virus will thus decrease and as the DI viruses 
are dependent on the standard virus for propagation, their numbers will also begin to 
decrease. Eventually, it is conceivable that the numbers of virus particles released from the 
cell will be so small that some neighbouring cells will only be infected by one particle. If it 
defective. it will be unable to replicate. If it is standard, then a new round of infection will 
begin. Again a DI particle will spontaneously arise and the process will repeat itself in a 
cyclical manner. Considerable support for this theory has been amassed, particularly for 
the Rhabdoviruses and Paramyxoviruses. (eg Palma and Huang, 1974; Kawai et ai., 1975; 
Cremer et aI., 1979). Mathematical modelling has shown that, given the correct input 
multiplicity of infection, Drs could sustain a persistent infection independently of other 
factors. such as interferon or co evolution of the host cell (Bangham and Kirkwood. 1990). 
Exactly how a DI virus population can exert its effect probably depends in part on 
the type of DI. what its deficiencies are and also on the host cell (different cell lines exhibit 
different levels of interference. Huang and Baltimore. 1970). It has been shown that DI 
particles are capable of interfering at the level of RNA replication (Huang and Manders, 
1972; Perrault and Holland, 1972; Holland et al., 1980). DIs can also exert an effect at the 
level of virus maturation. Tuffereau and Roux (1988) showed that in contrast to standard 
virus nucleocapsids, Sendai virus DI nucleocapsids were unable to stabilize M protein, 
meaning that M degraded more rapidly in cells of mixed infections. Because the 
M/nucleocapsid structure was not stabilized. the HN was not anchored into the membrane 
leading to decreased expression of HN at the cell surface. In a different cell line, virus 
assembly was inhibited in a different manner. In these cells, the M protein was stable but it 
was found that DI nucleocapsids could not recruit M onto internal membranes to be 
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transported to the plasma membrane, again leading to a decrease in expression of HN 
(Stricker et a/., 1994). 
2.6.2 Mutations Leading To Abortive Infections 
In the best characterised persistent Paramyxovirus infections, SSPE and MmE, a 
plethora of mutations have been described, most frequently affecting the M, H and F 
proteins. Although lytic virus has occasionally been recovered, the virus that is isolated 
from SSPE brains is usually defective in virion production and its spread through a cell 
population (and presumably the brain) is dependent on cell fusion (Wechsler and Meissner, 
1982; Swoveland, 1991). So, an SSPE virus requires the ability to replicate its genome and 
to spread this from cell to cell, but the functions required for the packaging of virus are 
negated. Liebert et a/. (1986) showed that in four cases of SSPE, although NP and P 
proteins were consistently detected, H was found in only two cases, F in \hree and M in 
only one. Cattaneo and co-workers have undertaken an extensive study of several SSPE 
and MIBE genomes, comparing them with sequences of several strains of measles virus. 
From this study, they concluded that NP, P and V were relatively untouched by mutation 
(Cattaneo et a/., 1988; Cattaneo et a/., 1989b; Cattaneo and Billeter, 1992}.The only defect 
that has been observed with the polymerase complex, is the accumulation of P-M 
bicistronic transcripts in two SSPE cases. Comparison of the gene boundary in this strain 
(and the adjoining sequences) revealed no differences from the Edmonston strain of MV 
(Cattaneo et al., 1986, 1987). It was concluded that the defect was not cis acting but rather 
was due to an inability of the polymerase to effectively recognise the gene junction. As it 
has been shown that it is the proximal gene of a bicistronic transcript that is translated 
(Tsurodome et a/., 1991), this defect would result in an imbalance of P to M in the cells. 
In contrast to the proteins of the polymerase complex, Cattaneo and co-workers 
found that the M protein was highly liable to extensive mutation. A common functional 
defect in M protein has been identified between four different SSPE strains (Hirano et al., 
1993). In this study, it was found that as opposed to strains of measles virus which cause 
lytic infection, none of the SSPE strains derived M proteins was able to bind to viral 
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nucleocapsid, whatever the nucleocapsid source. Chimeric M proteins carrying the amino 
terminal. carboxy proximal or carboxy terminal regions of one of the SSPE M proteins all 
failed to interact with nucleocapsid. This suggests that the overall conformation of M is 
important for nucleocapsid binding and that any alteration in the tertiary structure of M 
(readily achieved by random mutation) could abolish its nucleocapsid binding capacity. In 
other studies, M protein could not be detected at all (Carter et al., 1983; Haase et al., 
1985). despite the presence of M specific mRNA. In one of these cases the matrix mRN A 
isolated was unable to direct translation of a detectable product either in infected cells or in 
vitro (Carter et al., 1983), suggesting either gross mutation of the gene, a frameshift 
mutation. premature termination or a failure in translation initiation. In another study of an 
SSPE cell line, it was found that M was synthesized in a similar ratio to that of Edmonston 
measles virus but that it failed to accumulate because it was unstable (Sheppard et aI., 
1985; Cattaneo et al., 1988). 
The H protein has also been identified as being prone to alteration in SSPE, 
although not to the extent of matrix protein. Cattaneo and Rose (1993) reported that in 
three of four cases of persistent measles virus infection, the H protein was defective in 
intracellular transport, glycosylation, dimeriiation and fusion helper function. In most 
cases studied, the F protein has been found to be comparatively well conserved through 
most of its length with the exception of the C-terminus. Cattaneo et al. (1989b), showed 
that in three cases (of four), F had been altered, in two cases a stop codon had been 
introduced leading to the abrogation of the last 24 and 19 amino acids, in the third case the 
deletion of a nucleotide had resulted in the replacement of the last 27 amino acids by 
another 11. In a more extensive analysis of eight SSPE cases, the region encoding the C-
terminal domains ofF was examined. In all cases the F proteins were altered either in 
length and lor changes in amino acids (Schmid et al., 1992). It was proposed that changes 
in this region might promote viral persistence (Schmid et al., 1992); the current model for 
measles virus assembly is that the C-terminal cytoplasmic domain ofF, in concert with the 
cytoplasmic tail of HN, is able to interact with the nucleocapsid, thus allowing maturation 
of the virus particle. In VSV, it has been found that minor alterations to the cytoplasmic 
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tail of the analogous glycoprotein, G, impaired G protein processing and transport (Whitt 
et al., 1989). H this was the case for measles (and SSPE), then the decreased level of F 
expression at the cell swface could aid the cells both to survive and also to escape humoral 
immune attack. 
2.6.3 Mutations Affecting Virus Virulence 
The mutations of the type described in SSPE and MIBE are characteristic of an 
abortive persistence, in which virus cannot be released to infect further individuals. In 
these cases, the polymerase complex remains fully operational and it is viral assembly 
which is at fault. Possibly of greater epidemiological significance, are mutations which 
allow the virus to continue to propagate, but in a non-destructive manner. Variants of VSV 
which do not induce shut off of host cell synthesis are examples of such mutants. It has 
been shown that during a prolonged infection with VSV a mutant virus arose with a 
peculiar phenotype. In this persistent infection, genomic RNA synthesis continued at 
equally high levels as in the wild type virus infection, but mRNA levels were reduced 
(Frey and Youngner, 1982; Jordan and Youngner, 1987). As it is thought that VSV 
mediates shut off of host metabolism via the transcribed leader sequence (Weck et al., 
1979) the effect that this mutant had, was to allow host synthesis to continue, hence 
ablating the cytocidal effect of the virus. Other mutants of VSV have been shown to 
dampen viral infectivity by being better inducers of interferon than the parental virus 
(Nishiyama et al., 1978). 
A number of studies of prolonged Paramyxovirus and Rhabdovirus infections in 
vitro, have described the generation of temperature sensitive mutants and small plaque 
mutants which replicate more slowly and have a reduced virus yield compared to the 
parent virus (Nishiyama et al., 1978; Youngner and Preble, 1980; Hodes, 1982; Youngner 
et al, 1986). Mutation of any viral gene could potentially lead to a decrease in the level of 
virus production and hence affect plaque morphology. A range of temperature sensitive 
mutants of VSV have been isolated, with mutations occuring in each of the viral genes 
(Pringle, 1977). Classsification of temperature sensitive mutants of VSV has shown that 
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mutations in any of the polymerase proteins can interfere at the level of secondary 
;, 
transcription and genome replication, to dominantly decrease Viral RNA synthesis in 
mixed wild type and mutant infections (Youngner and Quagliana, 1976; Youngner et al., 
1986). Mutations arising in either in cis acting signals of the genome, slowing down the 
efficiency of polymerase binding, or in proteins of the polymerase complex, could hinder 
viral replication, thus giving rise to a small plaque phenotype. Given that almost 70% of 
the viral genome codes for polymerase proteins, it is conceivable that a significant 
proportion of spontaneous mutations will affect RNA synthesis. Homann and co-workers 
(1990) showed that in a persisting Sendai virus infection, there was a reduction in the 
levels of all viral RNA synthesis with no evidence for the generation of sub genomic 
particles, suggesting that any mutation that was responsible was more subtle. These 
authors speculated that the constraint upon RNA synthesis in this infection could lie in a 
fault in the polymerase. An example of a defect in the viral polymerase machinery has 
been described by Garcin et al. (1994). In their study of a persistent Sendai virus infection, 
in addition to the wild type virus, a virus variant was generated which expressed a 
truncated P protein. This protein was found to consist of only the C-terminal region of P 
and was found to depress viral replication by 80%. This is presumably because the mutant 
P had retained the capacity to bind to the nucleocapsid template (and/or NP) but was 
unable to bind to L. The mutant was found to dominate over wild type virus and so could 
generally restrain viral replication and consequently the viral infection. A mutation in any 
one of the polymerase proteins might give a similar result, even a single amino acid 
change, if in a significant domain. If viral replication is sufficiently suppressed, it may be 
that the virus will not incur damage on the host cell, thus satisfying this criterion of 
persistence. 
2.6.4 Generation Of Mutant Viruses And Their Role In Persistence 
How do mutants arise? The low fidelity of the replication of RNA viruses 
(Domingo et al., 1978) means that possibly mutations arise all the time, which are selected 
against in a lytic infection. The evidence for incidental mutations lies in the fact that 
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occasionally there is virus variation within different SSPE cases, suggesting that several 
mutants have arisen spontaneously (Liebert et al., 1986; Schmid et al., 1992). In some 
cases, mutations might arise in a more directed manner. In an MIBE case examined by 
Cattaneo et al. (1988), it was found that in the M mRNA transcript there was a cluster of 
transitions which converted 50% of the U residues to C. This was a far greater mutation 
rate than was observed for the other cases studied. The hypennutation event was attributed 
to an enzyme activity known as "double stranded RNA unwindase" which converts A 
residues into inosine, a base able to pair with C (Bass and Weintraub, 1988; Bass et al., 
1989). Rataul et al. (1992) found this unwinding activity to be at greater levels in a 
neuroblastoma cell line than in Vero cells, suggesting that virus residing in the CNS might 
be predisposed to a higher chance of hypennutation than it would be in other cell types or 
organs. 
The extent to which viral mutants can contribute to the establishment of persistent 
infections in vivo, is probably dependent on the virulence of the infecting virus and on the 
regeneration properties of the target organ. RNA synthesis might not have to be greatly 
affected to ensure a persistent phenotype. Homann et al. (1990) observed that in a 
persistent infection by Sendai virus, virus release was extremely limited even though there 
was only a weak reduction of mRNA and genome synthesis, suggesting that slight 
restrictions at the RNA synthesis level could have a cascading effect on overall virus 
production. 
It is possible that "street viruses" that are circulating through different populations 
contain sufficient numbers of mutant viruses or defective interfering particles to 
occasionally establish persistence. As in vitro virus isolation techniques tend to select for 
the fastest replicating viruses with the most lytic phenotype, any such slow growing 
mutants may not be noticed. 
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2.7 CHRONIC DISEASES ASSOCIATED WITH PERSISTING 
PARAMYXOVIRUSES 
Even in the absence of direct cellular destruction by a persisting virus, the presence 
of a replicating virus over long periods of time could well have detrimental effects on the 
host. Although it is required that for the virus to persist, it must not cause a direct 
cytopathic effect, a long term viral infection could have an effect on the "luxury" functions 
of the cell. It has been shown that a persistent mumps virus infection of cultured neuronal 
cells can have an effect on cell excitability (Ziegler and Stauffer, 1987). In neuroblastoma 
cells, measles virus infection can have an effect on levels of protein kinase C and on the 
expression of various oncogenes (Wolfson et al., 1989; 1991), and persistently infected 
'6lial cells release altered levels of cytokines compared to,during a primary infection 
(Schneider-Schaulies J., et al., 1993). Alternatively, the virus might induce an autoimmune 
reaction. It has been found that NDV membrane protein binding to cellular actin can incite 
an autoimmune reaction to the actin molecule (Anomasiri et al., 1990). Autoimmunity due 
to the presence of persisting viruses has been proposed as a reason for demyelination 
during multiple sclerosis (Fazakerley and Webb, 1986). Finally, virus residing as a low 
grade infection may be continually prompting immune attack on the infected tissue which 
could eventually lead to manifestation of disease. Crohn's disease, Paget's disease of bone 
and subacute sclerosing panencephalitis are examples of diseases in which 
Paramyxoviruses are known or are suspected. to playa role. These examples are not 
exhaustive; Paramyxoviruses have been linked to many chronic diseases and may be 
involved in many others in which, as yet, a viral aetiology is unsuspected. 
2.7.1 Subacute Sclerosing Panencephalitis (SSPE) 
SSPE is a slow, progressive and fatal disease of the eNS, a rare consequence of 
measles infection. It often occurs in children who suffered an acute measles virus infection 
at less than two years of age. The disease usually manifests itself 6-7 years later, with a 
decline in school performance and behavioural problems being the first symptoms, 
ultimaltely leading to coma and death in almost all cases. SSPE is characterised by the 
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presence of eleyated levels of antiOOdies against measles virus in the serum and 
cerebrospinal fluid (CSF), with a low serum:CSF antibody ratio and oligoclonal CSF IgG, 
suggesting a local production of measles virus antiOOdies. Measles specific IgM can also 
be detected implying that there is continual stimulation of the immune system. 
Immunochemical staining invariably demonstrates the widespread presence of measles 
virus antigens throughout most areas of the brain (reviewed by Swoveland, 1991; ter 
Meulen and Hall, 1978). SSPE is now recognised as an abortive measles virus infection, 
the virus replicates but is unable to mature. A significant feature of SSPE tissue is that 
measles virus nucleocapsids cannot be seen aligning under the cell membrane, or budding 
from the surface of the cell, instead they accumulate into distinctive intranuclear and 
cytoplasmic inclusions (Liebert et a/., 1986; Swoveland, 1991). The reason for 
nucleocapsid accumulation lies with the prevalence of extensive mutations of the virus 
genome. particularly of the M gene. These mutations prevent the nucleocapsids from being 
exported from the infected cell. 
Although measles virus aetiology in SSPE is no longer in question, many aspects 
of the infection process remain unresolved. It is not known when the virus gains access to 
the CNS. and what the stimulus is to cause disease. Haase et al. (1981) have suggested that 
there is no specific stimulus, rather that the virus is introduced into the CNS at an early 
stage, into cells that are relatively non permissive. Because viral replication is restricted, 
the infection progresses slowly, but gradually viral gene products accumulate sufficiently 
to allow viral genetic information to spread from cell to cell. Cells will die, or become 
dysfunctional either because of the continued presence of a persistently infecting virus or 
because the virus comes into contact with cells which are permissive. Symptoms will 
emerge when the virus induced lesions become extensive or when functionally important 
areas are destroyed. 
Although this theory would explain why the disease symptoms of SSPE become 
apparent after a fairly standard incubation period. it fails to clarify why only defective 
viruses are found in SSPE brain tissue. The fact that only mutated virus is found, and that 
frequently only one mutant is isolated in each brain or area of brain tissue suggests that 
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there may be sc:lective advantages for variant viruses which allow them to be propagated in 
preference to wild type. Work carried out by Hirano (1992) showed that in mixed 
infections of an SSPE virus and wild type measles virus, the SSPE virus had the effect of 
prolonging the wild type virus infection, but ultimately dominated, so that following seven 
weeks in culture, the wild type proteins were no longer detectable. It could be inferred 
from this result that once a variant virus has arisen, it will predominate and thus abortive 
infections might become established more readily than if they were dependent on the 
occurrence of several independent mutational events. An alternative hypothesis, to explain 
why only mutant genomes are isolated froin SSPE brains, has been suggested by Randall 
and Russell (1991). These authors proposed that SSPE might be dependent on the MHC 
repertoire of the afflicted individual, in that CILs in such individuals are only able to 
recognise viral antigens that are superfluous for cell associated persistence (M and H). In 
this scenario, the original acute viral infection could be controlled by the cell mediated 
immune response, but mutated genomes would escape detection and so would be able to 
persist. This explanation would account for the low incidence of SSPE in a population in 
face of a high incidence of acute measles virus infection. 
2.7.2 Paget's Bone Disease 
Paget's disease is a chronic disease of bone tissue which can be asymptomatic, but 
in some cases can result in painful and deformed bones. Examination of this condition has 
shown that osteoclast cells, cells that are responsible for the absorption of bone, are 
overactive leading to uncontrolled resorption. Osteoclasts are haematopoeitic cells and are 
possibly of a similar lineage to macrophage cells (Scheven, 1986). Paramyxoviruses were 
implied as aetiological agents of the disease because of the finding of inclusion bodies in 
the nuclei and cytoplasm of osteoclast cells, reminiscent of the inclusions observed in 
SSPE infected tissue (Harvey et ai, 1982; Howatson and Fornasier; 1982). 
Immunocytochemical analyses which have been employed to search for the presence of 
viral proteins, have revealed most frequently the presence of measles virus protein (Basle 
et ai., 1985;1987). However proteins of other members of the Paramyxovirus family have 
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been detected, including those of RS virus (Mills et al., 1981), PIV3 (Basle et ai, 
1985;1987) and SV5 (Basle et ai, 1985, 1987). COV viral sequences have been detected 
by in situ hybridisation (Cartwright et al., 1993). What is not known from any of these 
studies, is whether Paramyxoviruses are aetiological agents of the disease, or whether the 
virus is present as a bystander, possibly having been taken up as a result of the scavenging 
activities of the cells. 
2.7.3 Crohn's Disease 
Crohn's disease is a disease of the intestines, characterised by inflammation of the 
submucosal microvasculature and ulceration of the overlying epithelium. The frequent 
observation of giant cell granulomas in foci of vascular inflammation led to the suggestion 
that the disease is caused by a persistent viral infection (Wakefield et al., 1990). 
Transmission electron microscopy studies found Paramyxovirus-like particles in the 
endothelial cells, which were under attack from immune cells, but not in the normal 
surrounding cells. In situ hybridisation and immunohistochemistry showed the presence of 
measles virus specific RNA and antigens in the cells in the periphery around the lesions 
(Wakefield et al., 1993). From these results the authors tentatively suggested that a 
persisting measles virus infection could be responsible for the onset of Crohn's disease. 
Epidemiologic studies support this hypothesis, with the fmding that a significant excess of 
individuals developed Crohn's disease if they were born during or just after a measles virus 
epidemic (Ekbom et al., 1994). 
2.8 PERSISTENCE: IMPLICATIONS FOR THE VIRUS AND HOST 
It would be anticipated that an ability to persist would be an advantage to the virus. 
In this way, the virus is able to continue to replicate for prolonged periods of time. 
Continued replication may be of benefit in evolutionary terms. Furthermore, it may be 
possible for progeny virus to be continually shed from a host, allowing it to be propagated 
to many more individuals in the population than it would be during an acute infection. 
Again, this situation could be of evolutionary benefit to the virus. 
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The fact that some chronic human diseases are attributed to persisting viral 
infections, demonstrates that viral persistence can sometimes have grave consequences for 
the host. However, the effects of a persisting virus might not all be negative. Infection with 
measles or mumps virus usually leads to a lifelong immunity to the virus (Krugman, 
1965). It has been suggested that a lifelong immunity is developed due to a non productive 
persistent infection, in which measles (or mumps) virus antigens are occasionally produced 
in sufficient amounts to restimulate the immune system (ter Meulen et al., 1982). Even for 
parainfluenza and respiratory syncytial viruses, which are known to be able to give rise to 
recurrent infections, the effects of a prolonged infection could be to keep the immune 
system continually stimulated and help to avoid further acute infection for a short term 
period. In a study at an isolated antarctic research station, in which it was found that 
several apparently healthy individuals shed infectious virus throughout the winter, there 
was at least one person who was shedding virus on each occasion that he .was tested, but 
who did not succumb to overt acute respiratory infection at all during the 8 month period 
(Muchmore et al., 1981). Whenever Paramyxoviruses have been investigated as the 
causative agents of chronic disease, it has not been infrequent to fmd evidence for 
persisting virus in the tissues of healthy control subjects (Randall and Russell, 1991; 
Wakefield et al., 1993). These findings would suggest that at the least, viruses can reside 
in their hosts in a innocuous manner and that virus persistence is not necessarily a 
disadvantage for the host. 
2.8 OBJECTIVES OF THE WORK 
It is clear that although the general characteristics of Paramyxovirus persistence 
have been elucidated: incomplete assembly of virus particles or decreased levels of virus 
replication, the way in which a persisting virus avoids clearance by cytotoxic T cells has 
largely been overlooked. It is possible that factors such as the MHC haplotype of an 
individual may be involved in rare situations such as SSPE. However, the fact that 
Paramyxoviruses can be found to persist in a large proportion of the population (as 
previously mentioned, Paramyxoviruses are sometimes found in control populations in 
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which there is I!O evidence of any chronic disease), may suggest that MIle haplotypes and 
virus tolerance do not sufficiently explain all cases of viral persistence. It is possible that a 
more general mechanism is in place to permit most cases of virus persistence. For this 
reason. a persistent SV5 infection of cultured fibroblast cells was studied. with the aim of 
characterising the persistent state and attempting to understand how this scenario could be 
applied to persistent infections in vivo. Furthermore, factors which it was thought might 
influence the persistent state were examined in the hope that it might be possible to control 
the persistent state. 
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MA TERIALS AND METHODS 
1 CElLS AND VIRUS 
1.1 Maintenance of mammalian cell lines 
A number of cell lines were used in this study: 
HeLa cells; a human cervix carcinoma cell line obtained from Flow laborotories. 
Vero cells; a continuous line of African Green monkey kidney cells obtained from Flow 
laboratories. 
BHK21 0.13 (referred to as BHK -21); a continuous line of baby hamster kidney cells 
obtained from Flow laboratories. 
293 cells; a human cell line transformed by DNA from human adenovirus type 5 donated 
by Frank Graham (McMaster University, Hamilton). 
L-929 cells; a line of cells derived from mouse connective tissue, obtained from Ian Kerr 
(lCRF, Lincoln's Inn Fields). 
BF cells; a continuous fibroblast cell line cloned from a primary culture of a Balb/c mouse 
embryo. 
Each cell line was grown as a monolayer in 75cm2 or 25cm2 tissue culture flasks 
(Coming) in Glasgow modified Eagle's tissue culture medium (GMEM; Gibco-BRL). The 
medium was supplemented with 10% (v/v) newborn calf serum (NBCS; Gibco-BRL), 
penicillin at 50U/ml and streptomycin at 50J.lg/ml. The cells were incubated at 37°C under 
5% CO2. The cells were passaged every 4 to 5 days using trypsin (HeLa, Vero, BHK-21 , 
L929 and BF cells) or versene (293 cells). 
1.2 Preparation of a working stock of SVS 
The strain of SV5 that was used throughout this study was LN. This strain is a 
human isolate of SV5, isolated by co-cultivation of human bone marrow cells with a 
permissive cell line (Goswami et al., 1984). A working virus stock of virus was prepared 
by infecting a confluent monolayer of Vero cells in roller bottles, with a virus master stock 
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(prepared by D: Young) at a multiplicity of infection (moi) of 0.1 plaque fonning units/ml 
diluted in 2% (v/v) NBCS in GMEM. The virus was adsorbed for 2 hours after which time 
the medium was replaced with 20mls of 2% (v/v) NBCS in GMEM. The roller bottles 
were incubated on a rotator for 30-40 hours by which time plaques began to develop in the 
monolayer. The supernatant was then collected and centrifuged at 5,OOOx g to remove cell 
debris. The virus stock was stored in aliquots at -70·C. Titration of the virus was carried 
out using a plaque assay method and both cells and virus were examined for mycoplasma 
contamination by DAPI staining (Russell et al., 1975). 
1.3 DAPI staining of cells and virus 
Cells were seeded onto coverslips in 24 well plates (Coming) at a density of 5x104 
cells/well. and grown until slightly subconfluent (approximately 3 days). The medium was 
removed from the cells and the cells washed with methanol. The coverslips were then 
covered with a solution of 4,6 diamidino-2-phenylindole (DAPI), diluted to a 
concentration of IJlg/ml in methanol and incubated for 15 minutes at 37°C. The staining 
solution was then removed and the cells washed with methanol. The coverslips were 
mounted on slides in Citifluor (Citifluor LTD) and examined using immunofluorescence 
microscopy. Uncontaminated cells have a brightly fluorescing nucleus with no visible 
cytoplasmic fluorescence. If contaminated with mycoplasma. the cytoplasm and areas 
surrounding the cells will fluoresce. Virus stocks were checked for mycoplasma 
contamination by infecting a cell monolayer known to be mycoplasma free, and incubating 
the infected cells for several days. The cells were stained as described above. 
1.4 Plaque assay titration of virus stocks 
5xlOS Vero cells were seeded into a 6 well Linbro plate (Coming) and allowed to 
grow overnight (until just confluent). A ten-fold series of dilutions of the virus stock was 
made in 2% (v/v) NBCS and Iml of each dilution was used to inoculate each well of cells. 
The cells and virus were incubated on a shaker at 37·C for 2 hours to allow adsorption of 
the virus. The inoculum was then removed and replaced with 5ml of 2% (v/v) NBCS, 
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0.5% (w/v) car!>oxy methyl cellulose. The infected cells were incubated for 5 days. After 5 
days, the monolayer of cells was fixed by incubating for 10 minutes in a solution of 5% 
(v/v) fonnaldehyde, 2% (w/v) sucrose in phosphate buffered saline (PBS). After washing 
with 1 % (v/v) NBCS in PBS, the cells were permeabilized with a solution of 0.5% (v/v) 
nonindet-P 40 (NP40), 10% (w/v) sucrose and 1 % (v/v) NBCS in PBS for 5 minutes. To 
detect the foci of infection, the monolayers were incubated with a mixture of antibodies 
against SVS (1 in 500 dilution of ascitic fluid of each antibody, 0.5mls of antibody mix per 
well) for 1 hour. The wells were then washed with PBS containing 1 % (v/v) NBCS and the 
cells incubated for 1 hour with peroxidase conjugated anti mouse Ig antibody (SAPU, 1 in 
500 dilution, 0.5 ml per well). Following washing with PBS, an ELISA reaction was 
carried out using o-dianisidine. o-dianisidine staining solution was prepared by shaking 
=100mgs of o-dianisidine with 0.5 ml of absolute ethanol and adding 50mIs of water. The 
solution was fIltered through Whatman number 1 fIlter paper and hydrogen peroxide was 
added to 0.06% (v/v). The o-dianisidine solution was added to the wells and the plate 
incubated in the dark for 15 to 30 minutes. This procedure stains the virus plaques a dark 
brown colour, thus allowing them to be easily counted. Virus titre is expressed as plaque 
forming units per ml of virus stock (Pfu/ml). The working stock of virus was typically in 
the range of lx107 to lxlOS pfu/ml. 
1.S Virus infection of cells 
Slightly subconfluent cell monolayers were typically infected with SV5 at a 
multiplicity of infection (moi) of 5-10 pfu/cell. The virus was diluted in sufficient medium 
(2% (v/v) NBCS in GMEM) to cover the cell monolayer; 5mlsf75 cm2 flask, 3mls/25 cm2 
flask. The inoculum was incubated with cells for 1-2 hours on a rocking shaker at 37"C to 
allow virus adsorption. This medium was then replaced with fresh 2% (v/v) NBCS and the 
cells incubated at 37°C under C02 for the required time. Mock infections were carried out 
in a similar manner, except that 2% (v/v) NBCS in GMEM was substituted for the virus 
inoculum. 
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1.6 Single cell ~Ioning of infected BF cells 
Infected BF cells were trypsinized, counted and examined by light microscopy to 
ensure that a single cell suspension had been obtained. The cell suspension was diluted so 
that there was approximately 1 eel V well of a 96 well plate (i.e. 5 cells/mI). Two 5-fold 
dilutions of this suspension were made and the cells seeded into 96 well plates. The wells 
were checked at the outset to ensure that any colonies that grew were derived from a single 
cell. The cells were grown in GMEM supplemented with 20% (v/v) foetal calf serum (Sera 
Lab) until 50% confluent. When there was a sufficient number of cells in a well, they were 
trypsinized and divided into two. Half the cells were seeded onto coverslips for 
immunofluorescence analysis. The other half were seeded onto monolayers of Vero cells, 
which were growing on coverslips in a 24 well plate. The co-cultivated Vero and BF cells 
were grown together for a further 3 days before being prepared for immunofluorescence 
microscopy (details of immunofluorescence microscopy in section 3.7) 
2 RNA ANALYSIS 
2.1 Extraction of total cellular RNA 
The procedure used for isolation of total cellular RNA was based on the protocol 
described by Pharmacia in their mRNA purification kit and is a modification of the method 
described by Okayama et al. (1987). Cells were grown and infected in a 75cm2 flask. At 
the appropriate time post infection, cells were scraped into a solution of guanidinium 
thiocyanate; 4M guanidinium thiocyanate, 0.5% (w/v) sodium N-Iauryl sarcosine, 25mM 
sodium citrate, pH 7.0, O.IM ~mercaptoethanol, pH 7.0. Approximately 18m1s of buffer 
was used to lyse Ig of cell (12mls of buffer was usually used for a confluent 75cm2 flask 
of cells). The lysate was passed through a 16 to 18 guage needle at least 20 times, in order 
to shear the cellular DNA. The lysate was transferred to a sterile disposable centrifuge tube 
and centrifuged at 5,OOOx g for 20 minutes at I5-C, to pellet any insoluble material. The 
supernatant (2.5mls or 8.Om1s) was layered on top of a cushion of caesium trifluoroacetate 
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(Pharmacia) of.a density of 1.51± 0.01 g/ml, O.IM EDTA, pH 7.0 (2.7mls or 8.5m1s). The 
samples were then centrifuged at 125,000x g for 24 hours at 15·C. This procedure pellets 
the RNA at the bottom of the tube and collects the DNA in the lower third of the gradient. 
The supernatant was carefully aspirated off and the tubes inverted and allowed to drain. 
The RNA pellet was resuspended in 200 to 4OOJ.1l of TE buffer pH 8.0 (l0mM Tris-CI, pH 
8.0, ImM EDT A). The RNA solution was then transferred to a sterile microcentrifuge tube 
and vortexed. The RNA solution was then heated to 65°C for 10 minutes and then 
centrifuged briefly to remove any insoluble material. The supernatant was transferred to a 
clean, sterile microcentrifuge tube. At this stage, the concentration of the RNA was 
determined by an optical density reading at 260nm (1 absorbance unit is equal to 40J,Lg of 
RNA) and the purity of the RNA was analysed by comparing the optical density at 260nm 
with that at 28Onm. The ratio between the readings at 260nm and 280nm should be 1.8. 
Values less than this are an indication of protein contamination. The RNA was divided into 
appropriately sized aliquots and stored under ethanol at -70·C. When required, the 
precipitated RNA was collected by centrifugation at high speed in a bench microfuge for 
30 minutes at 4·C and by resuspending the pellet in double distilled sterile water. 
2.2 Northern blotting of RNA 
Total cellular RNA samples, purified as described in section 2.1 were prepared for 
electrophoresis by denaturing in 50% (v/v) fonnamide, 2.2M formaldehyde, lxMOPS 
buffer (Ix MOPS is 20mM 3-(N-morpholino) propane-sulphonic acid, 5mM sodium 
acetate, ImM EDTA, pH 7.0). The RNA mixture was incubated at 65°C for 5 minutes and 
then placed on ice. Gel loading buffer was added to a final concentration of 5% (v/v) 
glycerol, 0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol . Electrophoresis of 
the RNA was carried out in a horizontal slab gel consisting of 1 % (w/v) agarose, Ix MOPS 
buffer, 6.3% (v/v) formaldehyde. The running buffer was 1x MOPS buffer. 
Electrophoresis was carried out at 50 to looV until the bromophenol blue band had run 
two thirds of the length of the gel. Following electrophoresis, the RNA was transferred to 
nylon membrane, Hybond-N+ (Amersham) by Northern (capillary) blotting. In this 
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procedure. a re~ervoir of lOx SSC (3.0M NaCI, O.3M sodium citrate) is placed below a 
platform upon which a wick of Whatman 3MM paper is arranged so that the ends of the 
filter paper are lying in the lOx SSe. The gel is laid on top of the wick and in tum is 
overlaid with a sheet of Hybond-N+ , cut to the same size as the gel. On top of the Hybond-
N+ are placed 3 pieces of filter paper soaked in 2x SSC and then 7 pieces of dry filter 
paper. The assembly is completed with a 2 to 3 inch layer of paper towelling and a glass 
plate. The whole assembly is compressed with a weight. The transfer was allowed to 
proceed for at least 12 hours (usually overnight). Following transfer, the filter paper was 
removed and the RNA crosslinked to the membrane by exposure to UV light for 4 minutes 
using a transilluminator (UVP). After fixing, the filter could be stored for up to a week at 
4-C or used directly in a hybridisation reaction. 
2.3 Dot blotting of RNA 
Doubling dilutions of RNA solution were made in sterile water in a 96 well plate. 
A denaturing solution was added to each well to give a final concentration of 50% (v/v) 
formamide,6% (v/v) formaldehyde, Ix SSC. The plate was then heated in a water bath at 
6S-C for 15 minutes. The dot blot apparatus was prepared by washing first in O.IN NaOH, 
then rinsing with sterile distilled water. 2 sheets of Whatman 3MM filter paper soaked in 
20x SSC were placed on the bottom of the apparatus. A piece of Hybond-N+ was 
smoothed onto the underside of the top and the two parts put together and screwed down 
tightly. The denatured RNA was then applied to the dot blot apparatus under a vacuum. 
The wells were rinsed twice with lOx SSC. After the fmal rinse, the vacuum was left on 
for a further 10 minutes. Once the filter was removed from the apparatus, it was allowed to 
air dry prior to fixing with UV irradiation. The filter was now ready to be used in a 
hybridisation reaction. 
69 
2.4 Probe preparation 
Three different types of probe were used to detect RNA: 
2.4.1 End labelled oligonucleotide probe 
Cellular actin mRNA was detected using an actin specific oligonucleotide: 
5'GTGCCAGATCITCfCCATGTC3' (section 5.2 for oligonucleotide preparation), which 
was end labelled with [y32p] ATP (Amersham). The labelling reaction was carried out 
using 40ng of oligonucleotide and 20J,LCi of [-y32p] ATP in a reaction mixture consisting of 
10mM MgCh, 1000~-mercaptoethanol, 50mM Tris-Cl pH 8.0 and lOU of 
polynucleotide kinase (Amersham). The reaction was incubated for 1 hour at 37"C. Half of 
the reaction product was used in a hybridisation reaction. 
2.4.2 Random primed cDNA probe 
P and HN specific genomic, antigenomic and sub-genomic RNAs were detected 
using random primed cDNA inserts. Plasmids containing P and HN cDNA inserts 
(Paterson et ai., 1984) were used as templates in PCR amplifications with P and HN 
specific primers (see section 5.4 for details of PCR protocols). The products of the two 
PCR amplifications were subjected to electrophoresis on a 1 % low melting point agarose 
gel (FMC; see section 5.6 for procedure for agarose gel electrophoresis). The bands which 
represented P and HN specific DNA were excised using a clean scalpel and placed into 
microfuge tubes. The gel slices were weighed and 3mls of sterile water added per gram of 
gel. The tube was heated to 65·C for 2 minutes to melt the agarose. An aliquot of the 
resulting solution was used as a template in a random priming reaction in the presence of 
[32p] dCfP (Amersham). The reaction was carried out using a T7 Quickprime kit 
(Pharmacia) according to the manufacturer's instructions. Following labelling, the probe 
was purified by spun column chromatography as described by Maniatis et ai .(1982). 
Briefly, 5OJ.1.l of TE (PH 8.0) was added to the reaction mixture. The resulting solution was 
applied to a G-50 Sephadex column prepared in a glass wool plugged Iml syringe. The 
column and sample were centrifuged at 1,6OOx g for 5 minutes, and the eluate collected. 
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This fraction contained the purified labelled DNA. 1/4 of the purified product was used as 
a probe in a hybridisation reaction. The DNA probe was heated to 95-1()(YC for 2 minutes 
immediately prior to addition to the hybridisation reaction. 
2.4.3 Single stranded DNA probe 
Negative sense viral RNA was detected using a labelled single stranded DNA 
molecule that was generated by a unidirectional PCR (modified from Sturzl and Roth, 
1990). In this procedure, a plasmid containing a P cDNA insert was linearized at the 3' end 
of the P gene (mRNA sense). This restricted plasmid was used as a template in the PCR. 
The PCR amplification was carried out using only one oligonucleotide primer, of mRNA 
sense, which bound to the other end of the gene (see figure 9). The PCR amplification was 
carried out in a 50~1 volume containing 200ng to 1 ~g of restricted plasmid DNA, Ix PCR 
buffer (Appligene), 2~M primer, unlabelled d(A,T,G)TP at 200jJ.M and d.CTP (Pharmacia) 
at 6.25~M, 25~Ci of [a32p] dCfP (Amersham), 4.2U Taq DNA polymerase. The reaction 
mixture was overlaid with mineral oil and subjected to the following cycling program: 
94·C, 1 minute; 37°C, 2 minutes and 72"C for 3 minutes. 40 cycles were carried out. The 
mineral oil was removed from the reaction tube. No further purification of the PCR 
product was required, and 1/4 of the PCR reaction mixture was used in a hybridisation 
reaction. 
2.S Hybridisation 
Prior to the hybridisation reaction, ftlters were subjected to a prehybridisation step. 
The filters were placed in glass chambers of a Techne hybridisation oven. Pre-
hybridisation was carried out in 15m1s of hybridisation buffer: 5x SSC; 5m1s Denhardt's 
solution (l00x Denhardt's solution is 2% (w/v) bovine serum albumin, 2% (w/v) Ficoll, 
2% (w/v) polyvinyl pyrollidone); 0.5% (w/v) SDS; 50% (v/v) fonnamide at 42°C for 30 
minutes. The solution was then removed and replaced with 25m1s of hybridisation solution 
to which the appropriate probe had been added. If the end-labelled or PCR generated 
probes were used (which had not been purified from unincorporated label), sodium 
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The primec is the same sense as viral mRNA (the initiator codon is underlined) 
and is specific against the PN gene of SV5. PBS = primer binding site 
Figure 9: A schematic diagram showing the synthesis of a probe 
specific against negative stranded viral RNA. 
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pyrophosphate ~as added to the reaction to a final concentration of 0.1 %. The 
hybridisation reaction was allowed to proceed at 42·C for at least 18 hours. Following 
hybridisation, the filter was washed with an increasingly stringent series of wash solutions: 
lOOmIs 2x sse for IS minutes; lOOmIs 2x sse for IS minutes; lOOmIs 2x SSC with 0.1 % 
(w/v) SOS for 1 hour; lOOmIs O.lx SSC for 15 minutes. Having been washed, the filter 
was removed from the chamber and sealed within a plastic bag, with air bubbles removed. 
The fllter was then exposed to X-ray film with intensifying screens, at -70·C, for the 
required period of time. The same fllter was used for each probe by stripping in SmM Tris 
pH8.0, 2mM EDTA pH8.0, O.lx Denhardt's solution for 1-2 hrs at 6S·C. The filter was 
then autoradiographed to ensure that all label had been removed. If the filter was clean, it 
could then be used ina subsequent hybridisation reaction. 
3 PROTEIN ANALYSIS 
3.1 Antibodies 
All monoclonal antibodies (MAbs) used in this study were described by Randall et 
aI., (1987). NP, P, M, F and HN were all detected using speciflc monoclonal antibodies 
(MAbs). V was detected using a monoclonal antibody which also reacts against P. There 
were no MAbs available against SVS L. This protein was detected using an antiserum, 
supplied by Dr. R.E. Randall. The antiserum was raised in rabbits inoculated with L 
protein which had been isolated from a Coomassie stained polyacrylamide gel. 
3.2 [3SS] labelling of cells 
The cells were grown and infected as previously described. At the appropriate time 
post infection, the monolayer was washed with PBS and labelling solution: SO-l00J.1Ci/ml 
protein labelling (methionine/cysteine) mix (NEN), 2mM glutamine, 1 % (v/v) NBCS in 
methionine/glutamine free GMEM (Gibco-BRL) was added. A sufflcient volume of 
labelling mix was added to cover the cell monolayers and the cells and labelling mixture 
were incubated on a shaker at 37·C for the required length of time. After the labelling 
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period, the cell monolayers were washed twice with ice-cold PBS and prepared for 
immune precipitation. The procedure for the pulse followed by a chase was as above. 
except that folowing the labelling period, the cell monolayers were washed and complete 
GMEM with 2% (v/v) NBCS was added. The cells were then incubated at 37·C under CO2 
for the appropriate period of time. 
3.3 Immune precipitation of viral proteins 
Immune precipitation of viral proteins was carried out following the protocol 
described by Harlow and Lane (1988). Cell monolayers were lysed with an appropriate 
volume (e.g. 3mls /107 cells) of ice-cold immune precipitation buffer (0.65M NaCl, 20mM 
Tris-HCI pH 7.8, 1mM EDTA, 0.5 % (v/v) NP40, 0.1% (w/v) azide, 0.1% (w/v) SDS). 
The cell lysate was usually stored at -70·C at this stage. The lysed cells were then collected 
into an appropriately sized tube and sonicated using an ultrasonic probe. ~f necessary, at 
this stage a small fraction of lysate (approximately 1/10) was removed for total cell antigen 
analysis. The remainder was centrifuged at 4OO,OOOx g for 1 hour at 4·C, after which the 
supernatant was harvested and a further fraction removed if required for total soluble 
antigen analysis. Immune precipitation of viral proteins was carried out by incubating 100 
to 1000~1 of soluble antigen extract with 1~1 of ascitic fluid of each MAb for 1 hour on 
ice. The antibody-antigen complexes were precipitated by adding 20~ of a 10% fixed 
suspension of Cowan A strain of Staphylococcus aureus and incubating on ice for 1 hour. 
The precipitate was pelleted by centrifugation at a low speed on a bench top microfuge for 
2-3 minutes. The resulting pellet was washed 4 times in immune precipitation buffer. Mter 
the final wash, the pellet was resuspended in disruption buffer: 10% (w/v) SDS, 0.25M 
Tris-CI pH 7.0,3.25 M ~-mercaptoethanol, 12.5% (v/v) glycerol, 0.1 % (w/v) bromophenol 
blue, which had been diluted 1 in 4 with immune precipitation buffer. Similarly disruption 
buffer was added to total cell and soluble protein extracts (already in immune precipitation 
buffer) in a 1:3 ratio. The suspensions were boiled for 4 minutes and subjected to SDS-
polyacrylamide electrophoresis (see section 3.4). After the completion of electrophoresis, 
the gel was stained with a solution of 0.2 % (w/v) Coomassie Blue R-250 in 20% (v/v) 
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acetic acid, 20% (v/v) methanol for 1 hour. The gel was then de stained in 20% (v/v) 
methanol, 10% (v/v) acetic acid for 3 to 4 hours or overnight, dried and exposed to X-ray 
film at room temperature for the required length of time. Following exposure, the films 
were developed using an automatic developer (Kodak). 
3.4 SDS polyacrylamide gel electrophoresis 
Denatured proteins were fractionated by electrophoresis through polyacrylamide 
gels containing SDS (Laemmli, 1970). Gels were poured into gel rigs either consisting of 
assembled glass plates, or using Bio-Rad mini Protean System gel rigs, which were 
assembled according to the manufacturer's instructions. The resolving gel was prepared by 
mixing 0.375M Tris-Cl pH 8.5, 15% (w/v) acrylamide, 0.4% (w/v) N, N-
diallyltartardiamide (DA ID), 0.1 % (w/v) SDS and 0.035% (w/v) ammonium persulphate 
with 25J.11 of TEMED. The mixture was immediately poured into the pre-assembled gel rig 
and overlaid with water to leave a smooth interface after polymerization. When the gel had 
polymerized, the water was drained away, and the stacking gel; 4.6% (w/v) acrylamide, 
0.12% (w/v) DAID, 0.1% (w/v) ammonium persulphate, 0.12M Tris-CLpH 7.0,0.1% 
(w/v) SDS mixed with 7J.11 ofTEMED, was layered on top of the resolving gel. A comb 
was inserted to create wells. The stacking gel was allowed to polymerize for 1 hour before 
the complete gel assembly was placed into the electrophoresis tank. Electrophoresis was 
carried out in 0.19M glycine, 0.025M Tris, 0.1 % (w/v) SDS for 1200V hours for large gels 
or 150V hours for mini gels, until the bromophenol blue band had reached the bottom of 
the resolving gel. 
3.5 Western blotting of viral proteins 
Western blotting was carried out based on the protocol described by Harlow and 
Lane (1988). Cells were scraped into a minimum volume of disruption buffer diluted 1 in 4 
in immune precipitation buffer. The resulting lysate was collected and sonicated with an 
ultrasonic probe. After sonication, the suspension was boiled for 5 minutes and centrifuged 
at a high speed on a bench top microfuge to remove particulate matter. The supernatant 
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was denatured by boiling for 3-4 minutes and electrophoresed through a 15% SDS 
polyacrylamide gel. Following electrophoresis, the separated polypeptides were transferred 
to nitrocellulose using an LKB semi dry electroblotter. 4 sheets of 3MM Whatman filter 
paper, cut to the same size as the gel, were soaked in 20% methanol, 0.025M Tris and 
placed on the bottom graphite plate (anode). A sheet of pre-wetted nitrocellulose paper was 
placed on top of the 4 sheets of filter paper and overlaid with the polyacrylamide gel. A 
further 4 sheets of filter paper soaked in 20% (v/v) methanol, 0.025M Tris were placed on 
top of the gel. The upper graphite plate (cathode) was positioned on top of the sandwich. 
The gel was blotted for 1 hour at a constant current of 1 rnNcm2 of sandwich. Following 
transfer, the nitrocellulose filter was blocked with 5% (w/v) dried milk, 0.1 % (v/v) Tween-
20 in PBS, and then incubated with the appropriate monoclonal antibodies (1 in 2000 
dilution of ascitic fluid in blocking solution) at room temperature for 30 minutes. Mter 
several washes in PBS, 0.1 % (v/v) Tween-20, the filter was incubated with protein A 
conjugated horseradish peroxidase (Amersham) which bound the antibody. The bound 
protein A was in turn detected using an electrochemical light reaction (Amersham) and 
autoradiography. 
3.6 Dot blotting of viral proteins 
Cells in 75cm2 flasks were infected as described previously. At the appropriate 
time post infection, cells were collected by adding 3mls of ice cold PBS and scraping the 
cell monolayer from the wall of the flask (cells could be stored at -70·C at this stage). The 
cell suspension was sonicated using an ultrasonic probe and the resulting extract was 
diluted in doubling dilutions in a 96 well plate. 12J.1.1 aliquots were placed into each well of 
a Terasaki plate, 1 plate was set up for each antibody pool (ie. one for each protein, 5 in 
total). A prewetted sheet of nitrocellulose was placed over the wells and a sheet of 
Whatman 3MM paper placed over the nitrocellulose. A second Terasaki plate was placed 
on top of the other, sandwiching the protein extracts, the nitrocellulose and the 3MM 
paper. The sandwich was held firmly together with bulldog clips. The plates were inverted 
for I hour after which they were pulled apart and the nitrocellulose allowed to dry. The 
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filters were thep incubated with pools of monoclonal antibodies against each of the viral 
proteins NP, M, P, HN and F. The antibodies were diluted in blocking solution at 
concentrations which were determined to be in excess. The antibodies were detected using 
protein A conjugated horseradish peroxidase and an ECL reaction, as described above. 
3.7 Immunofluorescence microscopy 
Cells were infected as previously described. Immediately following infection, the 
cells were trypsinized and counted. They were then seeded onto coverslips in 24 well 
plates at a concentration of 2x 105 cells/well if required at one day post infection or 2x104 
cells/well if required for 5 days post infection analysis. The cells were then incubated at 
37-C for the required length of time. In order to carry out immunofluorescence detection of 
proteins, the cells were fixed and permeabilized as described in section 1.4. Following 
washing with 1 % (v/v) NBCS, 1 % (w/v) azide in PBS, the coverslips were incubated with 
the appropriate antibody. For double staining fluorescence, which .enables two proteins to 
be detected simultaneously, the cells were incubated with either NP, M, F, HN ascitic fluid 
or L antiserum, diluted 1 in 100 in 1 % (v/v) NBCS, 1 % (w/v) azide in PBS. Following this 
incubation, the cells were washed with 1 % (v/v) NBCS, 1 % (w/v) azide in PBS and 
incubated for 1 hour at room temperature with an anti mouse Ig antibody, conjugated to 
the fluor. Texas red (Sera Lab). P was detected on the same cover slips by using a pool of 
anti P monoclonal antibodies which had been directly conjugated to fluorocein 
isothiocyanate (FITC). For an indication of cell density. DAPI (at lOJ.1g1ml) was included 
in the final incubation to stain cell nuclei. The antibody incubations were carried out by 
inverting the coverslip onto a slide on which a 5 to 1OJ.11 drop of antibody had been placed. 
The slides and coverslips were incubated for 30 minutes, in a humidified container at 
37-C. When the incubations had been completed. the coverslips were washed and mounted 
in citifluor and examined using the immunofluorescence microscope. 
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4 CYTOTOXICITY ASSAYS 
Cytotoxicity assays were carried out to compare the level of killing by SVS specific 
cytotoxic T cells, of BF cells which had been infected for varying periods of time. The 
assay used is based on a method described by Brunner et al . (1968). Target cells, the 
infected BF cells, were labelled with [SICr] in the form of sodium chromate. The target 
cells were then incubated with SVS specific CfLs. If the target cells were expressing SVS 
specific antigens in association with MHC class I molecules, they should have been 
recognised and lysed by the CfLs. Lysis of the BF cells would result in release of [SICr] 
into the medium. The level of released [SICr] was then equated to percentage cell lysis by 
elLs. 
4.1 Priming of cytotoxic T Iympbocytes (CTLs) 
The generation of SVS specifi~ CILs was carried out following a.similar method 
described by Bangham et al. (198S) for generation of RS virus specific cn.s. Priming of 
the CILs took place in two stages. Firstly, the CfLs were primed in vivo by intranasal 
infection of Balb/c mice with SVS. The second stage was to collect spleens from mice and 
to restimulate the CfLs in vitro following the method described by Taylor et al. (1987). 
Spleens were collected from 2 mice 6 to 8 weeks after the initial SVS infection. The 
spleens were washed briefly in PBS and then pressed through a sterile stainless steel mesh 
in a Petri dish containing 1000s of PBS. The cell suspension was collected into a 10 m1 
conical tube and centrifuged at 400x g for IS minutes. The supernatant was discarded and 
the pellet was resuspended in 8mls of 167mM NH4CI and the suspension allowed to stand 
at room temperature for S to 10 minutes. After standing, the suspension was underlayed 
with NBCS and again centrifuged at 400x g for IS minutes. The resulting pellet was 
resuspended into 2mls of complete RPMI: RPMI 1640 medium (Gibco-BRL) 
supplemented with 2mM L-glutamine; SO~M p-mercaptoethanol; lOOU/ml penicillin; 
l00~g/ml streptomycin and 10% (v/v) foetal calf serum (Gibco-BRL), which had been 
heat inactivated by incubating at S6-C for 30 minutes. Approximately 4OO~ls of the cell 
suspension was removed for infection with SVS. SVS was added to the cells at a 
78 
multiplicity of !-5 pfu/cell. The virus/cell mixture was mixed and incubated at 37·C for 2 
hours. Following infection, the cells were collected by centrifugation at 400x g for 10 
minutes and washed twice with complete RPMI medium. These cells were then added to 
the remainder of the spleen cell suspension. The cells were incubated in 50m1s complete 
RPMI in an upright 75cm2 flask for 5 to 6 days. 
4.2 CTL assay 
4.2.1 [51Cr] labelling of target cells 
Three sets of target cells were prepared; BF cells that had been infected with SV5 
at a moi of 5 to 10 pfu/cell for either 1 or 5 days and BF cells which had been mock 
infected. The cells were trypsinized and counted. 1x106 cells from each set of targets were 
collected by centrifugation at 400x g for 10 minutes. The cell pellet was resuspended in 
2mls labelling mix; 0.2 mCi [51Cr] (Na25ICr04) made isotonic with lOx PBS in 
complete RPMI, and incubated at 37·C for 1 hour. After the labelling period, the cells were 
washed 3 times with complete RPMI, the last wash being allowed to continue for 1 hour. 
The labelled cells were then collected by centrifugation and resuspended in 10m1s of 
complete RPMI. 
4.2.2 Preparation of effector cells 
Most of the medium was aspirated from the bulk culture of CfLs (prepared as 
described in section 4.1). The cells were dispersed by gentle agitation and viable cells were 
counted using Trypan Blue exclusion. Cells were diluted to a density of 2x106 cells/ml in 
complete RPMI medium. Two-fold dilutions of the effector cells were carried out in 
complete RPMI medium in a round bottomed 96 well plate (1 OOj.1Vwell). Three sets (one 
for each target cell type) of dilutions were carried out in triplicate. In addition, two sets of 
control wells were established, in which the effector cells were replaced with complete 
RPMI medium alone (to measure spontaneous [51Cr] release) or 1 % (w/v) SDS (total 
[51Cr] release). 
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4.2.3 Estimatio!1 of CfL activity 
Target cells were plated out at 100J.Lllwell onto the plate with the effector cells and 
controls. The plate was centrifuged for 1 minute at 150x g in order to gently pellet the 
target and effector cells. The plate was then incubated for 4 to 5 hours at 37·C under C02. 
Following the incubation, the plate was centrifuged for 2 minutes at 250x g in order to 
collect the cells and cell debris at the bottom of the well. Immediately following 
centrifugation, l00~1 of supernatant was harvested from each well and transferred to a 
scintillation vial (Packard). The radioactivity in each vial was counted in a gamma 
scintillation counter. The percentage killing of each target cell type was calculated using 
the following equation: 
[(c.p.m. in presence of CfL-spontaneous [S1Cr] release)/ (total [51Cr] release-
spontaneous [ S1Cr] release)] x 100%. 
5. RECOMBINANT DNA TECHNIQUES 
5.1 Overview or the cloning strategy for V 
A cDNA copy of the V gene of SVS was created by reverse transcription of total 
RNA using a PN gene specific primer. The V cDNA thus synthesized was then used as a 
template in a PCR reaction using two primers. The resulting cDNA copy of the gene was 
first cloned into the vector pUC I 19 (Veira and Messing, 1987). This plasmid has an M13 
origin of replication which facilitates the production of single stranded DNA copies of the 
inserted sequence. The single stranded DNA thus obtained was then used for sequencing 
analysis. From the pUC119 plasmid, the V cDNA insert was subcloned into two 
expression vectors; pGEM 3fz+ (Promega), which enabled transient expression of the V 
gene, and pREP8 (InVitrogen), for stable expression. 
Two primers were used to construct V cDNA (figure 10), designed with each of the 
plasmid vectors in mind. The forward primer (primer 1) contained the recognition 
sequence for Kpn I, a restriction site common to all three vectors and the A TO start codon 
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Figure 10: Cloning strategy for the V gene of SV5. 
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of the PN genc~ of SV5. The reverse primer (primer 2) contained a Sal I site, which is a 
site in pUC 119 and pGEM 3fz+, and a Not I site, which allowed insertion of the gene into 
pREPS. This primer also contained the end of the P gene in antisense. The cloning 
procedure for V is shown schematically in figure 10. A cDNA copy of the V gene was 
obtained by means of a reverse transcriptase reaction using Primer 1. This primer will only 
hybridise to the viral genomic RNA (as opposed to antigenomic and mRNA). As the viral 
genome codes for V rather than P, a reverse transcription reaction will result exclusively in 
the synthesis of V specific DNA. The V cDNA thus synthesized was then used as a 
template in a PCR reaction using both primers. The product was restricted using Sal I and 
Kpn I and the resulting fragment ligated into the pUC119 plasmid (prepared by restriction 
with Kpn I and Sal I). The pUC119 V construct was then selected for and amplified by 
transfonning the plasmid into E. coli and selecting for ampicillin resistant colonies. 
Plasmid containing cells were then used either to generate single stranded DNA for the 
purpose of sequencing the cloned gene or as a source of plasmid containing V. From 
pUC119 V, V cDNA was restricted using Not I and Kpn I for subcloning into the pREP8 
plasmid vector, and with Sal I and Kpn I for subcloning into pGEM 3fz+. 
Many of the techniques described below are based on those described by Sambrook 
et aI. (1989). 
S.2 Preparation of oligonucleotides 
Oligonucleotides, for use as primers and probes, were synthesized on an Applied 
Biosystems 381 A by I. Armitt. The oligonucleotides were resuspended in 200J.11 of sterile 
water and precipitated with 1/10 volume of 3M sodium acetate, 1/100 volume 1M 
magnesium acetate and 3 volumes absolute ethanol. The precipitate was collected by 
centrifugation at 4-C for 15 mintes at high speed on a benchtop rnicrofuge. The resulting 
pellet was then resuspended in 200 to 500J.11 of sterile water. The concentration of the 
oligonucleotide solution was measured by optical density measurement at 260nm. At this 
wavelength, an optical density reading of 1 is equal to 25J.1g/ml of oligonucleotide. If 
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necessary, the molarity of the solution was calculated using the fact that the mass of 1 base 
is 329 daltons. 
5.3 Reverse transcription of cDNA from viral RNA 
Total cellular RNA was extracted from SV5 infected BHK cells using the method 
described in section 2.1. 4J.1g of total RNA were used as a template in a reverse 
transcription reaction. The 1O~ reaction mixture also included Ix PCR buffer (Appligene), 
4OOJ.1M of each of the dNfPs, 2.5mM primer 1, 0.5J.11 placental ribonuclease inhibitor 
(RNasin) and 2J.11, 400U Moloney murine leukaemia virus reverse transcriptase (Gibco-
BRL). Two negative control reactions were also established in which the either the RNA 
or the reverse transcriptase were omitted. The reaction mixtures were each incubated at 
42"C for two hours. The cDNA product was amplified by incorporating the reverse 
transcriptase reaction into a PCR reaction. The 10J.11 reverse transcriptase.reation mix was 
included as template in a typical PCR mixture (see below) of l00J.1l. 
5.4 Polymerase chain reaction (PCR) amplification of DNA 
PCR amplification of cDNA was utilised for a number of purposes: to amplify 
cDNA prepared in a reverse transcriptase reaction to enable it to be inserted into a cloning 
vector, to prepare probes and as a screening procedure to determine if cells contained the V 
containing plasmid. A typical PCR was carried out using I to lOng of template DNA. In 
addition the reaction mixture contained IJ.1M of each primer, 200J.1M of each dNTP, Ix 
PCR buffer (Appligene) and 2U ofTaq DNA polymerase (Appligene) in a total volume of 
20 to lOOJ.1l. The reaction mixture was overlaid with approximately 50J.11 of mineral oil to 
prevent evaporation of the reaction components during the thermal cycling. Amplification 
was carried out in a Techne DNA thennal cycler using the following parameters: 94°C for 
1.5 minutes, to denature the DNA; 55°C for 1.5 minutes to allow the primers to anneal to 
the DNA; 72"C for 2 minutes to allow extension of the primers by the Taq DNA 
polymerase. The amplification was carried out for 30 cycles, with a 10 minute extension 
(72"C) at the end in order to ensure that the majority of the product was full length, double 
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stranded DNA. After the 30 cycles had been completed, the PCR mixture was removed 
from the mineral oil. IT necessary 1/10 of the product was subjected to electrophoresis on 
an agarose gel in order to ensure that the PCR product was of the expected molecular 
weight. The remainder of the product was purified by phenoV choroform extraction 
followed by an ethanol precipitation. The precipitate was then resuspended in SOj.Ll of 
sterile water. 
5.S Restriction enzyme digestion of DNA 
Digestion of DNA by restriction enzymes was carried out either in a preparative 
capacity during the cloning procedure or alternatively restriction enzyme digests were used 
as a means to ensure that DNA preparations restricted as would be expected. Typically 0.2 
to 2J.lg of DNA was digested. Restriction digests were carried out in 20 to SO J.ll volume 
reactions in buffers that were supplied by the manufacturer (either New England Biolabs, 
or Gibco-BRL) diluted to the appropriate concentration. If necessary, acetylated bovine 
serum albumin (New England Biolabs) was included in the reaction, following the 
manufacturer's instructions. IOU of the appropriate restriction enzymes were added. 
Digestions were carried out for 2 to 4 hours at 37-C.1f two enzymes were being used for 
the digest, which were incompatible in their buffering requirements, the enzyme requiring 
the lowest salt buffer was used first. The buffer was then adjusted to the correct salt 
concentration for the second enzyme reaction, and the second enzyme was added. If the 
DNA being restricted was the vector backbone to be used in a ligation reaction, its ends 
were dephosphorylated by the inclusion of O.SJ.ll (12U) of alkaline phosphatase (Boeringer 
Mannheim) in the last hour of the digestion reaction. Following digestion, the alkaline 
phosphatase was inactivated by adding EGT A to a final concentration of 20mM and 
incubating at 6S-C for 10 minutes. Following the restriction digest, the resulting DNA 
fragments were separated by electrophoresis through an agarose gel. 
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5.6 Agarose geJ electrophoresis of DNA 
Electtophoresis of DNA was carried out in a horizontal slab gel consisting of 1 % 
(w/v) agarose (Sigma) dissolved in lxTBE (0.089M Tris-borate, 0.089M boric acid, 
0.OO2M EDT A). DNA samples were applied to the gel in 5% (v/v) glycerol, 0.05% (w/v) 
bromophenol blue, 0.05% (w/v) xylene cyanol. Electtophoresis was carried out at 50 to 
lOOV in lxTBE containing l~g/ml ethidium bromide. Following electrophoresis, the DNA 
bands were visualised by illumination from a UV transilluminator (UVP). Molecular 
weight maIkers of bacteriophage A DNA, restricted with EcoR I and Hind ill, were also 
electrophoresed, in order to guage the molecular weight of DNA in a sample and to gain an 
estimation of the concentration of the DNA. Bacteriophage A DNA molecular weight 
markers were prepared by diluting A DNA (Promega) to a concentration of 40ng/~. The 
DNA was then completely digested with EcoR I and Hind ITI. 5 to 10 ~l of the marker 
solution was applied to an agarose gel. 
5.7 Purification of DNA fragments from agarose gels 
DNA fragments generated by PCR amplification, or restriction digests which were 
to be used for cloning purposes, could be isolated following separation by electrophoresis. 
Two different methods were used to recover DNA from the agarose gel; electroelution or 
purification using a SpinBind® DNA recovery system (FMC). Long wave UV illumination 
allowed visualization of the DNA fragments. To electtoelute the DNA, a sterile scalpel 
was used to cut a block out of the agarose slab, just below the DNA band of interest 
Sufficient electrode buffer (lxTBE) was poured into the gel rig to cover the electrodes (but 
not the gel) and the trough created by the removal of the agarose block was filled with 
buffer. Electrophoresis was continued at lOOV for a 45 second interval after which the 
buffer in the ttough was collected into a sterile eppendorf tube and replaced with fresh 
lxTBE. This procedure was repeated until the DNA had moved from the gel and had bee~ 
collected into the eppendorf tubes. The different fractions of DNA solution were examined 
by UV illumination and the DNA rich fractions were pooled together. The DNA was 
recovered by extraction through phenol and chloroform and precipitation with ethanol. The 
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resulting precipitate was washed with 70% (v/v) ethanol and resuspended in 20-5~1 ofTE 
(pH 8.0). 
Recovery of DNA fragments using the SpinBind® DNA recovery kit was carried 
out following the manufacturer's instructions. Briefly, the required DNA fragment was 
excised from the gel using a sterile scalpel and placed in an eppendorf tube. The gel slice 
was weighed and 3 volumes of a solution of 7.2M NaI, 20mM dithiothreitol, O.lM sodium 
phosphate. pH 6.0 were addded (lmg of gel ... lOOJ.1l). The sample was then heated to 60°C 
for 10 minutes to dissolve the gel. The sample was then applied to a SpinBind® column 
and the column washed, firstly with 4.8M NaI, 20mM dithiothreitol, O.066M sodium 
phosphate buffer, pH6.0, then with 80% (v/v) ethanol in 10mM Tris-CI, 0.2mM EDTA, 
pH8.0. The DNA was eluted from the column with 25 to SOJ.1l of either TE pH 8.0 or 
sterile water. 
Once the DNA had been extracted from the gel (by either method) its concentration 
was estimated by electrophoresing a fraction (eg.1/lO) on an agarose gel. Comparison of 
the intensity of the purified band, with that of the molecular weight marker bands (for 
which the quantity of DNA in each fragment could be calculated), allowed an approximate 
estimation of the amount of purified DNA which has been applied to the gel, and hence its 
concentration in the solution. 
5.8 Ligation of DNA fragments 
Ligation reactions were carried out to combine the DNA insert (in this case SV5 V 
gene cDNA) with the plasmid vector of choice. DNA insert fragments were either 
generated by reverse transcription and PCR followed by restriction with the appropriate 
enzymes, or were restricted from a previously constructed plasmid. The plasmid vector 
into which the cDNA fragment was to be inserted was prepared by means of a large scale 
preparation of plasmid DNA (section 5.13), followed by restriction of the plasmid with the 
appropriate enzymes and purification of the restricted DNA. The ligation reaction was set 
up with the aim of having equimolar amounts of the vector and insert present. Usually 0.1 
to IJlg of each of the vector and insert were incubated together in a 20JlI reaction mixture 
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containing 0.5W (200U) of T4 DNA ligase (New England Biolabs) and Ix ligation buffer 
(supplied). The ligation reaction was carried out for 16 to 24 hours at 16"C. The ligation 
reaction mix was then used, without further purification, to transfonn competent E. coli 
cells. 
5.9 Bacterial strains and culture 
The strain of E. coli used depended on the plasmid with which it was being 
transformed. pUCl19 V and pGEM3fz+ V were both tranfonned into E. coli strain TO 1 
(supE hsd Mthi A(lae-proAB) F'[traD36 proAB+ lacIq lacZL1M15]). pREP8 V was 
transformed into E. coli strain TOP 10 (mcrA ~mrr hsdRMA mcrBC) ~80 Alae AM15 
AlacX74 deoR reeAl araD139 A(ara,leu) 7697 galU galK k rspL entIA1 nupG). Liquid 
bacterial cultures were grown in Luria broth; 10g/l bacto-tryptone (Difco), 5g/1 yeast 
extract (Difco), 10mM NaCI, pH 7.5, supplemented with the appropriate antibiotics; T01 
cells containing either pUC119 V or pGEM3fz+ V were grown in medium containing 
ampicillin at 75J.1g/ml. TOP 10 cells containing pREP8 V were grown in tetracycline, 
12.5J.1g/ml and ampicillin, 75J.1g/ml. Solid media contained Luria broth supplemented with 
1.5% (w/v) agar (Difco) and 10mM MgS04, again supplemented with the appropriate 
antibiotics. 
Bacteria that were to be used to produce single stranded DNA for sequencing 
purposes, were cultured in minimal media. Liquid media was 2x TYE (16g/l tryptone, 
10g/1 yeast extract, 20mM NaCI pH7.5) and solid medium was minimal glucose agar 
(l5g/1 agar, 4g/l glucose, O.Olg/l thiamine, 0.3g/l MgS04, 15g/l KH2P04, 5g/l (Nl4) 
2HP04.H~). The appropriate antibiotics were added. 
5.10 Preparation and transformation of competent E. coli cells 
Competent E. coli cells were prepared using the method described by Dagert and 
Ehrlich (1978). A 5ml culture of E. coli was grown to saturation. Im1 of this culture was 
diluted into 49m1s of L-broth and shaken at 37"C for approximately 3 hours until the 
OD600 was between 0.45 and 0.55 units. At this stage, the cells were incubated on ice for 
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10 minutes afte! which they were harvested by centrifugation at 4000x g, at 4°C, for 10 
minutes. The pellet of cells was resuspended in 25mls of ice cold 50mM CaC12. When the 
cells were completely resuspended, they were incubated on ice for 15 minutes. Following 
this, the cells were again collected by centrifugation as above. The resulting pellet was 
resuspended in 3.33m1s of ice-cold 50mM CaCI2. The cells were now competent and were 
stored on ice until required, or at 4°C for up to 3 days. The transformation efficiency of 
cells prepared in this way is at an optimum between 12 to 24 hours after preparation. 
Transformation of the competent cells with plasmid DNA was carried out as 
follows: 1~ of competent cells were put into a microfuge tube and up to 50ng of DNA 
in a volume of lOJ.Ll, or 5-IOJ.LI of a ligation reaction, were added. The suspension was 
mixed by gentle shaking and incubated on ice for 30 minutes. The E. coli were then heat 
shocked by placing at 42°C for 90 seconds exactly. Following heat shock, 800J.Ll of L-broth 
(not containing antibiotics) was added and the cells incubated at 37°C to allow them to 
recover and to start expressing the antibiotic resistance gene. Varying volumes (IOJ.LI to 
250J.LI) of the cell suspension' were plated onto L-agar plates containing the appropriate 
antibiotic. When the suspension had been absorbed into the agar, the plates were incubated 
for 12 to 20 hours at 37°C until single colonies had begun to develop. 
5.11 Colony peR amplifications 
Colony PCR amplification involves PCR amplification of DNA, directly from 
bacterial cells. This procedure allowed colonies that grew following tranformation, to be 
screened to determine if the clones obtained contained the V cDNA insert. Single colonies 
were picked and used to inoculate Iml ofL-broth. The same colony was dotted onto a 
master LB-agar plate for long term storage. The Im1 culture was grown for I hour in the 
presence of antibiotics. IJ.LI of the resulting culture was then used as a template in a mini 
PCR amplification in a total volume of 10 to 20 J.Ll. The PCR amplification was carried out 
as described in section 5.4. 
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5.12 Small sca!e preparation of plasmid DNA 
Small scale preparations of plasmid DNA were usually carried out as an analytical 
step prior to a large scale preparative plasmid purification. Small scale plasmid 
preparations were carried out in order to verify that a plasmid created by cloning was of 
the expected molecular weight and yielded fragments of the expected size when subjected 
to restriction enzyme digestion. 
The method that was used is based on the protocol described by Birnboim and 
Doly (1979). Single colonies of E. coli were picked and grown for 12 to 18 hours at 37°C 
in 2mls of L-broth, containing the appropriate antibiotics. 1.5mls of the culture was 
centrifuged at high speed on a bench top microfuge at 4·C for 30 seconds. The supernatant 
was removed and the pellet resuspended in l00J.1l of ice cold solution I (50mM glucose, 
25mM Tris pH 8.0, 10mM EDT A pH8.0). 200~ls of solution II (0.2N NaOH, 1% (w/v) 
SDS) were added and the solutions mixed by inverting the tube 5 times. After 5 minutes 
l~ls of solution III (3M potassium, 5M acetate) was added and the tube vortexed for 10 
seconds. The mixture was incubated on ice for 5 minutes and then centrifuged at high 
speed on a bench top microfuge for 5 minutes at 4·C. The supernatant was removed to a 
fresh tube and the DNA purified by extracting with equal volumes of phenol and 
chloroform and precipitation with 2 volumes of ethanol at room temperature for 2 minutes. 
The DNA precipitate was collected by centrifugation for 5 minutes on a bench top 
microfuge at 4·C, washed with 70% (v/v) ethanol and resuspended in 50~1 TE pH 8.0. 
5.13 Large scale preparation of plasmid DNA 
Large scale plasmid purifications were carried out either to isolate a recombinant 
plasmid that had been constructed by ligation and subsequent transformation of E. coli, or 
to provide large quantities of plasmid to use as a vector in a cloning procedure. Large scale 
plasmid purifications were carried out using a QUIAGEN maxi kit. The method used by 
this kit is a modification of the protocol described by Birnboim and Doly (1979) which is 
outlined above. Single colonies of the appropriate E. coli strain were picked from LB-agar 
plates and grown up in IOmls of L-broth, containing the appropriate antibiotic, for 12 
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hours at 37·C. ?mls of this culture was used to inoculate 500mls of antibiotic containing L-
broth, and this culture was grown for 12 hours on a rocking shaker at 37°C. The bacterial 
cells were harvested by centrifugation at 4·C for 15 minutes at 6,000x g. The supernant 
was completely removed and the bacterial pellet was resuspended in IOmls of l00J.1g/ml 
RNase A (supplied), 50mM Tris-CI, 10mM EDTA pH8.0. 1000s of 200mM NaOH, 1 % 
(w/v) SDS was then added to the suspension and the mixture was incubated at room 
temperature for 5 minutes. IOmls of ice cold 3.0M KAc, pH 5.5 was added and the 
suspension immediately mixed by inverting the tube several times. The mixture was then 
incubated on ice for 15 to 20 minutes. The sample was then subjected to centrifugation at 
4·C at 3O,000x g for 30 minutes and the clarified supernatant removed. The supernatant 
was then applied to a QIAGEN-tip 500 which had been equilibrated with a solution of 
750mM NaCl, 50mM MOPS, 15% (v/v) ethanol, pH7.0, 0.15% (v/v) Triton X-l00. The 
QIAGEN-tip was then washed with 1.0M NaCl, 50mM MOPS, 15% (v/v) ethanol, pH 7.0 
and the DNA eluted with 15mls of 1.25M NaCl, 50mM Tris-CI, 15% (v/v) ethanol, pH 
8.5. The DNA was precipitated from the solution by the addition of 0.7 volumes of 
isopropanol, followed by centrifugation at 15,000x g, at 4·C for 30 minutes. The resulting 
DNA pellet was washed with ice cold 70% (v/v) ethanol, air dried and resuspended in 500 
to 1 ~s of TE pH 8.0. The concentration and purity of the DNA was confmned both by 
optical density analysis at 260 and 280nm and by restriction digests followed by 
electrophoresis through a 1 % (w/v) agarose gel. 1 absorbance unit at 260nm is equal to 
50J.1g/ml of double stranded DNA. As with RNA, comparison of the ratio of absorbance at 
260nm to 28Onm, gives an indication of the purity of the sample. 
6. SEQUENCING OF RECOMBINANT DNA CLONES 
6.1 Preparation of single stranded DNA 
The plasmid pUC119 V was transformed into E. coli cells strain TO 1 cells. 
pUC119 V containing cells were grown to saturation then diluted 1 in 100 in 2mls of 2x 
TYE broth. Helper phage M13K07 (Promega) was added at a multiplicity of infection of 
lOpfu/cell and the cells and phage were incubated in the presence of ampicillin for 1 hour. 
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After 1 hour, kanamycin was added to the culture to a concentraion of 70~g!ml, to select 
for those cells which contained the phage. 8 hours after the addition of kanamycin, the 
culture was transferred to two microfuge tubes and the cells pelleted by high speed 
centrifugation on a bench top microfuge. The supernatant containing the phage and the 
packaged pUCl19 single strands was retained and the phage collected by precipitating 
with 2001Jl of a solution of 20% (w/v) polyethylene glycol 4000, 2.5M NaCl. The 
precipitation step was allowed to proceed for 15 minutes at room temperature, after which 
the phage were pelleted by centrifugation on a bench top microfuge. The supernatant was 
removed, with care taken to remove all traces of the polyethylene glycol solution. The 
pellet was resuspended in l00~1 ofTE and the DNA was purified by phenol, chloroform 
extraction followed by an ethanol precipitation. The resulting DNA pellet was air dried and 
resuspended in 3O~1 of TE. 5~1 of this DNA solution was used as a template in each 
sequencing reaction. 
6.2 Dideoxy sequencing of the V insert 
Sequencing of the V insert was carried out using Sequenase™ version 2.0 
sequencing kit (United States Biochemical). This kit uses the method described by Sanger 
et al. (1977). To sequence the gene, 3 primers were used, each in a separate reaction. One, 
supplied with the Sequenase kit, bound to the M13 origin of replication, which is upstream 
of the polycloning site. Using this primer permits sequencing of the start of the inserted 
gene. The other primers were specific for the V gene: 
Primer sequence 
5' to 3' 
CCCTTnGGTACCATGGATCCCACTGATCTGAGC 
GCCATIGTGCCAGCA 
binding position on 
open reading frame 
1-21 
250-264 
Table 2: Table showing the V gene specific primers that were used to sequence V. 
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The sequencing reactions were carried out as follows: primer, at a concentration of 
3ng/ml was annealed to the template DNA (5J.11 of single stranded DNA prepared as 
described above) in 40mM Tris-CI, pH7.5, 20mM MgCI2, 50mM NaCI in a total volume 
of 1OJ..Ll. The annealing step was carried out by heating the mixture to 65°C for 2 minutes, 
then cooling slowly to 35·C. The next stage was extension of the primer with Sequenase 
Version 2.0 17 DNA polymerase to incorporate [35S] dA TP into the nascent DNA. This 
step was carried out by adding the primer:template complex mixture to IJ.1II00mM 
dithiothreitol, 2J..Ll of labelling mix; d(G, C, T)TP at 1.5J.1M, Sequenase Version 2.0 T7 
DNA polymerase which had previously been diluted I in 7 in 10mM Tris.CI pH7.5, 5mM 
dithiothreitol, 0.5mg/ml bovine serum albumin and 10J.1Ci [35S] dATP (Amersham). The 
components were mixed and incubated at room temperature for 2 to 5 minutes. The 
extension reaction was halted by dividing the reaction contents between 4 termination 
reactions, one each for G, A, T and C. In this step 3.5J.11 aliquots were added to 2.5J.11 of 
each termination mixture containing the appropriate ddNfP (eg. ddG mix: 80J.1M d(T, A, 
G, C). 8J1M ddGTP. 50mM NaCI). The termination reactions were incubated at 37·C for 5 
minutes after which they were halted by the addition of 4J.11 of stop solution (95% (v/v) 
formamide, 20mM EDTA. 0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene cyanol). 
The samples were heated to 75·C for 2 minutes prior to loading 2J.11 of each reaction onto a 
7M urea, 6% (w/v) polyacrylamide gel. 
6.3 Electrophoresis of sequencing reactions 
Sequencing gels were cast using a Sequi-Gen® Nucleic Acid Sequencing Cell (Bio-
Rad). The gel consisted of Ix TBE, 7M urea, 6% (w/v) acrylamide in a total volume of 
75mls. A few grains of bromophenol blue were added to the mixture (to enable easy 
visualisation of any bubbles in the cast gel) and the concoction was polymerized by adding 
75J.11 ofTEMED and 75J.11 of a 25% (w/v) solution of ammonium persulphate. After the gel 
solution had been poured into the cast, the gel comb was inserted between the glass plates 
so that its horizontal edge was adjacent to the gel surface. When the gel had polymerized, 
the comb was inverted so that its teeth were lying next to the gel. The spaces between the 
92 
comb teeth thus fonned the wells into which the samples were loaded. Prior to loading the 
samples, the gel was allowed to wann up to 50·C by being subjected to a voltage of 2000V 
for 1 hour. When the gel had wanned, the 4 different reactions (ie. G, A, T, C) were loaded 
and were electrophoresed at 2000V for the appropriate length of time; usually until the 
bromophenol blue had reached the bottom of the gel although longer runs were 
occasionally carried out in order to detect different regions of the sequence. Following 
electrophoresis, the gel was transferred to 3MM Whatman fIlter paper, dried at 80°C under 
vacuum and exposed to X-ray fIlm at room temperature. The sequence was read from the 
bottom to the top of the autoradiogram, which presented the cDNA sequence in the 5' to 3' 
orientation. 
7. EXPRESSION OF FOREIGN DNA IN MAMMALIAN CELLS 
7.1 Transient transfection of 293 and Balb/c fibroblast cells 
Cells were plated out into wells of a six well plate at a density of approximately 
2xl05 cells/well. They were grown until the monolayer was about 60% confluent. One 
hour prior to transfection, the cell monolayer was infected with a vaccinia virus 17 
polymerase recombinant virus (Fuerst et al., 1986) at an moi of Ipfu/cell. For each well 
that was transfected, the following solutions were prepared: l00J.1l of OPTIMEM® reduced 
serum medium (Gibco BRL) containing lotJ.g ofpGEM 3fz+ V and 10J.11 of Lipofectin 
Reagent (Gibco BRL) in 9OJ.11 of OPTIMEM® medium. The two solutions were combined 
and incubated at room temperature for 15 minutes. Following this incubation, 0.8 ml of 
OPTIMEM® medium was added to the mixture. The cells were washed twice with 2ml of 
OPTIMEM® medium before overlaying with the Lipofectin Reagent:DNA complexes. 
The cells were incubated with the overlay for 16 hours, after which they were harvested 
and assayed for the presence of V by immune precipitation of available V followed by 
Western blotting of the immune precipitate. 
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7.2 Electroporation of BF cells 
107 cells were suspended in 500J..Lls of 10% NBCS in GMEM. 10 to 2OJ..Lg of 
pREP8 V DNA was added to the cells, mixed gently and allowed to stand at room 
temperature for 10 minutes. The cell suspension was then transferred to an electroporation 
cuvette which was placed in the electroporation chamber. Electroporation was carried out 
in a BRL electroporator on the low resistance, high speed setting at 1180J..LFD and 260V. 
Following electroporation, the cells were transferred to either a Petri dish or a 6 well plate 
and maintained in 10% NBCS in GMEM at 37·C under CO2. After 48 hours the medium 
was relaced with medium containing histidinol to select for transformed cells . 
7.3 Isolation of histidinol resistant clones. 
Cells which contained the pREP8 V plasmid were selected from untransfected cells 
by growing the cells in the presence of 2.5mM histidinol (Sigma). Untransfected controls 
were also established to ensure the activity of the histidinol. The selection medium was 
replaced every 3 days. When colonies had begun to develop and consisted of 
approximately 50-100 cells, they were isolated by placing a metal ring around the colony 
and trypsinizing the cells within. The trypsinized cells were transferred to a 24 well plate 
and from here to two 25cm2 flasks. One of the flasks was used to test for V expression, by 
immune precipitation with a V specific MAb followed by Western blotting of the 
concentrated antigen. 
7.4 peR amplification of V specific DNA from transfected BF cells 
Transfected BF cells in a 25cm2 flask (approximately Ix 106 cells) were 
trypsinized and washed in PBS. The washed cells were then resuspended in Iml of PBS. 
I~ of this suspension (approximately Ix 105 cells) was used as a template in a PCR 
reaction (section 5.4). 
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8. INTERFERON RELEASE ASSAY 
8.1 Overview of method 
In this assay, medium was collected from SV5 infected BF cells and its antiviral 
activity was compared to that of an interferon sample of known activity. The interferon of 
known activity was a human AID Bgi hybrid interferon which is active on mouse cells, 
IFXA (Rehberg et ai., 1982). Antiviral activity was assayed by using medium from BF 
cells and IFXA to protect L929 cells from encephalomyocarditis (EMC) virus infection. 
The IFXA, EMC virus stock and L929 cells were kindly provided by Dr. Ian Kerr (ICRF, 
Lincoln's Inn Fields, London). 
The following sets of wells were established 
a) Cells which received EMC virus but no interferon medium. 
b) Cells which received IFXA but no EMC virus, IFXA at 100 U/ml was added. 
c) Cells which received doubling dilutions ofIFXA starting from 100U/ml as the highest 
concentration. These cells were infected with EMC virus. 
d) Cells which received doubling dilutions of medium from BF cells that had been infected 
at either 50, 10 or 2 pfu/ml. These cells received EMC virus. 
e) Cells which received the same medium as the cells in d), but which did not receive 
EMCvirus. 
8.2 Collection of medium from infected BF cells 
BF cells in 25 cm2 flasks were infected with SV5 at three different moi; 50, 10 and 
2 pfu/cell. Following virus adsorption, the inoculum was replaced with 5mls of 2% (v/v) 
NBCS in GMEM. The infection was allowed to proceed for 24 hours after which time 1 ml 
of medium was removed from each flask to be assayed for interferon activity. The medium 
was centrifuged at high speed at a bench top microfuge at 4°C for 10 minutes in order to 
remove cell debris. The resulting supernatant was then stored at 4°C until required. 
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8.3 Antiviral a~ay for mouse interferon 
L929 cells were plated out at a density of 2x104 cells per well in a 96 well plate. 24 
hours later, IFXA and BF medium was added to the wells in a total volume of l00J.1l. 5% 
(v/v) NBCS in GMEM was added to the controls wells which were not receiving 
interferon. The following day, the medium containing interferon was removed and 
replaced with either 2% (v/v) NBCS in GMEM or 2% (v/v) NBCS in GMEM, containing 
encephalomyocarditis (EMC) virus at a multiplicity of 10 to 15 pfu/cell. The infection was 
allowed to proceed for 36 hours at which time the control wells, to which no interferon 
was add~ were examined by light microscopy to ensure that cell lysis had occurred. The 
wells were vigorously washed to remove lysed cells and cell debris and the surviving cells 
then fixed with 5% (v/v) formaldehyde, 2% (w/v) sucrose in PBS for 10 minutes. The 
fixing solution was removed and the fixed cells washed with PBS after which they were 
stained with crystal violet (0.1 % (w/v) in PBS) for 10 minutes. This procedure enabled 
ready visualisation of wells which contained intact cells. 
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RESULTS 
PART 1: CHARACTERISATION OF SVS PERSISTENCE 
SV5 is readily able to infect a number of cell lines. Typically, if cells are infected at 
a high multiplicity (5-10 pfu/cell), they begin to show a cytopathic effect after 36 to 48 
hours. The appearance of the infected cell sheet varies, depending on the cell line and on 
the strain of virus. In some cases, the virus induces fusion and the formation of syncytia. In 
other cases, the cells simply round up and detach from the plastic. The length of time 
required for a high multiplicity infection to destroy the monolayer can vary; BIlK cells are 
usually dead within 48 hours whereas a Vero or HeLa cell monolayer can sometimes 
survive up to 4 or 5 days post infection (pj.). In each case, almost all the ~ells in the 
population are killed by the virus. 
Infection of BF mouse fibroblast cells (BF cells) takes a different course. In this 
study it was found that following infection with SV5, the majority of cells survived the 
infection, even though immunofluorescence staining for viral antigens showed that almost 
every cell in the population was infected (figure 11). The cell monolayer remained intact 
and there was no evidence for cell to cell fusion. The infected cells remained healthy 
following passage and could be passaged for several months without cell crisis. It had 
previously been shown that SV5 can initiate and maintain a persistent infection in the 
lungs of immunocompromised Balb/c mice (Young et al., 1990). In light of its behaviour 
in vivo, it was thought that the restricted nature of SV5 infection in BF cells might have 
been because the virus was intiating a persistent infection. For this reason, the course of 
SV5 infection in BF cells was studied, with a view to investigating virus persistence. 
97 
\0 
00 
p DAPI 
" 
\ .. ~ ~ 
• 
p ~ 
.. 
) 
... 
~ '" 
~ 
• 
"' , ... : 
Figure 11: Immunofluorescence staining ofBF cells 1 day following infection with SV5. The cells 
were stained with a pool of anti-P MAbs linked to FITC to show infected cells, and a DNA stain, 
DAPI, which stains cell nuclei to show the total number of cells present. 
1.1 CHARACTERISATION OF SVS INFECTION OF CULTURED BALB/C 
CELLS 
1.1.1 RNA levels in infected cells 
In light of the apparently restricted nature of SV5 infection in BF cells, the levels 
of viral RNA were studied to investigate to what extent the cells were infected with viral 
RNA, at different times p.i. Total RNA was isolated from uninfected cells and infected 
cells at 1, 3 and 5 days p.i., and dot blotted in doubling dilutions onto a nylon membrane. 
The membrane was then probed with a [32p] labelled positive sense DNA probe, which 
would hybridise to the P gene of the negative sense viral RNA. Following 
autoradiography, the membrane was stripped and probed with an oligonucleotide specific 
against cellular actin RNA. Comparison of the relative levels of actin specific RNA at 1,3 
and 5 days pj. ensured that approximately equal levels of RNA had been applied for each 
timepoint (figure 12). Negative sense viral RNA (Figure 12a) could be detected at 
consistently high levels over 5 days of infection. This result suggested that the cells had 
become infected following virus adsorption and that they were maintaining the viral 
genome RNA over the 5 day period. 
In order to differentiate between different molecular weight species of viral RNA, 
to look for the presence of defective genomes and to examine the levels of mRNA, the 
same RNA samples were subjected to denaturing gel electrophoresis and Northern blot 
analysis. The Northern blot was probed using a [32p] labelled probe which had been 
generated by random priming of either P or HN specific cDNA. These probes would detect 
both positive and negative sense RNA. Again, an actin specific oligonucleotide probe was 
used as a control to ensure that similar amounts of RNA had been loaded into each track. 
The same fIlter was used for each probe by stripping between each hybridisation reaction. 
Major bands, of a similar molecular weight to actin mRNA, could be detected 
using the probes against the P and HN genes. These bands were assumed to represent P 
and HN mRNA species. In contrast to the results obtained for negative sense viral RNA, 
the mRNA levels of both P and HN, although initially high, showed a decrease between 1 
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Figure 12: Figure showing the levels of viral RNA in SVS infected BF cells. 
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a) Dot blot analysis of total RNA extracted from SVS infected cells at 1, 3 and S days p.i (as indicated). The RNA was dotted in 
doubling dilutions onto a nylon filter and probed with a labelled positive sense DN~ probe to detect genomic sense viral RNA. The 
filter was then stripped and rehylxidised with an actin specific oligonucleotide p-obe, to show that equal quantities of RNA had been 
applied to the filter. Lanes U indicate uninfected cell extracts. 
b) Northern blot analysis of the same RNA extracts that WCle used in the dot blot described in la) probed with random primed cloned 
gene probes specific for the P gene and HN gene and with the actin probe that is described above. Again the same filter was used for 
each probe by stripping and then rehylxidising. 
c) Northern blot analysis of total RNA extracted from BF cells infected with SVS for 1 and 3 days probed using a random primed 
cloned gene probe specific for the P and HN genes. 
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and 3 days pj., but then remained stable between 3 and 5 days pj .. This result shows that 
having penetrated the cells, SV5 was able to generate viral transcripts. However, the result 
also suggests tha~ following an initial stage in which the virus polymerase was._3Ctive, 
there was a second phase of infection, in which the transcriptional activity of the virus, 
within the cell population, was reduced. The extent of reduction was the same for both the 
P and HN mRNAs suggesting that the inhibition of transcription was a general effect and 
not specific for an individual gene. 
When the blot shown in figure 12b was exposed for a longer period of time, a 
number of higher molecular weight bands could be detected in addition to the mRNA 
bands (12c). These were presumably polycistronic mRNAs and genomic length RNA. Like 
the mRNA bands, most of these bands showed a decrease in intensity between 1 and 3 
days pj .. However, there was a single band which migrated near the top of the gel, which 
could be detected with both P and HN specific probes. This band was presumed to be 
genomic and/or anti genomic RNA. In keeping with the results from the dot blot analysis, 
this band did not diminish by 3 days pj .. 
In summary, viral messenger, polycistronic and genomic RNAs could be detected 
in infected BF cells. However, although the levels of genomic RNA remained at a constant 
level throughout the infection period, the levels of subgenomic RNAs declined, suggesting 
that there had been a decrease in the level of viral transcription between 1 and 3 days pj .. 
1.1.2 Comparison of viral protein synthesis in infected BF and BHK cells 
It had previously been found that viral antigens could be readily detected in 
infected BF cells (figure 11). This rmding, coupled with the result showing that mRNA 
levels were initially high in BF infected cells suggested that following entry to BF cells, 
the viral infection proceeded normally with the generation of viral specific RNA and 
proteins. However, from these results, it was not known if the BF cells could support viral 
protein synthesis to the same extent as other cell lines, or if they were able to correctly 
modify the virus encoded polypeptides. It was possible that the reason for a limited 
infection in BF cells was that the cells were unable to sustain a significant level of viral 
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protein synthes!s, or that in these cells there was an increased attenuation of viral 
transcription, leading to relatively low levels of synthesis of the glycoproteins and L 
protein. 
To examine whether BF cells were able to synthesize SV5 proteins in a similar 
manner to other cell lines, the molecular weights and relative amounts of viral proteins 
synthesized in BF cells, were compared to those of proteins synthesized over the same 
timecourse in a parallel infection of BHK cells, a permissive cell line. Infected BF and 
BHK cells were metabolically labelled with [35S] for 2 hours at I day pj., after which 
time the viral proteins were precipitated using monoclonal antibodies. The viral proteins 
purified from the two cell types were then compared by denaturing gel electrophoresis 
(figure 13). 
The levels of overall viral protein synthesis in the two cell types can be related to 
one another by comparing the intensity of the purified viral antigens and the levels of total 
cellular protein synthesis. This analysis shows that at this early stage in infection, there 
was very little difference in the levels of overall viral protein synthesis between the two 
cell types. Close examination shows that there was slightly more virus protein synthesis 
with respect to cellular protein synthesis in BHK cells as compared to BF cells. This 
finding could either reflect a greater rate of viral protein synthesis or alternatively a down 
regulation of host cell protein synthesis in the BHK cells. There is no evidence that the 
SV5 5' proximal genes were being expressed at a relatively lower level in BF cells than in 
BHK cells, as the intensities of each of the protein bands are similar, relative to one 
another in the two cell types. 
This figure also provides some information as to the protein-protein interactions 
that were occurring in the two cell types. From both the BF and BHK cell extracts, the L 
and NP proteins co-precipitated with P and lor V (although V is hardly detectable in this 
figure). As the immune precipitation was carried out in the presence of 0.1 % SDS, this 
result would suggest that the interactions involved in these associations were quite stable. 
Given that NP is reported to be the most abundant protein in infected cells (Lamb et 
al., 1976), it is strange that the NP specific monoclonal antibody precipitated such a 
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Figure 13: PAGE comparing levels of viral protein synthesis in a) BHK and b) BF 
cells. Tracks 1 and 2 show the levels of total cellular polypeptides synthesized in 
uninfected and SV5 infected cells respectively. Tracks 4 to 8 show polypeptides 
isolated from the soluble protein fraction of infected cells following incubation with 
monoclonal antibodies against NP, PN, M, F and HN respectively. Track 3 is a 
negative control of uninfected cell extract, probed with a pool of the same MAbs 
described above. 
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small amount of protein, both from BF and BHK cells. It can be seen from the soluble 
antigen extract track (lane 4) and from the heavy NP band precipitated by the PN MAb, 
that there was significantly more NP available for precipitation, than was actually 
precipitated. As, under these experimental conditions the NP specific MAb did not 
detectably co-precipitate P, it would seem that there were at least two populations of NP; 
one of which was immunoreactive with the NP specific MAb but which did not form a 
stable association with P, and another, which was associated with P and which was not 
recognised by the NP MAb. This result would suggest that in both cell types, NP had 
undergone some sort of maturation stage to give rise to a heterogenous population of 
protein. 
An alternative explanation as to why the infection was limited in BF cells could 
have been that BF cells do not have the enzymes necessary for FO cleavage, or that the HN 
and F proteins were not glycoslyated. In this experiment, the F specific MAb precipitated 
two polypeptides from both BHK and BF cells, one of which was the correct molecular 
weight to be FI (the F2 band was very weak and cannot be seen on the photograph). The 
F 1 and F2 bands and the band for HN are diffuse, which would suggest that the proteins 
were being glycosylated, although from this analysis, it cannot be determined if the 
glycosylation patterns were similar in both BF and BHK cells. 
1.1.3 SVS Protein Synthesis in BF Cells Over Time 
The results described above suggested that BF cells were capable of synthesizing 
viral proteins in a similar fashion to permissive cells. However, the restricted nature of the 
SV5 infection in these cells, coupled with the decreased levels of viral mRNAs at later 
times in infection, suggested that the levels of protein synthesis seen at 1 day pj. were not 
maintained. To examine viral protein synthesis at later times in infection, SV5 protein 
synthesis was examined over a 5 day infection period. Infected BF cells were pulsed with 
[35S] methionine/ cysteine, for 2 hours, at daily intervals for 5 days. Immediately 
following the pulse, protein extracts were made and the viral proteins precipitated from the 
soluble fractions using a pool of MAbs against NP, M, F and HN proteins and a MAb 
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Figure 14: An SDS-PAGE analysis of SV5 proteins synthesized in BF cells at 1 to 5 
days pJ. Oanes 1 to 5). Infected cell monolayers were labelled with [35S] 
methionine/cysteine mix for 2 hours following which the viral proteins were purified 
from soluble antigen extracts by immune precipitation. a) shows the proteins 
precipitated by a pool of monoclonal antibodies against the NP, M, F and HN proteins 
and b) shows the proteins precipitated from the same soluble antigen extract by a 
monoclonal antibody which recognises an epitope on the P and V proteins. 
105 
which recogni~s an epitope common to P and V (figure 14). Levels of total cellular 
protein synthesis were also compared and showed that the extent of label incorporation 
was the same at each time point (data not shown). 
In agreement with the levels of viral mRNA at different times of infection, it was 
found that viral protein synthesis was high at 1 day pj. but decreased significantly by 2 
days p.i.. Viral protein synthesis then continued at a consistently low, but detectable rate 
from 2 to S days pj .. The relative levels of synthesis of each of the proteins did not vary 
over time, indicating that the decline in synthesis was uniform and not as a result of a 
changing pattern of transcription . . The molecular weights of the proteins also remained 
unchanged, which would suggest that the proteins that were being synthesized, were being 
modified in a consistent manner throughout the infection. This assay was repeated on a 
number of occasions and consistently gave results similar to those shown, although it was 
found that the time at which the rate of protein synthesis changed did vary slightly on 
different occasions. However, in each case, the rate decrease had taken place by at least 48 
hours p.i .. 
1.1.4 Levels of virus released from infeded BF cells 
The protein synthesis results would suggest that in BF cells, SV5 proteins were 
being synthesized correctly. To conftrm whether the BF cells were capable of supporting a 
complete cycle of viral infection, and to investigate the differences in virus release at 
different times post infection, virus release over 12 hour periods at 1 and 5 days pj. was 
assayed. BF cells were infected with SV5, after which any unbound inoculum was 
removed by extensive washing. At 12 hours pj., the cell monolayer was washed again and 
fresh medium was added. At 24 hours pj., the medium was harvested and the levels of 
virus present in the supernatant quantitated, as described in materials and methods. The 
cells were counted and the levels of virus release expressed as pfu/l05 cells/12 hours. 
Using the same method, levels of virus release from Vero cells from 12 to 24 hours and 
from BF cells from 4 to 5 days pj., were quantitated. The results are shown in table 3. 
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cell type time p.l. virus release 
(pfu/l05 cells/12hours) 
Vero 1 day 
- 2.7 x 1~ 
BF 1 day 6.8 x 103 
BF 5 days 1 x 1()2 
Table 3: Levels of virus release:· a table showing the levels of virus released from Vero 
and BF cells at early times in infection, and from BF cells at later times in infection. 
It was found that, compared to Vem cells, BF celIs only released low levels of 
virus, even in the initial stages of infection. A number of factors could account for low 
levels of virus release such as, inefficient budding of the virus or a low capacity for the 
released virus to infect further cells (Le. during the virus titration procedure). By 5 days 
p.L, the titre of virus released by the BF cells was too low to be accurately quantified, 
although a small number of plaques did develop. Using immunofluorescence analysis, it 
was also found that supernatant isolated from BF cells was able to infect uninfected BF 
cells (data not shown). 
These results show that despite their apparent insouciance to viral infection, BF 
cells were susceptible to SV5 entry and had the capacity to support a complete round of 
virus replication. Virus particles were released which were able to infect both Vero and BF 
cells. This finding would imply that the virus which was produced by the BF cells, was the 
same as wild type virus and that each of the viral proteins had been correctly synthesized 
and modified by the BF cells. At later times p.i., only low levels of virus were released. 
This result corresponded with the decreased levels of virus mRNA and protein synthesis at 
this time of infection. 
1.2 CHARACfERISATION OF THE PERSISTENT STATE 
The RNA, protein synthesis and virus release assays relate together to suggest that 
SV5 was able to infect the BF cells, and for the first day, the infection proceeded in a 
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similar fashion.to a productive infection. However, following the initial wave of virus 
synthesis. the infection seems to have been inhibited. By 72 hours pj., there were only low 
levels of mRNA transcripts and protein synthesis. Possibly because virus activity was 
restricted at an early stage in the infection, the BF were able to survive. Despite the 
decreased level of virus activity, genomic RNA could still be detected at high levels at 5 
days p.i.. This fmding suggests that the virus was still present in the cells. Taken together 
these results suggest that the SV5 infection in BF cells had changed from a productive to a 
persistent state within the frrst few days of infection. In the next section of results, cells at 
5 days pj. were compared with cells at 1 day pj. with the aim of further characterising the 
persistent state. 
1.2.1 Immunofluorescence studies of infected BF cells 
As described above, it appeared that by 5 days pj., SV5 was residing in a persistent 
manner in BF cells, with only low levels of transcription and protein synthesis. However, 
in each of the experiments described so far, whole populations of cells were being assayed. 
From these analyses, it was not possible to know if the activity of the virus was decreased 
in every infected cell, or if the infected cell population was diverse, with the virus active in 
some cells but not in others. With the aim of distinguishing between these possibilities, 
immunofluorescence microscopy was used to examine the distribution of viral antigens at 
different times post infection. 
Cell monolayers were infected at a similar multiplicity to those in the previous 
experiments and incubated until the appropriate time pj .. The infected monolayers were 
then fixed and examined for viral antigens using antibodies against each of the viral 
proteins. The antibodies were bound, either directly or indirectly, to one of two different 
fluors, Texas Red or FITC. Using this technique, it was possible to look for two different 
proteins within the same cell. 
Figure 15 shows immunofluorescence of uninfected cells and cells at 1 and 5 days 
p.i .. In this experiment, the cells were labelled with monoclonal antibodies against P and F. 
In addition, the cells were also stained with DAPI (which binds DNA) to gain an 
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Figure 15: Immunofluorescence studies of the distribution of viral proteins in BF 
cells at 1 and 5 days pj .. Each coverslip of cells was fixed and stained with MAbs 
specific for the F protein using indirect immunofluorescence, before being counter-
stained with a mixture of FITC conjugated MAbs specific for the P protein and DAPI. 
The photograph shows threee different fields of view; uninfected cells, cells at 1 day 
p.i. and cells at 5 days pj .. 
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indication of th~ density of cells on the coverslip. This figure shows that at both 1 and 5 
days pj., P protein could be detected in almost every cell, indicating that almost the whole 
cell population was infected throughout the timecourse. This result demonstrates that the 
decreased levels of virus transcription and protein synthesis which were observed at 5 days 
pj., were not as a result of infected cells dying, or uninfected cells outgrowing the infected 
cell population. In contrast to the staining pattern observed for P at 5 days pj. the F protein 
could only be detected in a small proportion of cells, even though at 1 day pj., this protein 
could be detected (albeit at low levels) in most of the cells. Thus at 5 days pj., there were a 
number of cells which were still positive for P but which had become negative for F. 
Although P could be detected throughout the timecourse, its distribution within the cells 
had changed between 1 and 5 days pj .. At 1 day pj., both F and P could be detected as a 
diffuse staining pattern throughout the cell cytoplasm. At 5 days pj., in those cells in 
which both proteins could be detected, their distributions were similar to 1 day pj .. 
However. in the cells in which P alone could be detected, it tended to be localised into 
discrete cytoplasmic inclusions. These results suggested that at 5 days pj., the level of 
virus activity was varied between different cells, suggesting that the persistently infected 
cell population was diverse in nature. 
Further immunofluorescence studies were carried out to compare the distribution of 
P with other viral proteins at different times p.i.. Figure 16 shows cells at 1 day pj. stained 
for P and HN and P and M. As shown previously, at this stage in infection, P was 
distributed throughout the cell cytoplasm in small punctate dots. giving a granular 
appearance to the cell. M and HN were both readily detected as a diffuse pattern spread 
throughout the cytoplasm and possibly at the plasma membrane. Figure 17 shows the 
contrasting image seen at 5 days p.i., with cells that were probed for P and HN. Similarly 
to figure 5, P could be detected in most cells in the population, either distributed 
throughout the cell cytoplasm, or in small cytoplasmic foci. On the other hand, HN could 
only be detected in a fraction of the cells which were positive for P. In the cells in which P 
alone could be detected, this protein tended to be present in discrete inclusions, whereas in 
the cell in which both proteins could be detected, their staining patterns were diffuse. M 
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Figure 16: Immunofluorescence analysis of cells at 1 day p.i.. The figure shows two 
fields of view; a) P and HN and b) P and the corresponding M. M and HN were 
detected by indirect immunofluorescence using anti-mouse conjugated Texas Red 
antiserum and P was detected using a pool ofFITC conjugated MAbs. 
111 
p HN 
a) 
b) 
Figure 17: Immunofluorescence analysis of cells at 5 days p.i .. The distribution of P 
and HN are shown for two fields of view (a and b). P and HN were detected in the 
same way as described for figure 16. 
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Figure 18: Figure showing the distribution of p. NP and L in infected BF cells. 
a) Double staining fluorescence of P and NP in cells at 5 days pj .. NP was detected 
using indirect fluorescence against a monoclonal antibody. P was detected as 
described previously. 
b) Double staining fluorescence showing P and L proteins within cells at 1 month 
post infection. The L protein was detected using a rabbit antiserum which had been 
raised against L antigen isolated from a polyacrylamide gel. Both P and L were 
detected by indirect immunofluorescence. 
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protein was found to have a similar pattern of expression as lIN and F; at 5 days pj., it 
could be readily detected in cells in which P had a general cytoplasmic staining pattern, 
but in most cells in the population, in which P was present as viral inclusions, M was 
found to be absent (data not shown). 
When the distributions of NP and L were examined, it was found that in contrast to 
the situation seen with M, F and lIN, these proteins could be detected in all cells which 
contained P throughout the infection. Furthermore, at 5 days and 1 month p.i., these two 
proteins were found to co-localise with P in cytoplasmic inclusion bodies (figure 18). 
1be immunofluorescence data coupled with the protein synthesis results suggested 
that at 5 days pj., the infected cell population contained only a small proportion of cells in 
which the virus was active. In these cells, all the viral proteins were being generated and M, 
F and HN could be detected. However, it appeared that in the majority of cells in the 
population, only NP, P and L could be detected. The RNA and protein sypthesis data 
showed that the decrease in virus expression was uniform along the genome, which would 
suggest that NP, P and L were not being synthesized in cells in which M, F and HN were 
absent. This result suggests that in the majority of cells at 5 days p.L, in cells with 
inclusions, the virus was transcriptionally quiescent. The nucleocapsid proteins may have 
been present because they were stable and were surviving from an earlier stage in infection. 
1.2.2 Relative protein levels in infected BF cells 
Viral protein levels present in the infected cell population were analysed in order to 
quantify the immunofluorescence results and to obtain information as to the relative 
quantities of each viral protein present in the persistently infected cells. Cells were isolated 
on each day of a five day infection period and suspended in PBS. The cell suspensions 
were sonicated, to disrupt the cells and to create a homogeneous suspension, and then 
dotted in doubling dilutions onto nitrocellulose filters. Monoclonal antibodies specific for 
P (but not V), NP, M, F and HN were then used to probe the fllters and were in tum 
detected using an EeL reaction. This assay thus shows the levels of each antigen on each 
day of infection. The results are shown in figure 19. It was found that NP protein 
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Figure 19: Analysis of the relative amounts of the NP, P, M, F and lIN proteins in 
lysates ofBF cells infected with SV5 for 1 to 5 days (columns 1 to 5 respectively). 
Doubling dilutions of total cell extracts were bound to nitrocellulose and the 
respective antigens detected with pools of specific monoclonal antibodies. Bound 
antibody was detected in an EeL reaction following the reaction of the blot with 
HRP-conjugated Protein A. 
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was present in the cell population at consistently high levels over the 5 day infection 
period. This result was consistent with the immunofluorescence data which showed that 
NP was still present in the cells at 5 days pj .. The levels ofF, M and-HN all decreased 
.-
over time, with HN decreasing more gradually than M and with F disappearing the most 
rapidly. These findings correspond with the immunofluorescence analysis, particularly as 
the lIN protein tended to be more readily detectable by fluorescence than F, at later times 
in infection. The level of P protein was found to decrease slightly over the 5 days. This 
result is not necessarily inconsistent with the immunofluorescence analysis, as it is 
possible that a proportion of P remains in the cells in inclusions but that the remainder 
disappears. lit addition, the pool of MAbs used to detect P in the dot blot analysis would 
also detect p. and p. (Young; unpublished observations). p. and p. are uncharacterised 
proteins which co-precipitate with P (Thomas et al., 1988). It was not possible to 
detennine from dot blot analysis which species of P protein was staying qonstant and 
which was disappearing. 
In order to examine the absolute levels of full length P protein, and also to 
investigate the levels of V protein in the persistently infected cells, infected cell extracts 
isolated on each day from 1 to 4 days p.i. were subjected to Western blot analysis. The 
viral proteins P, V and M were detected using two MAbs, one against M and the other 
against an epitope common to both P and V. Neither of these antibodies would detect the P 
related proteins p. and P*. The Western blot analysis is shown in figure 20. Using this 
analysis, the P protein appears to have been maintained at relatively higher levels than M 
at later times in infection; the quantity of M protein decreased rapidly over the 4 days. The 
V protein was short lived in the cell population; although easily detectable at 1 day pj., 
this protein could hardly be seen by 2 days p.i.. These data would suggest that it was full 
length P protein which could be detected in inclusions in cells by immunofluorescence 
analysis. This theory is supported by the results of a Western blot carried out by D. Young, 
using a monclonal antibody which recognises the p* and p. proteins as well as full length 
P. This analysis showed that the level of full length P stayed consistent between 1 and 5 
days pj. 
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Figure 20: Autoradiogram of a Western blot in which MAbs were used to detect the 
P and V proteins and the M protein in total cell extracts of BF cells that had been 
infected with SV5 for 1 to 4 days (lanes 1 to 4 respectively). PolYPeptides were 
separated by electrophoresis through a 12% SDS-polyacrylamide slab gel. 
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whereas the truncated P related proteins, although present in significant quantities at 1 day 
pj., were not detectable at 4 days pj. (data not shown). 
Given that viral protein synthesis had been shown to have decreased substantially 
between 1 and 2 days pj., the absolute proteins levels from 2 to 5 days pj. could be 
interpreted as a reflection of the stabilities of the proteins. Thus NP and to some extent P, 
appear to have been particularly stable in the cells whereas the other proteins were being 
degraded. 
1.2.3 Pulse chase analysis of viral proteins 
Although the absolute protein levels indicated that NP was antigenically stable in 
BF cells, they did not show whether the protein was being maintained in its entirety or as 
degradation products of the full length protein. This question was addressed by examining 
the survival of full length NP over time. Infected cells were pulsed with @5S] 
methionine/cysteine at 1 day pj., and chased with "cold" medium until 5 days pj .. Total 
and soluble antigen extracts from the cells were compared with cell extracts isolated 
immediately following the pulse at I day p.L, using SDS-PAGE. Because NP is 
synthesised in large quantities, it is readily identified by comparing infected and uninfected 
cell extracts. This method of identifying NP avoids the use of immune precipitation which 
may isolate only a subset of the protein, as suggested by figure 13. Figure 21 shows an 
autoradiogram of total cell protein and soluble protein extracts from infected and 
uninfected cells either collected at 1 day pj. or following a chase until 5 days pj .. 
Coomassie blue staining of the gel ensured that similar quantities of protein had been 
applied to each track (data not shown). By this analysis, NP appears to have been 
particularly stable, following the 4 day chase period, it could be detected more readily than 
most cellular proteins. In addition, by comparing the intensities of bands at 0 hours post 
pulse (track 3) with 4 days post pulse (track 7), a considerable proportion of the full length 
NP had remained in the cell population. Hence, it appears that NP was very stable in the 
BF cells and was residing in its intact form. 
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NP-
Figure 21: SDS-PAGE of total and soluble antigen extracts from cells pulsed for 8 
hours and harvested at 1 day p.i. (lanes 2 to 5) and cells pulsed for 8 hours at 1 day 
p.i. and then incubated with unlabelled medium until harvesting at 5 days pj .. (lanes 6 
to 9). Lane 1 shows SV5 polypeptides purified from an infected cell extract by 
immune precipitation (as described previously) to act as markers of viral proteins, the 
position of NP is shown. Lanes 2 and 6 are total protein fractions of uninfected cells, 
lanes 3 and 7 are total cell fractions of SV5 infected cells, lanes 4 and 8 are soluble 
protein fractions of uninfected cells and lanes 5 and 9 are soluble protein fractions of 
SV5 infected cells. 
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PPNMFHN PPNMFHN 
Figure 22: Pulse chase analysis showing the stabilities of the SV5 proteins relative to 
one another. The figure shows an SDS-PAGE analysis of SV5 proteins isolated from 
the same extracts as described for figure 21. a) shows the proteins labelled at 1 day 
pj. and b) shows the labelling pattern of proteins from cells which have been 
"chased" until 5 days p.i .. The viral polypeptides were precipitated using monoclonal 
antibodies against P, PN, M, F and HN as shown. 
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To cont:mn the dot blot results, the stabilities of the other viral proteins, relative to 
one another, were examined by immune precipitating the different viral antigens from the 
same cell extracts that are described above. Figure 22 shows the results for P, V, M, F and 
HN. 22a) shows the levels of synthesis of each of the proteins at 1 day pj., and figure 22b) 
shows the survival of the proteins that had been synthesized at day I, to day 5. The pulse-
chase autoradiogram required a long exposure time before any protein bands could be 
detected. P, M and HN could be detected at low levels at 5 days pj., suggesting that at 
least some of each of these proteins was stable. In keeping with the previous results, F 
appears to have been the least stable protein as it could barely be detected, however long 
the exposure time of the autoradiogram. 
In light of the immunofluorescence and dot blot data, the finding that by pulse 
chase analysis P was not significantly more stable than M is interesting. There is a possible 
explanation for this finding. Because the pulse chase analysis described above utilizes an 
immune precipitation procedure, this experiment has the disadvantage that it measures the 
stabilities of the proteins in the soluble fractions of cells. Thus it is possible that a large 
proponion of P was stable, as suggested by western blot analysis, but that this population 
of the protein was not accounted for in the pulse chase because it was insoluble and so was 
not present in the soluble antigen fraction of the infected cell extract. If this was the case, 
then the P which can be detected in inclusion bodies using immunofluorescence 
microscopy would be predicted to be insoluble. 
The results presented so far would suggest that at 5 days pj., the cells which 
contained NP, P and L as inclusions, there was no, or almost no, virus activity. Instead, it 
seems that these proteins were stable and were able to survive in the cells following 
synthesis at an earlier time. It had previously been found that the genomic RNA was 
maintained at a consistent level in the cell population. This result, and the finding that NP, 
P and L co-Iocalised in inclusions suggested that the inclusions may have consisted of 
aggregated nucleocapsids. 
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1.2.4 Passage ~f persistently infected cells 
Each of the experiments described so far was carried out on cells up to 5 days pj .. 
At 5 days p.i .• almost all the cells in the population were found to be infected, and the 
infected cell population was heterogeneous, with some cells in which the virus was 
residing as inactive inclusions of nucleocapsids, and other cells in which the virus was 
apparently active. It was possible that if the infected cells were maintained for longer 
periods of time, the virus would become inactive in every infected cell and that the 
infected cell population would become uniform in nature. When cells which had been 
infected for longer periods of time were examined by immunofluorescence, it was found 
that the situation did not change from that at 5 days pj .. The virus could be detected in 
both active and inactive states. varying from cell to cell (data not shown). Cell monolayers. 
isolated at varying times pj. were examined by immunofluorescence on a number of 
occasions. The conclusion of this analysis was that once the state had become diverse, as 
seen at 5 days p.i., the state of the virus within the infected cell population continued to be 
varied (although the proportions of cells exhibiting the two different infection states did 
fluctuate). It was not possible to attain a cell population in which the virus was residing 
entirely as inclusion bodies and, after 5 days p.L, neither was it possible to find an infected 
cell population in which the virus was active in every cell. 
A further observation that was made at later times in infection was that the 
proportion of infected cells in the population diminished following passage. There were 
two possible explanations for this phenomenon. Even following a high multiplicity 
. 
infection, it is unlikely that every cell in the population would be infected. It was possible 
that the reason for the decreasing proportion of infected cells was that the few uninfected 
cells in the population were dividing more rapidly than the infected cells. Alternatively, if 
the virus was residing as inactive micleocapsids, as hypothesized, then it might be 
expected that the rate of cell division would exceed that of virus spread, thus resulting in 
an increasing proportion of uninfected cells. . 
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1.2.S Single cell cloning of infected cells 
To test the possibility that the virus was transcriptionally inactive in some of the 
infected cells, infected BF cells were cloned out so that the resulting clones were each 
derived from a single cell. By cloning the cells, the possibility that a few uninfected cells 
in the culture might divide more rapidly than those that were infected, was overcome. 
Infected BF cells were seeded at a low density into a 96 well microtitre plate .. Each day, 
the wells were examined to ensure that any colonies that grew, originated from a single 
cell. The clones were transferred to grow on coverslips and once confluent, were examined 
by immunofluorescence microscopy. 
Eleven clones were obtained; only five of these showed any positive fluorescence. 
Significantly, in each clone which showed fluorescence, only a small proportion of cells 
was infected. This experiment clearly demonstrated that in the majority of cells, the virus 
was residing in an inactive state. Similarly to the experiments described ~ve, the 
fluorescence pattern in these cells was similar to that of cells at 5 days p.i.; some cells were 
positive for all the viral proteins, whilst others showed fluorescence only for NP and P (the 
presence of L was not investigated), localised as discrete cytoplasmic foci. Some examples 
are shown in figure 23. 
The fact that some cells showed fluorescence for a full complement of viral 
proteins suggested that the virus in these cells must have been active. H this was the case, 
then it was possible that infectious virus might have been being synthesized in the cloned 
cell population. The cloned BF cells were co-cultivated with Vero cells in an attempt to 
rescue infectious virus. After just three days of co-cultivation, plaques could easily be seen 
in the cell monolayer and immunofluorescence studies demonstrated that there was 
widespread invasion of the virus into the Vero cell population. Figure 24 shows some 
examples of co-cultivated Vero and BF cells. There were a few cells in which inclusion 
bodies (positive for P but not for HN) could be seen, these were most likely to be some of 
the input BF cells, in which the virus was still in a dormant state (figure 24a). In other cell 
groups, it appeared that the infected BF cell could still be seen, but that the infection was 
beginning to spread into the Vero cells, with an accompanying expression of HN (figure 
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b) 
Figure 23: Photograph showing the distribution of the HN and P proteins in monolayers of 
cloned BF cells (for details of cloning see text). Only a small proportion of the cell 
monolayer was infected. Of the infected cells, some were positive for both P and HN e.g. 
(a); most cells were positive only for P (b). In these cells, the P protein was usually 
confined to single cytoplasmic foci (arrowed). 
124 
P HN 
a) 
b) 
c) 
Figure 24: Immunofluorescence showing the distribution of the P and HN proteins in 
monolayers of Vero cells co-cultivated for three days with the BF infected clones 
shown in figure 23. Three fields of view are shown. In panel a) there appears to have 
been no spread of infectious virus from the infected BF cell (arrowed), in panel b) 
virus is just beginning to spread into the Vero cell population and panel c) a distinct 
plaque has developed in the monolayer. 
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24b). Fig 24c rg>resents an example typical of the majority of the cells in the population. 
In this case, the cells resembled those undergoing a normal productive infection, with high 
level expression of both P and HN and apparent spreading of virus to neighbouring cells. 
Medium collected from the co-cultivated cell cultures was found to contain 
infectious virus which could give rise to normal plaques on Vero cell monolayers. This 
evidence shows that the virus being harboured within at least some of the cells in the 
persistently infected BF cell population, was still. infectious and also that the restricted 
infection observed in BF cells was cell dependent. 
1.2.6 Susceptibility of persistently infected cells to CTL attack 
The evidence presented sO far suggests that it is possible for SV5 to reside in BF 
cells as stable aggregates of nucleocapsids, in a transcriptionally inactive state. IT this 
scenario was to occur in vivo, then it is possible that the viral proteins prevailing in the 
cells may not be available for proteolytic processing and so might be able to remain in the 
cell without incurring CIL attack. This hypothesis was tested by carrying out cytotoxic T 
cell assays on cell cultures at 1 day p.i., when the virus was active in most cells, and at 5 
days post infection, when the virus was quiescent in most of the cells. In this assay, 
infected cells were labelled with [51Cr], which they take up by passive diffusion, and then 
incubated with varying numbers of primed immune cells. Several hours later, the cells and 
cell debris were collected by centrifugation and the radioactivity in the supernatant fraction 
counted. The cells which were lysed by the CILs would have released [51Cr] into the 
surrounding medium. By including controls of target cells that were completely lysed (eg. 
by SOS) or which did not receive immune cells, it was possible to calculate what 
percentage of cells were lysed by the CfLs. 
This assay was carried out on several occasions and similar results were achieved 
each time. The graph shown in figure 25 is a typical example of one of these assays. It can 
be seen that, as the proportion of T cells to target infected BF cells increased, the level of 
cell lysis also increased. For all three immune cell concentrations, the level of killing of the 
1 day pj. cells was in excess of lysis of cells at 5 days pj. In fact the level of killing of 
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Figure 25: Cell mediated lysis of BF cells that had been infected with SV5 for 1 or 5 
days. Uninfected cells were used as controls for non specific lysis. Cytotoxic T cells 
were generated as described in materials and methods and incubated in varying 
densities with [51Cr] labelled target cells in a standard [51Cr] release assay. The 
percentage lysis was calculated as [(sample c.p.m.- backgroud c.p.m.)/(total c.p.m.-
background c.p.m.)] x 100, where total c.p.m. is the radioactivity released by targets 
treated with 0.1% SDS. 
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cells at 5 days p.i. was not much greater than that of nonspecific death of uninfected cells. 
This result would suggest that at 5 days pj., the virus was residing in BF cells in a manner 
in which it was able to avoid lysis by cytotoxic T cells. 
1.2.7 Summary 
The results presented in this chapter suggest a possible model for Paramyxovirus 
persistence. In this model, the persistent state does not consist of a uniform population of 
cells, instead, it appears to be comprised of some cells in which the virus is active, and 
others in which it is completely or almost completely inactive. In the cells in which it is 
inactive, the virus resides as aggregates of nucleocapsids which seem to be relatively stable 
in the cells. These cells appear to be insusceptible to cell mediated lysis. It is possible that 
the persistent state is not static, but instead, the virus is able to flux between activity and 
quiescence, accounting for the continued diversity of the infected cell population following 
passage. IT this situation was to occur in vivo, it may be possible for the virus to continue 
replicating in some cells, whilst remaining hidden from the immune system in others. If the 
two states could flux, the virus might be sustained in the host for extended periods, even in 
the face of an active immune response. 
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PART 2: FACTORS INFLUENCING SVS PERSISTENCE 
In the previous section, a model for Paramyxovirus persistence was proposed. In 
this mode4 the virus seems to reside in cells as inclusions of inactive nucleocapsids. The 
results suggested that it may be possible for the virus to reactivate from the inclusions to 
initiate a further round of infection. One approach to determining if reactivation of the 
virus could occur, was to identify and manipulate factors which may have induced the 
persistence in this cell line. This chapter describes the attempts to analyse the effects of 
.. ~ .. 
two different factors; fIrstly, the effects of varying the relative levels of the polymerase 
proteins, P and V and secondly, the role of interferon. The aim was to study the roles of 
these factors not only in BF cells but also in a permissive cell line, with the intention of 
investigating if factors known to be involved in virus persistence, might induce a state of 
trancriptional indolence in what would normally be an acute infection. 
2.1 P AND V RATIOS IN INFECfED CELLS 
2.1.1 Potential roles for P and V in establishment of persistence 
It would be envisaged that for a fruitful virus infection, with efficient production of 
progeny virus, the processes of transcription and replication would have to be controlled 
with respect to each other. IT viral replication was to surpass transcription, there may be 
insuffIcient protein to encapsidate and package the newly synthesized RNA. Conversely, if 
transcription was continuing at too high a rate relative to replication, there may be nothing 
for the resulting proteins to assemble. There is some evidence to suggest that it is P and V 
which detennine whether the viral polymerase complex becomes committed to 
transcription or replication (Curran et aI., 1991). The shared N-tenninal sequences make 
these proteins ideal candidates for such a role, as they could potentially compete for the 
same binding site on the polymerase assembly and, via their C-tenninal sequences, dictate 
which process the polymerase was to engage in. If this scenario is correct, then it could be 
inferred that in order for the virus infection to be productive, it is required that the relative 
levels of P and V are well controlled throughout infection. 
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During SV5 infection ofBF cells, there is a sudden decrease in the level of viral 
transcription. It was thought that there may be a specific switch mechanism which brings 
viral transcription to a halt in some of the cells. If this is the case then, once viral 
transcription has ceased then the infection may not be able to proceed in these cells, a 
situation which possibly either forces or allows the virus into inclusions and thus 
persistence. In respect of the potential roles for P and V in coordinating the infection, it 
was speculated that an imbalance of these proteins may have caused the transcriptional 
shut off, and consequently persistence, in the BF cell line. It was thought that if their 
relative levels could be altered by overexpressing either of them by artificial means, it may 
be possible to avert the persistent state in BF cells and also to induce a persistent state in a 
permissive cell line. A study of this nature could give an insight into the mechanisms 
potentially underlying viral persistence, and also might throw light on the elements 
controlling the transcriptase/ replicase complex during an acute Paramyxovirus infection. 
2.1.2 Approach for studying the roles of P and V 
The approach to studying the roles of P and V proteins during SV5 infection was to 
infect a population of cells expressing either of the two proteins and then to study the 
progress of infection. Given that an SV5 infection of a population of BF cells gives rise to 
different infection states, with variation from cell to cell, then in order to observe the 
effects of overexpression of P or V in this cell line, it was necessary that almost all the cells 
in the population were expressing the relevant protein. The experience of this laboratory 
was that transfection procedures are not efficient enough to deliver plasmid DNA into 
every cell in a culture. It was found that transfection efficiencies varied widely, depending 
on the method of transfection used and the cell type transfected. BF cells were found to be 
particularly resistant to transfection often with <5% showing detectable expression of the 
transfected plasmid. Thus in order to study overexpression of either P or V in these cells, it 
was necessary to obtain clones of stably expressing cell lines, specific either for P or V. 
In this study, SV5 V was chosen to be expressed. The plasmid pREP8 was selected 
as a vector for stable expression. This plasmid has the Epstein Barr virus origin of 
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replication and .nuclear antigen gene. These features should allow the vector to be 
maintained extrachromosomally in transfected cells. The vector also carries a histidinol 
resistance gene, to allow selection of plasmid containing cells, and a polycloning site 
which places the inserted gene under the control of the Rous Sarcoma virus promoter and 
the SV40 termination signal. Prior to cloning into pREP8, V specific cDNA was cloned 
into the plasmid pUC 11 9. This plasmid has an M13 origin of replication which facilitates 
the production of single stranded DNA copies of the inserted sequence. The single stranded 
DNA thus obtained could then be used as a template in a DNA sequencing reaction. 
2.1.3 Cloning of V 
(For a complete description of the cloning procedure, see materials and methods 
section 5.1). SV5 V specific cDNA was generated by a reverse transcription reaction from 
viral RNA, followed by a PCR amplification using PN gene specific primers. The 
resulting PCR product was then digested with the appropriate restriction enzymes and 
cloned into pUCl19. 
2.1.4 Sequencing of the V fragment 
Once the PCR product had been cloned into the pUCl19 plasmid it was digested 
with different combinations of restriction enzymes which resulted in fragments consistent 
with the insert being the PN gene (results not shown). To be certain that this was the case, 
the insert was sequenced. The sequence obtained is shown in Figure 26. The differences 
from the previously published PNgene of the W3A strain of SV5 are highlighted in bold 
type. The sequence analysis demonstrated that although there were a number of 
substitutions, the integrity of the open reading frame was maintained. Most of the 
substitutions were in the third base position and so did not alter the amino acid sequence. 
There were only three amino acid changes as a result of the substitutions, which are shown 
in bold type. 
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a) 
ATGGATCCCACTGATCTGAGCTTCTCCCCAGATGAGATCAATAAGCTCAT 
AGAGACAGGCCTGAATACTGTGGAGTATTTTACTTCCCAACAAGTCACAG 
GAACATCCTCTCTTGAAAAGAATACAATACCACCAGGGGTCACAGGACTA 
CTAACCAATGCTGCAGAGGCAAAGATCCAAGAGTCAACTAACCATCAGA 
AGGGCTCAGTTGGTGGGGGTGCAAAACCAAAGAAAOOGCGACCAAAAAT 
TGCCATTGTGCCAGCAGATGACAAAACAGTGCCOGGAAAGCCGATCCCAA 
ACCCTCTATTAGGTCTGGAITCCACCCCGAGCACCCAAACTGTGCTTGATC 
TAAGTGGGAAAAC,ITTACCATCAGGATCCTATAAGGGGGTTAAGCTTGCG 
AAATTnGGAAAAGAAAATCTGATllACACGGTTCATCGAGGAACCCAGGG 
AGAATCCTATCGCAACCAGTrICCCCATIGATTTTAAGAGGGGCAGGGAT 
ACCGGCGGGTTCCATAGAAGGGAGTACTCAATIGGATGGGTGGGAGATG 
AAGTCAAGGTCACTGAG~TGCAATCCATCCTGTTCTCCAATCACCGCT 
GCAGCAAGGCGATTTGAATGCACTTGTCACCAGTGTCCAGTCACTTGCTCT 
GAATCTGAACGAGATACTTAA 
b) 
G 
MDPIDLSFSPDEINKLIETGLNTVEYFTSQQVTGTSSLEKNTIPPGVTGLLTNA 
AEAKIQESTNHQKGSVGGGAKPKKPRPKIAIVPADDKTVPGKPIPNPLLGLDS 
I S 
TPSTQTVLDLSGKTLPSGSYKG~GKENL~PRENPLATSFPll)F 
KRGRDTGGFHRREYSIGWVGDEVKVTEWCNPSCSPITAAARRFECTCHQCPV 
TCSESERDTZ 
Figure 26: 
a) The sequence of the V specific cDNA which was cloned into pUCl19. The 
differences from the published sequence of the W3A strain of SV5 (Paterson et al., 
1984) are underlined. 
b) The predicted sequence of the peptide product of 26a) with those sequences that 
are different to the W3A V protein sequence, highlighted and the W3A residue 
indicated above. 
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2.1.5 Transient Expression of V 
As a precaution to ensure that the cloned V gene could code for V protein, the gene 
was subcloned from pUC119 into pG.~M 3fz+, a transient expression vector. By 
expressing the gene in a transient expression system, the ability of the cloned gene to 
encode a protein product which was antigenic and of the correct moleCular weight could be 
rapidly determined. The polycloning site in pOEM vectors places the gene of interest under 
the control of the bacteriophage T7 promoter. The inserted gene can be expressed in 
mammalian cells if the transfected cells are also expressing bacteriophage T7 polymerase. 
This polymerase can be provided by a simultaneous infection with a vaccinia T7 
recombinant virus (Fuerst et al., 1986). 
TIle transfection of the pOEM 3fz+ V was carried out using lipofectin. The 
infection and transfection were carried out as described in materials and methods. 18 hours 
after transfection the cells were harvested into Ix disruption buffer, sonicated and 
subjected to SDS PAGE. Following electrophoresis, the proteins were transferred to 
nitrocellulose membrane by electroblotting and the V protein detected using a specific 
antibody. Figure 27 shows the products expressed from BF and 293 cells. This result 
shows that a product was expressed which was of the same molecular weight as V and able 
to react specifically with an anti-V antibody. 
2.1.6 Stable expression of V in BF and 293 cells 
Having ensured the integrity of the cloned V gene, the insert was subcloned into 
pREP8 for stable expression in BF cells. This construct was termed pREP8 V. The pREP8 
V construct was transfected into BF and 293 cell cultures by electroporation. The 
successful transformants were selected for by supplementing the medium with histidinol, a 
potent and reversible inhibitor of protein synthesis in mammalian cells. The action of 
histidinol can be abrogated by histidinol dehydrogenase, encoded for by the pREP8 
plasmid, which oxidises histidinol to histidine. The colonies that grew were ring cloned 
and expanded. Eight clones of each cell type were tested for expression of the V protein by 
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1 2 3 4 5 6 Lane: 
~-
l-untransfected BF cells 
2-untransfected 293 cells 
3-293 cells infected with SVS 
4-293 cells tranfected with pGEM 3fz+ V 
S-BF cells infected with SVS 
6-BF cells transfected with pGEM 3fz+ V 
Figure 27: An autoradiogram of a Western blot showing the expression of V from 
SVS infected cells and recombinant V from the transient expression vector, pGEM 
3fz+. Lanes 1 and 2 are negative controls ofuntransfected cells (BF and 293 cells 
respectively). Lane 3 shows 293 cells infected with SVS, lane 4 shows 293 cells 
transfected with pGEM3fz+ V. Lane 5 shows BF cells infected with SV5 and lane 6 
shows BF cells transfected with pGEM3fz+ V. 
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Figure 28: Analysis by peR of transfected BF cell clones. The PCR was carried out 
using primers specific for the PN gene of SV5. which had been used in the original 
construction of the V clone. Lanes 1 and 10 show molecular weight markers of 
Lambda phage DNA. restricted with the enzymes HindllI and EcoRI. Lanes 2 to 7 
show the PeR products amplified from DNA extracts of the BF cell clones. Lane 8 is 
a negative control using untransfected cell extract as a template. and lane 9 is a 
positive control using the pREP8 V plasmid as a template. The position of the full 
length PN gene is marked a). b) marks the position of the smaller molecular weight 
bands. 
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immune precipitation of V from the transfected cells followed by Western blotting of the 
immune precipitate. None of the clones was found to express V (results not shown). 
2.1.7 PCR or DNA within the transrected cells 
To ensure that the clones did contain the input plasmid. cell extracts were prepared 
from each of the BF clones and used as template in a PCR amplification with the primers 
that were used to construct the V specific cDNA. A positive control reaction was 
established using some of the pREP8 V plasmid, which had been used to transfect the 
cells. The PCR products were analysed on a 1 % agarose gel (figure 28). This analysis 
showed that a number of clones did contain V specific DNA of the correct molecular 
weight. However. in each of the clones. but not the control plasmid DNA. there were 
additional smaller DNA bands. The presence of V specific bands of a smaller molecular 
weight than the full length gene suggested that parts of the insert had been deleted in some 
copies of the plasmid. 
2.1.8 Conclusion 
Because the attempt to attain a clone of BF cells or 293 cells which were 
expressing V was unsuccessful. it was not possible to test the effects of this protein on SV5 
infection in either a permissive or non-permissive cell line. However, the V gene has 
recently been expressed in cells using an alternative expression system and it is hoped that 
these types of experiments can soon be carried out. 
2.2 THE ROLE OF INTERFERON DURING SVS INFECTION OF BF CELLS 
Interferon can be released by cells following virus infection, sometimes resulting in 
the inhibition of the virus infectious cycle. Interferon has previously been implicated in the 
establishment and maintenance of persistent infections. with several cases documented in 
murine cell lines. Often in the infections in which interferon has been shown to have a 
limiting effect. it was found that the virus was able to enter the cells and to initiate virus 
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synIbesia ia • manner simjlar &0 • permissive infection. In these studies, it was only after 
ICYCft.I boars Ihat diffen:nca berweeD the ratriaed and permissive infections became 
appueoI. correWing with the production and accumulation of interferon. The SV5 
infection pattern of BF cells shares many features with those systems in which interferon 
has been found to playa role. The virus was able to enter the cell and direct its own 
transcription and polypeptide synthesis until between 24 and 36 hours post infection. It was 
also able to release virus (albeit at low levels) suggesting that there was not an absolute 
impediment to virus assembly which is causing a reduction of virus synthesis. 
Furthermore, the BF cells are fibroblast cells which would be expected to release interferon 
fi, upon induction. In light of these observations and the well documented role of interferon 
in infections of murine cell lines, it was of interest to investigate whether interferon might 
playa part during SV5 infection of BF cells. 
2.2.1 Release of interferon by infected BF cells 
The levels of interferon activity in a sample of medium can be measured using a 
biological assay. These assays utilise the anti-viral effect of the interferon to protect a 
normally susceptible cell line from virus induced lysis. To investigate whether infection of 
BF cells with SV5 could induce interferon release, BF cells were infected with SV5 at three 
different multiplicities of infection; 50, 10 and 2 pfo/cell. Medium was collected from these 
cells at 24 hours post infection and assayed for interferon activity by comparison with a 
sample of interferon of known activity (IFXA; kindly provided by Ian Kerr). In this assay 
method, L929 cells were incubated with doubling dilutions of either the IFXA, or 
supernatant collected from the infected BF cell cultures. Following a 24 hour incubation 
period, the interferon and BF cell supernatant were removed and replaced with 
Encephalomyocarditis (EMC) virus. The cells and EMC virus were incubated for a further 
36 to 48 hours by which time those cells which were not protected by the antiviral activity 
of interferon were destroyed by EMC virus induced lysis. The cell monolayers were 
vigorously washed to remove lysed cells and cell debris, and the remaining cells, which 
had survived the infection, were fixed and stained with crystal violet. Controls of IFXA 
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Figure 19: Assay showing the levels of antiviral activity present in supernatants 
collected from BF cell cultures. Columns 1 and 2 are control wells. Column 1 shows 
L929 cells which did not receive EMC virus. Column 2 is a control of L929 cells 
which were infected with EMC virus in the absence of interferon containing medium. 
Columns 3 to 12 are doubling dilutions of either interferon or medium collected from 
infected BF cells. Row A shows doubling dilutions of an interferon of known 
concentration (lFXA). The concentrations of interferon activity in these dilutions are 
indicated above each well. Rows B to D are doubling dilutions of samples of medium 
isolated from BF cells which had been infected with SV5 at moi's of 50, 10 and 2 pfu 
respectively. These wells were infected with EMC virus, and so show the levels of 
antiviral activity in each of the samples. Rows E to G were incubated with the same 
BF medium that is described for B to D (respectively). These wells did not receive 
any EMC virus and demonstrate that any cytolytic effects that were observed in the 
assay were wholly due to EMC virus and not to SV5. Following 36 hours of infection 
with EMC virus, the wells were washed, and the surviving cells fixed and then 
stained with crystal violet solution. 
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without EMC ~irus, EMC virus without interferon and BF medium without EMC virus (to 
ensure that SV5 did not contribute to cell mortality in any way) were also included in the 
assay. The results of the assay are shown in figure 29. 
Interferon activity was readily detected in the supernatants of infected BF cultures; 
the levels of interferon activity in each sample of culture fluid is shown in table 4. 
BF supernatant Interferon activity 
medium from cells infected at 50 pfu/ceU 400U/ml 
medium from cells infected at 10 pfu/cell 200U/ml 
medium from cells infected at 2 pfu/cell 12.5U/ml 
Table 4: Table showing the levels of interferon activity released from SV5 infected BF 
cells. 
These results show that the levels of interferon that were released from the infected BF 
cells, were dependent on the multiplicity of infection with which the cells had been 
infected with SV5. Cells infected at a higher multiplicity of infection had a greater 
concentration of interferon activity present in the supernatant at 24 hours p.i., than cells 
infected at a lower multiplicity. In the persistent infections of BF cells. described in part I 
of the results section. the cells were infected with SV5 at a moi of 5 to 10 pfu/cell. The 
assay described above shows that at this moi, easily detectable levels of interferon are 
released from the cells. This finding supports the possibility that interferon may be 
involved in the onset of viral persistence in this cell line. 
2.2.2 Effects of exogenous interferon on SVS synthesis in BF cell cultures 
Even though it was found that infected BF cells were able to release interferon, it 
may not have had an effect on the course of infection. The effects of interferon are 
complex and endogenously produced interferon can have different effects on different viral 
infections. To try to show whether interferon might have a restrictive effect on SV5 
replication, BF cells were treated with interferon prior to SV5 infection. Addition of 
interferon before a virus infection. primes the cells to initiate the antiviral response much 
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Figure 30: Autoradiograms showing a timecourse of SV5 protein synthesis in BF 
cells infected with SV5 either in the presence or absence of interferon. Cells were 
incubated with either 12.5U/ml or l00U/ml ofIFXA (as indicated) for 24 hours prior 
to SV5 infection. Following infection, the cells were incubated with fresh medium 
containing the same concentrations of interferon until either 12, 24 or 36 hours p.i. (as 
indicated above each well). At these times, the cells were pulsed with [35S] 
methionine/cysteine after which total antigen extracts were prepared and the viral 
proteins purified using a pool ofMAbs against NP, PN, M, F and HN. 30a) shows 
the levels of viral protein synthesis in each sample, whilst figure 30b) shows the 
levels of total cellular protein synthesis in the same samples. Comparison of the levels 
of total cellular synthesis in each sample shows that approximately equivalent levels 
of labelled proteins are isolated from each set of reaction conditions. 
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more rapidly than untreated cells once the viral infection is underway. Thus, in this 
experiment, it was anticipated that if interferon had any effect on SV5 synthesis in BF 
cells, these effects might be seen ahead of the synthesis decrease normally observed 
between 12 and 36 hours pj .. To see if this was the case, a timecourse of viral protein 
synthesis was carried out on interferon treated cells, and control cell cultures which did not 
receive interferon. 
BF cell cultures were treated with two different concentrations of interferon 
(chosen on the basis of the previous assay) from 24 hours prior to infection. Following 
virus infection, the cells were maintained in interferon until either 12,24 or 36 hours pj. 
after which time the monolayers were pulsed with [35S] methionine for 2 hours. Virus 
polypeptides were then isolated by immune precipitation as previously described and 
subjected to SDS-PAGE (Figure 30a). To ensure that the cells in each culture were labelled 
to the same extent (to allow comparisons of the different conditions), the total cell protein 
samples from each flask were also subjected to electrophoresis (figure 30b). 
Viral protein synthesis was clearly affected by the addition of exogenous interferon. 
In the control cultures to which no interferon were added, there were significant levels of 
virus protein synthesis at 12 hours pj. although by 24 hours these had reduced. In contrast, 
in the cultures that received interferon 24 hours before being infected, viral protein 
synthesis was barely detectable even at 12 hours pj., particularly in the cultures that had 
received the higher concentration of interferon. The variances between each culture could 
not be accounted for by a corresponding variance in the total protein synthesis. Therefore it 
seems plausible that interferon can have an effect on SV5 protein synthesis in BF cells, and 
may be involved in the onset of persistence in this cell line. 
2.2.3 Effects of exogeous interferon on EMC virus infection of HeLa cells 
Having speculated that the inhibitory effects of interferon might be responsible for 
the onset of SV5 persistence in BF cells, it was interesting to know whether induction of 
the antiviral state in a permissive cell line could similarly instigate a persistent SV5 
infection. This possibility was investigated by incubating a permissive cell line with 
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Figure 31: An assay showing the effect of interferon pretreatment on EMC virus infection 
of HeLa cells. Cells were either treated with IFXA at 200U/ml, but did not receive EMC 
virus, incubated with IFXA at 200U/ml for 24 hours prior to EMC virus infection or did 
not receive IFXA prior to infection with EMC virus. At 48 hours pj. the wells were 
washed and the live cells stained with crystal violet. 
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interferon prior. to infection with SV5. The intefferon that was available (IFXA), was a 
recombinant human/mouse hybrid interferon, so the cells used in this study were HeLa 
cells, a human cell line. Initially it was not known if the hybrid interferon would be potent 
to HeLa cells, so an experiment was carried out to determine whether this interferon could 
protect the cells from cytolysis by EMC virus (to which it was known HeLa cells are 
susceptible). 
Monolayers of HeLa cells were incubated with IFXA at 200 Vlml for 24 hours. 
After this time, the medium was removed and replaced with EMC virus at a multiplicity of 
10 pfu/cell. Control wells in which the cells received interferon but no virus, or virus but 
no interferon were also set up. The cells were incubated with virus for a further 24-36 
hours, then washed and stained with crystal violet. Those cells which had survived the 
infection remained intact and so were stained. The results of this assay are shown in figure 
31. Those cells which received virus alone were lysed completely by 36 hours p.i. whereas 
those which had been incubated with interferon prior to infection remained intact showing 
that the HeLa cells were responsive. to the -interferon and that the resulting antiviral effect 
was able to subven the EMC virus infection. 
2.2.4 Can interferon induce the formation of inclusions in HeLa cells? 
Having shown that HeLa cells were able to respond to the recombinant interferon, 
the effect of interferon treatment on SV5 infection was investigated. Immunofluorescence 
studies were carried out on control cells that did not receive interferon and cells that had 
received interferon at a concentration of 200Vlml from 24 hours prior to SV5 infection. 
The infected cells were maintained in interferon containing medium until 4 days pj .. At 
this time, the coverslips were fixed and the cells probed for P and F (figure 32). By this 
stage in SV 5 infection of BF cells, the persistent state was evident, characterised by a 
number of cells positive for P but not F, with P tending to be visualised in cytoplasmic 
aggregates in these cells. There was no evidence for a similar state being generated by 
interferon treatment in HeLa cells; there was no difference in those cells which had 
received interferon and those that had not (compare figures 32 b and c). There was a very 
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Figure 32: Immunofluorescence analysis of HeLa cells treated with interferon prior 
to infection with SV5. 5a) shows uninfected control cultures of He La cells. 5b) shows 
cells which were incubated with 200U/ml of interferon for 24 hours prior to and for 4 
days following infection with SV5. 5c) shows HeLa cells, which did not receive any 
interferon treatment, at 4 days pj .. Each coverslip of cells was fixed and stained with 
MAb specific for the F protein, using indirect immunofluorescence, before being 
counterstained with a mixture of FITC conjugated MAbs specific for the P protein. 
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Figure 33: Autoradiogram showing the effect of interferon pretreatment on SV 5 
protein synthesis in infected HeLa cells. Cells were incubated with 200U/ml of 
interferon either from 24 hours prior to infection or immediately following incubation 
with SV5. At 24 hours pj., the interferon containing medium was removed and the 
cells were incubated for 2 hours with, medium containing [35S] methionine/cysteine. 
Similarly parallel cultures of cells which did not receive an interferon pretreatment 
were infected with virus and labelled (lanes 1 and 4 marked -IFN). Lanes 4 to 6 show 
the levels of SV5 protein synthesis, whilst lanes 1 to 3 show the corresponding levels 
of total cellular protein synthesis, to illustrate that equivalent levels of labelled protein 
have been isolated from each set of reaction conditions. 
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2.2.5 Effects of interferon on SV 5 protein synthesis in HeLa cells 
Although the immunofluorescence data would suggest that, in HeLa cells interferon 
does not result in the fonnation of inclusions, similar to those found in BF cells, it does not 
show whether the preincubation step with interferon had any effect on viral protein 
synthesis. To investigate whether the presence of interferon affected protein synthesis in 
HeLa cells. in a manner similar to the situation observed in BF cells, a study of SV5 
protein synthesis was carried out Cells were incubated with interferon at 200U/ml either 
from 24 hours before infection or immediately following infection. The virus infection was 
allowed to proceed for 24 hours, after which the levels of viral protein synthesis were 
examined as described previously. The results are shown in figure 33. This analysis 
showed clearly that at 24 hours p.L, there was no difference in the levels of viral protein 
synthesis between the interferon treated cells and the untreated control cultures. 
Thus, surprisingly, interferon had no discernible affect on SV5 replication in HeLa 
cells, even though it was able to protect the cells from EMC virus infection. Unfortunately, 
because interferon was impotent on SV5 protein synthesis in HeLa cells, it was not 
possible to use IFN find out if a halt in viral protein synthesis in a permissive cell line 
would lead to a situation similar to that seen in SV5 infected BF cells. 
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DISCUSSION 
As described in the introduction to this thesis, although a number of ways have 
been described for RNA viruses to avoid the host immune response, these explanations 
may not cover all cases of Paramyxovirus P,ersistence. The main thesis to come from this 
work is a model which could explain how Paramyxoviruses are able to persist. The model 
suggests that a persistently infected population of cells need not harbour virus in a uniform 
manner. The model suggests that under certain conditions, a Paramyxovirus may be able to 
reside in cells in a transcriptionally inert state. This state of quiescence is characterised by 
the formation of inclusion bodies which consist of aggregates of inactive nucleocapsids. 
The inactive state may not be a dead-end predicament for the virus, but instead, it is 
possible that the nucleocapsids can resume functionality to initiate a further round of viral 
infection. It is proposed that when transcriptionally inactive, the virus may be able to avoid 
detection by the immune response, but when active, progeny virus could be released which 
infect neighbouring cells. By being able to flux back and fro between activity and 
inactivity. it is possible that the infection could be maintained in a tissue. 
1bere are four sections in this discussion. Firstly, the model described above will 
be accounted for, with reference to the results presented in this thesis. Secondly, the results 
concerning V and interferon will be considered. Thirdly, the model will be discussed in 
terms of persistent infections in vivo; the factors which may influence the establishment of 
this model of persistence,. the implications that the model has for immune surveillance and 
for the disease state. Finally future work which could be carried out, will be outlined. 
1 A MODEL FOR PARAMYXOVIRUS PERSISTENCE 
1.1 Can the virus exist in a transcriptionally inactive state? 
The crux of this thesis is the proposal that SV5 has the ability to reside in BF cells 
without maintaining virus transcription. From an analysis of the rates of viral protein 
synthesis, and of the levels of viral mRNA present in the persistently infected cell 
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population, it i~ apparent that within the population of persistently infected cells, 
transcription was only continuing at a reduced rate as compared to that observed in a 
productive viral infection. The decreased levels of transcription could have been because of 
a generalised reduction of viral transcription throughout the infected cell population. 
However, immunofluorescence studies of persistently infected BF cells, showed that 
throughout persistence, the state of the virus ;Varied from cell to cell. This fmding 
suggested the possibility that rather than there being a universal decrease in transcription in 
each infected cell, there were differences in ,virus activity from cell to cell. If this was the 
case then it might be expected that in the cells in which the virus proteins P, NP and L 
could be detected as inclusions, there would be no ongoing virus activity. In those cells in 
which all the viral proteins could be detected, the virus would be or recently would have 
been active. 
There are two pieces of evidence to suggest that in some cells the virus is 
completely (or almost completely) inactive. The cell cloning experiment demonstrated that 
in persistently infected BF cells, cell division was occurring more rapidly than virus 
spread. It would be expected that if the virus was at all active in a cell, when that cell 
divided, the infection would have been passed on to each daughter cell. Therefore, this 
result suggests that in some cells there was very little or no ongoing SV5 transcription. It 
could be argued that virus transcription was ongoing in all infected BF cells but that in 
some, the virus infection was compartmentalised Within the cytosol. In such cells, the viral 
nucleocapsids may only segregate into one daughter cell. This is possible. There is some 
evidence to suggest that during Paramyxovirus infections, nucleocapsids can be localised 
to dicrete sites within the cell cytoplasm and also that the infection can be polar within the 
cell (Dotti and Simons, 1990). However, coupled with other evidence, discussed below, it 
seems likely that in a number of persistently infected cells, the virus was indeed inactive. 
The most compelling piece of evidence to suggest that the virus was inactive in the 
cells which contain inclusions, is that in these cells, NP, P and L were readily detected, but 
M, F and HN were not. Most evidence concerning Paramyxovirus transcription suggests 
that there is a single promoter site which lies at the 3' end of the genome. If the single 
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prQmoter theory is CQrrect, then fQr L to. have been present in the cells with inclusiQns 
because Qf de novo synthesis, it would be expected that each Qf the preceding genes WQuid 
also.Pe expressed, as the L gene lies proximal to the 5' end Qf the genQme. It appears that 
M, F and HN were nQt expressed. The pulse chase analysis Qf lIN shQwed this protein to 
be fairly stable in BF cells. TherefQre, if transcriptiQn Qf all Qf the viral genes was QngQing 
in these cells, it WQuid be expected that HN WQuld have accumulated so that it was visible 
by immunofluQrescence micrOSCQPY. It could be argued that M. HN and F were being 
synthesized in the cells with inclusiQns but that their epitQpes were hidden. HQwever. in the 
persistently infected cells, M could Qnly be barely detected, even by Western blQt analysis 
in which a denatured epitope was being recognised. Furthermore, both M and lIN were 
almost undetectable in the persistently infected cells using dQt blQt analysis. in which these 
proteins were detected using a pool Qf MAbs. It may be possible that P, NP and L were 
being transcribed independently Qf M. lIN and F. but fQr this to. happen. a separate 
promoter for the L gene would be required. There is no evidence to date to. suggest that 
there could be an internal promoter specific for the L gene in any Qf the ParamyxQviridae 
Qr Rhabdoviridae genQmes. 
1.2 The inclusions may consist of stable aggregates of nucleocapsids 
WithQut having carried Qut in situ hybridisatiQn or electrQn microscopy analysis. it 
is nQt possible to. knQW if the inclusiQns seen in BF cells consist Qf nucleocapsids or were 
simply aggregates Qf protein. However. evidence WQuid suggest that at least SQme Qf the 
inclusiQns contained genome RNA. NQrthern blot analysis shQwed that levels of genQmic 
RNA were as high in the persistently infected BF cells as in initial stages Qf infectiQn. The 
levels Qf genQmic RNA were sustained in the persistently infected cells. despite the fact 
that transcriptiQn and protein synthesis were Qnly ongQing at reduced levels. Curran et al. 
(1991) have shQwn that de novo NP synthesis is essential to. maintain viral replicatiQn. As 
very little NP was actually being synthesized in the persistently infected BF cells. the bulk 
Qf the genomic RNA that eQuId be detected in these cells must have survived frQm a stage 
when transcriptiQn and protein synthesis were in progress. GenQmic RNA is always fQund 
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in an encapsidated form. Naked RNA would be liable to rapid degradation and it is known 
that one function of NP is to protect the RNA from nucleases which are abundant in the 
cytosol of the cell. Thus, it would be expected that any genomic RNA that was surviving in 
cells for 5 days would be encased in NP. As much of the NP that could be detected at 5 
days p.i. was found in the inclusions, it seems likely that at least some of the inclusions 
were harbouring genomic RNA. Finding that P and L also co-localised with NP in the 
inclusions, suggests that the inclusions may have been comprised of inactive 
nucleocapsids. 
It is curious that the M protein, which is known to be able to bind to nucleocapsids, 
was never found associated with the inclusion body structures. This is not because its 
epitope was being obscured within an inclusion, because Western blot analysis showed that 
there was little M present in the cell population at 5 days p.i.. This fmding would suggest 
that the inclusions are selectively comprised of the proteins NP, P and L, .and might 
suggest that these proteins have a specific propensity for aggregation. In this respect it is 
interesting to note that when P and NP of either RS virus, Rabies virus or SV 5 are 
artificially co-expresssed in mammalian cells, they form inclusions (Garcia et al., 1993; 
Chenik et al., 1994; Young, unpublished observations). It is plausible that nucleocapsids 
have a specific facility to form aggregates but that this tendency is inhibited during a 
productive infection, possibly because the nucleocapsids are engaged in transcription and 
replication, or are being exported to the cell surface. 
1.3 Was the virus active in some cells? 
In the persistently infected cell population, there was some evidence of virus 
activity. There was ongoing protein synthesis and virus release at 5 days pj., and when 
cloned cells,were co-cultivated with Vero cells, infectious virus rapidly spread through the 
Vero cell population. The immunofluorescence microscopy suggested that the virus was 
active in a small proportion of the cell in the population. It was possible to detect F in a 
few cells using immunofluorescence microscopy. From pulse chase and dot blot analysis, it 
was found that F is unstable in BF cells. For F to present in some cells in the population, 
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either it would Jlave to have been recently synthesized, or the cell population would have to 
be heterogeneous in its proteolytic activities. This latter possibility is unlikely, especially 
as the BF cells were originally derived from a cloned cell line. 
1.4 Reactivation from transcriptional quiescence 
The data discussed above suggests that persistently infected BF cells cannot be 
considered as a uniform population of infected cells. Instead, it appears that in this system 
the persistently infected cell culture is consistently comprised of at least two types of 
infected cells: those in which the virus is active~ possibly 100% active; those in which the 
virus is completely. or almost completely, transcriptionally quiescent. The fact that in the 
persistently infected cell population the virus was never found in a uniform state suggested 
three possibilities. Firstly, that following infection the virus had rapidly mutated so that a 
variety of genomes were present in the persistently infected population, some restricted, 
others productive. Secondly, that the BF cell population was heterogeneous such that each 
cell varied in its ability to support SV5 infection. Finally. that the persisting virus was able 
to flux between an inactive and an active state. These different scenarios are discussed 
below. 
Variation due to mutation of the virus genome can be considered in two ways. It 
could be that the wild type genome mutates and becomes defunct. This genome may then 
be unable to generate viral transcripts. Given that levels of virus transcription decreased by 
24 to 48 hours p.i., this scenario is unlikely. Alternatively, it may be that the wild type 
infection would normally proceed towards quiescence but mutation of some viral genomes 
enables them to avoid this outcome. If SV5 genomes were able to mutate to overcome the 
quiescent state and become active, then it would be expected that the variant viruses would 
overtake the population and infect each cell. On cloning of the infected BF cells, it would 
be expected that some clones would be obtained in which 100% of the population was 
infected. This did not happen. In addition, if the virus could mutate to overcome the 
inactive state then it would be anticipated that it would be possible to isolate virus which 
could yield a productive infection in BF cells. However, many attempts have been made to 
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adapt SV5 to replicate in BF cells, each of these attempts has failed (Young et ai., 
unpublished observations). 
An alternative to infection variation being due to virus mutation, is the possibility 
that the BF cell line was heterogeneous. The BF cell line that was used in these 
experiments was derived from a single clone. Therefore, it would be expected that the cell 
population would be homogeneous. Furthermore, following cloning of the SV5 infected 
cells, it was found that in the clones which showed evidence of viral infection, the 
infection state again varied from cell to cell. It would be expected that if the state of virus 
infection was dependent on the genetics of the host cell, a variety of clones would have 
been obtained. In those clones in which the original cell supported virus infection, all the 
cells would have been infected (or would have died). In clones in which the virus was 
inactive, only one cell would have been infected. The fact that this did not happen argues 
against the variety of the infection state being due to heterogeneity of the host cells. 
It is known from the results presented in this thesis, that active nucleocapsids 
became quiescent over time. It is possible that these inactive nucleocapsids were able to 
"reactivate" to initiate a fresh round of virus synthesis, giving rise to each of the viral 
proteins. In this scenario, it is envisaged that the state of the virus during persistent 
infection of BF cells was not static but instead fluxed between the two states of quiescence 
and activity. As previously discussed, the dormant aspect of virus persistence was 
characterised by the presence of inclusions of NP, P and L. The possibility that the 
inclusions were comprised of viral nucleocapsids has already been considered. The fact 
that the inclusions were sited in the cytoplasm of the cell, the normal location for SV5 
transcription and replication, suggests that if the inclusions did contain nucleocapsids then 
the virus had the potential to reinitiate transcription and replication. 
The arguments against the diversity of the persistent infection being due to either 
virus mutation or genetic variation of the BF cells strongly implies that in these cells, a 
persistent infection can become established in which the virus infection alternates between 
states of activity and quiescence. However, to unequivocally demonstrate that the infection 
can flux, it would be necessary to attain a uniform population of infected cells, in which 
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the virus was qpiescent, and then to show that following passage, these cells give rise to a 
varied population of infected cells. Unfortunately, this has not yet been achieved in the 
BF/SV5 system. 
1.5 Could the model be established under different conditions? 
There is evidence to suggest that the model described in this thesis is not restricted 
to SV5 infection of BF cells. Work has been carried out in this laboratory in which it was 
found that a similar situation occurred in Veto cells, a nonnally pennissive cell line. In this 
case, the persistent SV5 infection was established involving defective interfering particles. 
Examination of the persistently infected cells using immunofluorescence microscopy 
demonstrated that a number of cells were positive only for NP and P (the presence of L 
was not examined). In the cells which-were positive for NP and P only, these proteins were 
found to be aggregated into cytoplasmic inclusions in a similar fashion to that seen in BF 
cells. Little or no virus was released by the persistently infected Vero cells although, with 
difficulty. it was possible to recover infectious virus by co-cultivating the persistently 
infected Vera cells with uninfected Vero cells. It was found that if the persistently infected 
Vero cells were cloned, some clones were obtained in which not all the cells were infected 
(Fearns et m., 1994). This situation is similar to that observed during SV5 infection of BF 
cells and suggests that the virus was not actively replicating in all cells all of the time, 
otherwise it would be expected that all daughter cells would have been infected. 
2 POTENTIAL FACTORS AFFECTING THE ESTABLISHMENT OF 
PERSISTENCE IN THE SVSIBF SYSTEM 
When SV5 infects BF cells, there is a sharp reduction in virus transcription at a 
relatively early stage stage of infection. It seems likely that a specific mechanism is in 
force in these cells which induces transcriptional quiescence. Two factors which could 
potentially stem transcription were examined in this study. An attempt was made to 
examine the role of V protein, with a view to assessing the possibility that the virus itself 
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might induce t1!e persistent state. Interferon was investigated as a cellular component 
which might influence virus transcription. In addition, the effect of interleron on an SV5 
infection of HeLa was examined, with the aim of trying to recreate the persistence model 
in a normally pennissive cell line. 
2.1 Could V induce persistence? 
... .. , ... 
~. " .. 
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To be able to remain in a host, inaccessible to the immune system, while continuing 
replication may offer a virus an evolutionary advantage. It might be anticipated that viruses 
have evolved particular features which promote persistence. As yet, no specific mechanism 
to enable establishment of persistence has yet been identified in Paramyxoviruses. 
However. the virus may have more subtle properties which will predispose towards 
persistence. In this thesis, it has been suggested that the NP and P proteins of 
Paramyxoviruses may have a inclination towards aggregation. Aggregation of P and NP 
could be considered as a fundamental charateristic of the virus which. under circumstances 
which prevent virus replication. will instead allow the virus to become persistent. 
Given that many aspects of the replicative cycle of Paramyxoviruses are not fully 
understood, it is interesting to speculate that the virus may have a more specific means to 
promote persistence. Potential candidates for such a role are the V and C proteins which 
are encoded for by some Paramyxoviruses. These proteins are known to be non-essential 
for Sendai virus replication, yet are able to participate in transcription and replication. 
Because these proteins share the same amino acid sequences at their N-termini. but not C-
termini. and because P is known to be an integral part of the polymerase, it is thought that 
V is able to compete with P and to disrupt its function. In this respect. it has been found 
that V is able to inhibit replication (Curran et al .• 1991). In the study describe in this thesis, 
it was found that whereas P was stable throughout the infection. the level of detectable V 
protein disappeared almost immediately following the decrease in protein synthesis. This 
result suggested that V was either being degraded in the BF cells. or was being modified; 
the epitope recognised by the antibody against V is immediately followed by a serine 
residue. It is possible that this residue was being phosphorylated in the BF cells, 
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accounting for the disappearance of V. It. was thought that if V inhibits replication of the 
SV5 genome, then if it was being degraded or modified in BF cells, the level of V 
available to carry out this function may have been decre~!ng, leading to an imbalance 
between transcription and replication and resulting in transcriptional quiescence. 
It was thought that whether the V protein was being degraded or modified, 
supplying V using an artificial expresssion system might alter the course of infection in BF 
cells and also may induce persistence in a permissive cell line. Because of technical 
difficulties in achieving stable expression of V, attempts to rescue the virus from 
persistence by supplying V protein from a recombinant vector were unsuccessful. There 
are a number of possible explanations as to why it was not possible to attain stable 
expression of V in mammalian cells. A potentially significant factor may be the orientation 
of the V transcriptional cassette. Young and co-workers (1988) have reported that in their 
experience of using Epstein-Barr virus replicons, the level of expression of the foreign 
gene was highly dependent on whether it was in the same transcriptional orientation as the 
EBNA-1 gene. IT these two genes were in opposite orientations it was found that there was 
almost no expression of the cloned gene compared to very high levels of expression if the 
two transcriptional units were in the same orientation. In the pREP8 vector, the RSV 
promoter (the promoter under which the V gene was cloned) directs transcription in the 
opposite direction to that of the EBNA-1 gene, possibly explaining why there was no 
detectable expression of V. 
Another potential flaw in this expression system, is the use of the Rous Sarcoma 
virus (RSV) promoter element in conjunction with the SV40 polyadenylation sequence. It 
has been shown that levels of expression from the major immediate early (IE) promoter of 
cytomegalovirus (CMV), are greater if the accompanying termination sequences are also 
from the CMV IE gene and also that these levels of expression are 20 fold stronger than the 
RSV / SV 40 combination in a transient expression system (Wilkinson and Akrigg, 1992). 
This result would however be highly dependent on the cell type transfected. In the study 
cited, HeLa cells were used which might not be analogous to mouse fibroblast cells. 
155 
A third possible reason for failure to detect V, lies with the protein itself. As 
discus~ V seems to be either degraded or modified in BF cells. If it was not being 
synthesised at a sufficiently high rate, it might not accumulate to large enough quantities to 
enable detection on a Western blot. However, in the Western blot analysis carried out to try 
to detect V, any V that was present was first concentrated by immune precipitation. The 
protein would have to be synthesised at a much reduced rate compared to viral infection to 
remain undetectable by this means. 
Each of these factors may not be significant enough in isolation to explain why it 
was not possible achieve stable expression of V in 293 and BF cells. However a 
combination of two or more of the above possibilities could reduce the efficiency of 
expression from pREPS to an undetectable level. It is known that the plasmid-was being 
maintained in the transfected cells as the cells were surviving in histidinol and some 
complete V specific cDNA could be amplified from the clones by PCR. I.t was also shown 
that the cloned V gene was complete and was able to be expressed in a transient expression 
system. The fault must almost certainly lie with the efficiency of expression from pREPS, 
why this should be a problem is not known. 
So far in this thesis, it has been suggested that the relative stabilities of P and V 
could be implicated in persistence, however, it may be that the results presented here are 
true of a normal acute infection. If this is the case, the data concerning the relative 
stabilities of P and V suggest a simplistic control mechanism for regulating the relative 
levels of transcription and replication during a productive infection. Because the prevailing 
evidence would suggest that in the Paramyxovirus genome there is only one promoter site 
for transcription, it is thought that there is no means for the virus to have temporal control 
of its different processes; transcription, replication, assembly and release. However, the 
relative P and V stabilities may permit a biochemical temporal control strategy. Evidence 
would suggest that pseudo-templated transcription is a phenomenon highly dependent on 
the cis acting sequences of the genome (Park and Krystal, 1992). This evidence suggests 
that the relative rates of synthesis of the P and V mRNAs will be consistent throughout an 
infection. Indeed, Kawano and coworkers (1993) have shown that the ratio of P:V mRNA 
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transcripts is 1:5 at both 24 and 40 hours pj .. Therefore, given that apart from the presence 
or absence of the additional G residues within the transcript, the two transcripts are the 
same, with the same cap structures and polyadenylated tails of equal lengths. Hence, it 
would be expected that the relative rates of P and V proteins synthesis are consistent 
throughout infection (this notion was supported by the results of this thesis). It has 
previously been found that V protein is synthesized in a five-fold excess to P in SV5 
infected cells (Precious, unpublished data). But the results described in this thesis would 
suggest that V is less stable then P, also instability of mumps virus V has recently been 
observed in another cell line (Bu et a/., 1993). Therefore, the following scenario might be 
expected. The V protein is synthesized in excess of P and in the initial stages of infection, 
is the predominant of these two proteins in the population. However, as V is degraded 
more rapidly than P, as the infection progresses, the levels of P increase relative to V. In 
terms of transcription and replication, P is necessary for both processes, qut V inhibits 
replication. So in the early stages of infection, high levels of V may favour transcription 
rather than replication. This may be desirable in order to generate sufficient amount of NP 
for replication to take place. Then in the later stages of infection, as the V levels fall 
relative to P, replication will be permitted to take place in order to synthesize new 
genomes. As more is learned about Paramyxovirus transcription and replication, it is 
becoming apparent that these viruses are more complex than the size of their genomes 
might suggest. It is interesting to speculate that these viruses may have subtle control 
mechanisms which coordinate transcription and replication which may, under certain 
conditions, also propel the virus into persistence. 
2.2 Interferon 
In this study, it was found that SV5 was able to establish an immediate persistent 
infection in BF cells, but not in other cell lines; Vero, BHK or HeLa cells. This finding 
suggested that a host-related factor may have been influencing the onset of persistence in 
the BF cells. Interferon is one host cell factor which has been shown to be involved in the 
onset of Paramyxovirus persistence and was considered a possible factor in the situation 
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described here .• The cells used in this study were fibroblast cells. Fibroblasts are known to 
be able to release interferon 13 following virus infection. Furthermore, the pattern of SV5 
restriction observed in this study corresponded closely with previously published work in 
which it was found that IFN was "involved in restricting virus infection. In these studies 
(Nagai et m .. 1981; Yamada et ai., 1984; Hanada et ai., 1986), it was found that viral 
infection progressed "normally" for the first day of infection, viral proteins were 
synthesized and infectious virus was released. Then, once interferon had accumulated, 
levels of virus protein synthesis decreased dramatically, and the infection was restricted. 
The similarity of this pattern of infection with the situation observed during SV5 infection 
of BF cells, suggested that IFN might playa role in the establishment of persistence in this 
cell line. 
BF cells were assayed for their capacity to release IFN. It was found that the cells 
did release interferon following virus infection, with the levels of release being related to 
the multiplicity with which the cells were infected. To determine whether interferon could 
have an effect on SV5 gene expression in BF cells. the cells were preincubated with 
interferon and assayed for virus protein synthesis at various times post infection. By this 
method, it was found that exogenous interferon was able to restrict SV5 protein synthesis 
in BF cells. To defmitively determine whether interferon was influencing the onset of 
persistence in this cell line, an anti-interferon serum was required. However, the fmding 
that BF cells do release interferon following virus infection and that exogenous interferon 
is able to restrict virus protein synthesis in BF cells suggests that interferon is a good 
candidate as the instigator of persistence in this cell line. 
If interferon was playing a role in establishing persistence in BF cells, is it possible 
that this factor could be causing fluctuation between the two states? There is evidence to 
suggest that the effects of interferon may also be cyclical. In one study, in which it was 
found that interferon is able to limit the infection cycle of RS virus it was found that the 
titre of interferon reached a peak at 1 day pj .• but then decreased until 4 days pj., 
thereafter, it increased again. Measurement of virus yield demonstrated a relationship 
between the levels of interferon and virus release, with virus titres being restricted betwen 
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2 and 3 days p.i., but then increasing between 3·and 5 days pj., presumably because the 
. '. 
" 
restrictions imposed by interferon were diminished at this time (Hanada et aI., 1986). It 
would be envisaged that the sequence of events is as follows: following infection, the virus 
induces the release of interferon. As the interferon accumulates, it inhibits virus synthesis. 
Once virus synthesis has ceased, interferon will not be induced and so its levels will 
decline. Once interferon levels have dropped, the virus will no longer be restricted and will 
be able to reinitiate a further round of infection, again inducing the release of interferon. If 
virus persistence was induced by interferon, then it is improbable that interferon release 
would be synchronised beween different cells. Thus it might be expected that a diverse, 
dynamic population of infected cells could become established in which the virus 
fluctuates between activity and quiescence. 
1be effects of interferon on HeLa cells were investigated in the hope that a 
persistent infection similar to the one observed in BF cells could be established. It this had 
been achieved, it may then have ~n possible to have a control over the persistent 
infection. Unfortunately, it was found that although the HeLa cells were responsive to the 
interferon (they were protected from infection by EMC virus), the interferon response did 
not have any discernible effect on SV5 infection in this cell line. SV5 protein synthesis in 
IFN treated HeLa cells was similar to that in untreated cells, and immunofluorescence 
analysis demonstrates that the distribution of viral proteins was unchanged by interferon. 
In light of the results from the BF cells, the finding that interferon was impotent on SV5 
infection in HeLa cells was surprising. This result shows that interferon can affect different 
cells in different ways and may suggest that it is possible that in some cell lines, the virus 
is able to overcome an interferon response. 
3 IMPLICATIONS OF THE MODEL DURING IN VIVO INFECTION 
3.1 Could the model be established by other factors known to influence persistence? 
In BF cells, a decrease in the transcriptional activity of the virus preceded the 
fonnation of inclusions. This order of events would suggest that if a viral infection is 
inhibited at a transcriptional level, it may be possible for the redundant nucleocapsids to 
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aggregate together to fonn inclusions. As discussed, it may be that Paramyxovirus 
nucleocapsids have a propensity towards aggregation which is overcome during an active 
viral infection. 'f!tere are a number of factors which have been shown to be able to 
influence virus gene expression and to invoke persistent infections, for example, cell cycle, 
interferon and antibodies. It is possible that by decreasing levels of virus transcription, any 
of these factors could induce the formation of inclusions of nucleocapsids similar to the 
situation described in SV5 infected BF cells. Furthermore, as the actions of each of these 
factors is reversible, it might be imagined that if they were involved, a state of flux could 
arise. The possibility that the effects of interferon are cyclical has already been discussed. 
In infections in which cell cycle can playa role, virus transcription is inhibited while the 
cell is resting, but can then reinitiate when the cell re-enters the cell cycle (Joseph et ai., 
1975; Ehrnst, 1979). Similarly, in infections in which antibodies are able to modulate virus 
transcription, once the antibodies are removed, virus activity is restored (fujinami and 
Oldstone, 1980; Levine and Griffin, 1992; Schneider-Schaulies et ai., 1992). It is possible 
that occasionally, nucleocapsids are released from the inclusions. If the restraint on virus 
transcription was alleviated at that time, then it may be possible for the virus polymerase to 
become active again. 
It could also be envisaged that the model described in this thesis could also apply to 
persistent infections which arise due to inefficient packaging and release of the virus. In 
these situations, it may be that because they not being efficiently exported, nucleocapsids 
accumulate in the cell. If nucleocapsids do have a propensity for aggregation, as is 
suggested in this thesis, then it may be that they would then form inclusions. Even if the 
nucleocapsids were active prior to aggregation, it is possible that once ensconsed in an 
inclusion, virus transcription would be inhibited. The polymerase may be hindered and 
host cell components necessary for polymerase activity, excluded. Again, if nucleocapsids 
were occasionally released from the inclusions, they may be able to reinitiate virus 
replication. This scenario could explain persistent infections in which the virus continues 
to evolve in the host with the generation of mutant viruses. 
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3.2 A voidance of the host immune response 
One of the problems faced in understanding persistence in vivo, is to explain how 
the virus evades clearance by the host immune response. Cell mediated immune responses 
playa critical role during recovery from a Paramyxovirus infection (Randall, 1993). The 
cell mediated immune response is able to recognise a range of viral epitopes, including 
some on proteins of the polymerase complex (Oldstone, 1991). Because of the range and 
sensitivity of the cell mediated immune response, it is difficult to understand how a virus 
could be maintained in a host without being eradicated. Often when persistent infections 
are considered, escape from the immune response is explained by the suggestion that virus 
expression is altered. It is suggested that by expressing surface glycoproteins at low levels, 
humoral attack is avoided. By reducing all viral transcription, the numbers of viral 
molecules available for presentation to T cells are decreased. However, given the range and 
sensitivity of the cell mediated immune response, it is difficult to understfUld how a virus 
could be maintained by continued transcription and replication, without being eradicated. 
In the introduction to this thesis, a number of situations were described which 
explain how a virus could subvert the effects of the immune system and so, avoid 
clearance. The model that is described in this thesis may provide an alternative approach to 
the consideration of persistence. In this scenario, the virus does not avoid clearance by 
impairing the immune response but instead is able to enter a state of transcriptional 
inactivity in which it is maintained as aggregates of nucleocapsids. In the nucleocapsid 
containing cells, the viral glycoproteins are not detectable, which implies that these cells 
should not act as targets for antibody and complement mediated lysis. Furthermore, if the 
inclusion bodies are relatively stable to proteolytic degradation and no ongoing protein 
synthesis occurs, then such cells might not be recognised by virus specific CfLs, as the 
results presented here suggest. Given that the CIL response is far more sensitive than the 
humoral immune response, these cells should avoid clearance by either arm of the specific 
immune system. 
In the BF celV SV5 system described here, it was found that by 3 days pj., a 
number of cells containing virus in inclusions only, had arisen. In vivo, it has been shown 
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that it takes se~eral days for the cell mediated response to become fully established in 
response to viral infection (reviewed in Vainionpaa et aI., 1989). It is possible that during 
the initial stages of infection, in which elLs maybe ab~nt or present in only limited 
numbers in infected tissues, the virus infection would have an opportunity to establish 
persistence in some cells. The virus might only have to be able to survive in a very small 
number of cells in order to be able to persisL Once installed as aggregates of inactive 
nucleocapsids, the virus may be able to remain in a cell for extended periods of time; 
weeks, months or even possibly years. 
3.3 Can the model be applied to chronic disease? 
Olronic diseases due to persisting viruses pose a conundrum. How is it that the 
virus could be active enough to cause damage to the cells or to release progeny, yet remain 
hidden from the host immune response? The model that is described in this thesis could 
explain chronic disease. During SV 5 persistence o~ BF cells, it appears that the virus exists 
in the two different states at any given time. If this situation was to occur in vivo, then it 
may be possible for virus to be synthesized and released almost continually, even in the 
face of an active immune response. The cells in which the virus is present in inclusions 
will not be recognised as infected by the immune response. However, progeny virus could 
be released from the cells in which the virus was active. These cells would be targets for 
the immune response. As long as at any given time there are some cells in which the virus 
is in inclusions, then these cells can act as virus reservoirs. This scenario may explain 
infections in which it appears that infected individuals are able to release infectious virus 
for longer periods than normal. An example of such an infection comes from a study at an 
Antarctic research station in which it was found that in a closed population of individuals, · 
there were two outbreaks of parainfluenza infection over an eight month period. The 
investigators concluded that the most likely explanation for this phenomenon was that the 
virus was persisting in a productive fashion in one or more of the individuals at the station 
(Muchmore et al., 1981). 
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There are other types of persistent infections in which the infection culminates as 
chronic disease. It is possible that a virus is able to reside in a host, fluctuating between 
activity and quiescence. In this way, the virus may be able to avoid the immune response, 
but still cause a pathologic effect. It may even be that the pathology observed during 
persistent infections is due to fluxing of the infection state. Such flux may cause a 
continual low grade immune attack on th~ tissue, which materialises as a chronic disease. 
There have been a number of reports on chronic diseases, such as SSPE and Paget's bone 
disease, in which the virus could be detected as aggregates of nucleocapsids (Haase et aI, 
1981; Mills et al., 1981; Robbins, 1983; Basle et al., 1985; Robbins and Eagle, 1985). This 
evidence may imply that the model that is proposed in this thesis, is existent in known 
persistent Paramyxovirus infections. 
4. FUTURE STUDIES 
As described, there is some circumstantial evidence to suggest that the model 
proposed in this thesis can exist in vivo. It is known that persisting viruses are able to 
maintained in a host in a manner in which they are able to replicate, with examples of virus 
shedding (Muchmore et al., 1981) and evidence that it is possible to isolate intact virus 
from tissue, exemplified by the virus strain that was used throughout this study, which was 
isolated from human bone marrow (Goswami et al., 1984). In addition to the data which 
suggests the maintenance of the virus genome and ongoing virus replication, is the 
evidence that inclusion bodies are frequently observed during persistent infections. 
However, despite these observations, there is no firm confrrmation to show that the model 
described in this thesis has any relevance for persistent infections in vivo. Further evidence 
is required to validate this model. Epidemiological studies are required to in order to know 
if persistence can occur in situations that cannot be explained by tolerance or the MHC 
haplotype of an individual, if this is the case then the necessity for a model becomes 
greater. A suitable animal model is required to investigate the possibility that this scenario 
can occur in vivo . 
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Further .experiments could be carried out to characterise the model further. The 
drawback of the SV5/BF cell system as it stands, is that it is not possible to synchronise the 
infection and the persistently infected cell population is always diverse. For this reason, it 
is not possible to determine the stability of the inclusions or to categorically demonstrate 
their content or functionality. Currently efforts are ongoing in this laboratory to mimic the 
persistent state using artificially expressed viral proteins. Mammalian expression systems 
are a fast growing area of research with advances in the possibility of controlling levels of 
expression of foreign genes. Since the work described in this thesis was carried out, a more 
successful expression system has become available to this laboratory. This expression 
system utilises the control elements of the tetracycline resistance operon of E. coli. The 
main advantage of this system is that it is sensitive to varying concentrations of 
tetracycline and so the gene of interest can be expressed not only when desired, but also to 
varying degrees (Gossen amd Bujard, 1992). It is hoped that by using this system, the 
properties of the inclusion bodies and so the persistent state can be analysed with greater 
accuracy. 
As suggested in this thesis, it is possible that Paramyxoviruses have a specific 
mechanism to promote persistence. Until recently. molecular analysis of negative strand 
RNA viruses has been hampered because of the lack of a means to carry out genetic 
manipulation of the virus genomes. However in a number of laboratories, "reverse 
genetics" systems are now being developed in which the aim is the creation of infectious 
cDNA copies of negative strand viruses. A full length infectious cDNA clone of rabies 
virus has recently been reported (Schnell et al., 1994) and it is expected that infectious 
cDNA clones of Paramyxoviruses will soon become available. Such artificially created 
viruses should provide a tool with which the intricacies of the Paramyxovirus replicative 
cycle can be further investigated and with which it may be possible to determine if 
Paramyxoviruses have a subtle means which sometimes enables them to enter a persistent 
state. 
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